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Abstract 
Addressing the quantitation problem of contrast enhancing MRI compounds based on 
gadolinium (III) and manganese (II), the production of suitable radionuclides as well as 
activation and the authentic radiolabelling of MR contrast agents were examined. 
The existing cross section data of the natEu(d,x)147,149Gd and natEu(p,x)147,149Gd reactions 
were expanded up to 70.9 MeV and 44.8 MeV, respectively. The integral production rates of 
the natEu(d,x)147Gd and natEu(p,x)147Gd reactions were 177.3 ± 19.7 and 43.3 ± 4.4 MBq/µAh 
while the integral production rates of the natEu(d,x)149Gd and natEu(p,x)149Gd reactions 
amounted to 81.6 ± 8.5 and 61.8 ± 4.9 MBq/µAh, respectively. The formation of longer-lived 
radioisotopic impurities (146,151,153Gd) was below 7 %, but the use of enriched Eu target 
material was found to be necessary for a radionuclidically pure production of either 147Gd or 
149Gd. Since the production rates are higher than for the earlier proposed irradiation of highly 
enriched 144,147Sm with α- or 3He-particles, Eu is an interesting alternative for the production 
of 147,149Gd. 
In addition to the measurement of nuclear data, a new radiochemical separation of the bulk 
target material Eu and n.c.a. *Gd based on an extraction of Eu into Na-Hg amalgam was 
successfully developed. In a proof of principle synthesis, the obtained *Gd was complexed 
with the ligand DOTA and an adequate stability of the complex confirmed over 6 d in Human 
Blood Serum (HBS). In a comparison by in and ex vivo MR and autoradiographic 
measurements of the commercial Gd-DOTA complex, DOTArem™, and the synthesised 
radioactive complex on tumour bearing rats a rather similar accumulation in the tumour 
tissue and surrounding striatum was found. 
Furthermore, production yields of the proton induced nuclear reactions on natCr leading to 
52gMn, 52mMn and 51Cr were measured in the energy range from 8.2 to 16.9 MeV and satur-
ation thick target yields calculated as 2.6 ± 0.3, 7.0 ± 0.6 and 1.5 ± 0.2 GBq/µA, respectively. 
A new chromatographic separation method was developed which yielded 99.5 % of pure 
52gMn in 2 mL of 3M hydrochloric acid solution. Thereby, n.c.a. 52gMn can be provided more 
efficiently for the isotopic labelling of MR contrast agents. The radioactive nanoparticle 
precursor Mn(acac)2 was synthesised with a radiochemical yield of 73.9 ± 5.0 %. 
Additionally, activation studies with protons and neutrons were performed with commercially 
available water-dispersible Mn3O4 nanoparticles. The activated nanoparticles were 
characterised with DLS and TEM. No change between the initial and irradiated nanoparticles 
was found with neutron activation. A broader size distribution and the scattered appearance 
of bigger crystals were observed in the proton irradiated samples caused by partial melting 
and recrystallization of the samples during irradiation. Leaching experiments of the neutron 
activated particles in H2O and PBS resulted in 0.033 ± 0.005 % of released Mn after a 15h 
incubation time indicating a high stability of the compound.  

Kurzzusammenfassung 
Zur Quantifizierung von Kontrastmitteln mittels PET oder SPECT wurden die Produktion 
sowie die nuklearchemischen Eigenschaften von Radionukliden für eine authentische 
Markierung von Gadolinium (III) und Mangan (II) basierten MRT-Kontrastmitteln untersucht. 
Dazu wurden Wirkungsquerschnitte der natEu(d,x)147,149Gd und natEu(p,x)147,149Gd 
Kernreaktionen mit Projektilenergien bis zu 70,9 MeV bzw. 44,8 MeV gemessen. Die 
integralen Ausbeuten der natEu(d,x)147Gd und natEu(p,x)147Gd Kernreaktionen über den 
gemessenen Energiebereich wurden entsprechend zu 177,3 ± 19,7  MBq/µAh und 
43,3 ± 4,4 MBq/µAh bestimmt. Für die Reaktionen natEu(d,x)149Gd und natEu(p,x)149Gd 
konnten integrale Ausbeuten von 81,6 ± 8,5 MBq/µAh bzw. 61,8 ± 4,9 MBq/µAh berechnet 
werden. Die Bildung der langlebigen Verunreinigungen 146,151,153Gd lag dabei bei ca. 7 %, 
was die Nutzung von angereichertem Eu für eine radionuklidreine Herstellung von 147Gd oder 
149Gd notwendig macht. Die deutlich höheren Ausbeuten im Vergleich zur Nutzung von 
144,147Sm als Targetmaterial sprechen dennoch für die Verwendung von Eu.  
Ferner wurde eine Trennung von Eu und n.c.a. *Gd entwickelt, die auf der Extraktion des 
Targetmaterials Eu in ein Na-Hg Amalgam beruhte. Das so isolierte *Gd wurde mit dem 
Liganden DOTA komplexiert und die Stabilität in Humanserum (HBS) über 6 d nach-
gewiesen. Beim Vergleich des radioaktiven und kommerziellen Gd-DOTA-Komplexes bei in 
und ex vivo Messungen von tumortragenden Ratten mittels MRT bzw. Autoradiographie 
wurde eine Anreicherung im Tumorgewebe und dem umgebenden Striatum gefunden. 
Zur Herstellung von 52gMn, 52mMn und dem Nebenprodukt 51Cr wurden die Produktions-
ausbeuten der entsprechenden natCr(p,xn)-Kernreaktionen in einem Energiebereich von 8,2 
bis 16,9 MeV gemessen und die Ausbeuten im Sättigungsbereich zu jeweils 2,6 ± 0,3, 
7,0 ± 0,6 und 1,53 ± 0,15 GBq/µA berechnet. Es wurde eine neue chromatographische 
Trennung von Cr und Mn entwickelt, welche zu einer Elution von 99,5 % 52gMn in 2,1 mL 3M 
HCl führte. Damit ist 52gMn nun für die Markierung von Magnetoradiopharmaka wesentlich 
einfacher verfügbar. Bei der Synthese des Nanopartikel-Vorläufers Mn(acac)2 mit dem so 
isolierten 52gMn konnte eine radiochemische Ausbeute von 73,9 ± 5,0 % erreicht werden. 
Weiterhin wurden kommerzielle Mn3O4 Nanopartikel mit Neutronen und Protonen aktiviert 
und mit DLS und TEM charakterisiert. Bei der Aktivierung mit Neutronen wurden keinerlei 
Änderungen beobachtet, während bei Protonen-aktivierten Nanopartikeln eine breitere 
Größenverteilung und vereinzelte größere Kristalle beobachtet wurden. Dies konnte durch 
teilweises Schmelzen und eine anschließende Rekristallisation während der Bestrahlung 
erklärt werden. Die Neutronenaktivierungsstudie an kommerziellen Mn3O4-Nanopartikeln 
ermöglichte zudem die Ermittlung des freien Mangans nach Inkubation in H2O und PBS. 
Nach einer Inkubationszeit von 15 h wurden nur 0.033 ± 0.005 % des insgesamt ein-
gesetzten Mn Inventars in Lösung vorgefunden, was eine hohe Stabilität in Lösung anzeigt.  
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1. Introduction 
1. Introduction 
1.1 Radioactivity and its use in life science 
Radioactivity is defined as a property of unstable isotopes to undergo a stochastic and 
spontaneous nuclear transformation towards a more stable isotope under the emission of 
ionizing radiation such as α-particles, β-particles, γ-rays or Auger-electrons.[1] Unstable 
nuclei, also called radionuclides, can be classified as proton or neutron deficient, depending 
on an excess of neutrons or protons present in the nucleus. 
Since the discovery of this radioactivity in 1896 by Henri Becquerel and the isolation of 
radium in 1898 by Marie Curie, many applications for radioactive isotopes were developed in 
a multitude of areas. Radionuclides are applied in five fields of life sciences: ecology, 
physiology and metabolism, diagnosis, therapy, and elemental analysis.[2] Besides the study 
of the interactions among organisms ecology comprises also the investigation of the 
environmental uptake of abiotic compounds such as trace elements or radionuclides by 
plants, animals and humans. In physiological and metabolic studies, the reactions and 
biochemical processes of elements and compounds in the living world are assessed. The 
identification and localisation of diseases with imaging methods is the content of diagnosis, 
while therapy is the treatment of the diseases found. Elemental analysis comprises the 
assessment of compounds and trace elements in the living world. 
High amounts of radioactivity are needed for any therapeutic application, while for the 
analysis of chemical elements activation, mainly by neutrons, is of high importance. The 
radiotracer method, on the other hand, finds application in all fields of life sciences. The 
principle of this radiotracer method was defined, applied and thus founded by George de 
Hevesy and Friedrich Adolf Paneth as early as 1923[3]. These radiotracers are chemical 
compounds in which one or more atoms are replaced with a radioactive isotope. This 
enables the exploration of mechanisms by tracing the way of the radioisotope. The 
advantage over non-radioactive methods is the high measurement sensitivity enabling the 
determination of concentrations in the range of 10-12 mol. Therefore, the investigated system 
is not influenced by mass action of an excess of analytic material. 
At first, only few radioisotopes were available, mainly produced by the isolation from the 
primordial decay chains such as 212Pb which was used by de Hevesy and Paneth[3] in their 
research of lead uptake and distribution in plants. Since the development of the cyclotron in 
1930 by Ernest O. Lawrence[4], radiochemistry entered a new era with a wide spectrum of 
new accessible radionuclides. In addition to the production facilities, the detection capabilities 
of radioactivity also evolved. Starting with simple photo plates and films, going to scintillation 
 
1 
 
1. Introduction 
or semiconductor detectors, today’s tomographic methods like single photon emission 
computed tomography (SPECT) or positron emission tomography (PET) were developed. 
Both methods utilise the radioactive decay of specific radionuclides for non-invasive imaging 
of their distribution within a body. In combination with radiotracers, which are selective for a 
specific biological process, they are the foundation of modern nuclear medicine. However, 
PET as well as SPECT depicts the distribution of radioactive tracers in the body with no 
information about their chemical form and only limited morphologic information. While the 
more pronounced problem of the chemical form has to be solved by complex bio-
mathematical models and additional metabolism studies, the use of complimentary imaging 
methods like computed tomography (CT) or magnetic resonance imaging (MRI) can often be 
needed or advantageous to address the limited morphological information of PET and 
SPECT. 
In this study, the production parameters and separation procedures of radioactive isotopes of 
gadolinium and manganese were investigated. Both elements are most promising for the 
development of bi-modal probe concepts based on the isotopic labelling of MRI contrast 
agents. 
 
1.2 Magnetic resonance imaging (MRI) 
MRI is a non-invasive medical imaging method which yields a high morphologic resolution 
without exposing the patient to potentially harmful ionising radiation.[5] Like nuclear magnetic 
resonance spectroscopy (NMR-spectroscopy), it is based on the observation of nuclear core 
spins in a magnetic field.[5-10] One of the first experiments was already conducted in 1973 
showing the applicability of magnetic resonance for in vivo imaging.[11] 
Starting from one and two dimensional NMR spectroscopy in vivo, three-dimensional imaging 
rapidly evolved in the last 40 years to a diagnostic standard tool in clinical routine and 
research to solve biochemical as well as medical questions.[7] Additionally, no damage to 
DNA or other functional cell components in patients by the magnetic field or the excitation 
radiofrequency pulses was noticed until now as long as the basic safety regulations were 
observed.[12-15] This is one of the big advantages over other in vivo imaging methods like 
computed tomography (CT) which needs intense use of X-rays and therefore induces high 
radiation dose rates. But the measurement times of MRI are longer[10], and the availability of 
clinical scanners is still lower than for CT. Beside the pure morphological MR imaging the 
possibility to measure body functions such as blood flow, tissue perfusion[16] etc. was 
developed in the last two decades using functional MRI (fMRI).[17] Some fMRI methods are 
only possible with suitable contrast agents[5] which lead to a positive or negative 
enhancement of the imaging contrast what will be explained in detail below. 
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The combination of multiple imaging methods to acquire complementary data in a shorter 
time period would be the next logical development step to broaden the utility of imaging 
techniques even further and enhance the diagnostic efficiency. Therefore, the basic 
principles of each imaging technique have to be understood. 
 
1.2.1 Principle 
The basic principle of both NMR and MRI is the property of random arranged nuclear spins 
of nuclear cores to align themselves parallel or anti parallel to the direction of an applied 
magnetic field.[5] The coupling between the magnetic field and the spins thereby induced, 
known as Zeeman interaction[18], results in an energy gap with the parallel aligned spins 
being lower in energy than anti parallel aligned spins. The energy gap between both states is 
directly correlated to the strength of the magnetic field as expressed by the Larmor 
equation 1[5]: 
𝜔𝜔0 = 𝐵𝐵0𝛾𝛾2𝜋𝜋  
with ω0: Larmor frequency in MHz, 
 B0: magnetic field strength in Tesla (T), 
 γ: gyromagnetic ratio in s-1 T-1. 
According to the Boltzmann equation[19], more spins are distributed in the lower than the 
higher energy level and therefore aligned parallel to the magnetic field. This leads to a net 
magnetization, M0, of the material, also parallel to the magnetic field direction. If an 
alternating magnetic field, B1, is applied perpendicularly to the static magnetic field B0, the 
spins can switch their alignment and hence, the net magnetisation changes. However, only 
at the alternation frequency, known as resonance frequency, with the specific energy of the 
energy gap between both states, a transition between the two states is possible. The energy 
difference is proportional to the frequency ω0 as described by equation 2[5]: 
Δ𝐸𝐸 = ℎ𝜔𝜔02𝜋𝜋  
with ℎ: Plank’s constant, 6.626∙10-34 J s. 
Applying the definition of ω0 from equation 1 leads to: 
Δ𝐸𝐸 = ℎ𝛾𝛾𝐵𝐵04𝜋𝜋2  
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Once the radiofrequency pulse (RF) is stopped, the spins turn back to their equilibrium state, 
this mechanism being known as relaxation. This relaxation has to be stimulated because the 
small energy difference of the excited and steady state allows no spontaneous relaxation. 
The rate of relaxation depends therefore on the strength of the spin-lattice interaction 
(longitudinal relaxation, T1) and spin-spin interaction (transversal relaxation, T2). The 
previously absorbed energy is re-emitted in this process with the frequency ω0 and measured 
as a voltage using a detector coil. The recorded signal is better known as free induction 
decay (FID). The resulting amplitude of the emitted frequency ω0 is correlated with the 
density of excited spins or nuclear cores present. Therefore, the number of spins and thus 
the amount of targeted atoms (e.g. 1H, 23Na, 31P) can be measured in a sample non-
invasively and non-destructively. 
In addition to the information about the amount of atoms present, the knowledge of their 
spatial distribution is necessary for the generation of two- or three-dimensional images in 
MRI. Therefore, alternating magnetic fields are additionally applied in between the RF 
irradiation with the Larmor frequency[5] to generate a gradient in the static magnetic field. The 
Larmor frequency needed for excitation of spins is now slightly different throughout the 
measured sample due to the magnetic gradient. In depth explanation of the exact frequency 
pulse sequences needed for the spatial encoding, e. g. Single Spin Echo, Inversion 
Recovery or Spoiled Gradient Echo, and reconstruction of images is not within the scope of 
this work but can be found in the literature.[5] Briefly, defined small volumes (voxels) are 
obtained with these methods by the encoding of the three spatial dimensions. The voxels can 
be selectively excited and measured to be reconstructed into an image of the scanned 
spatial distribution of the spin density of a targeted atom. The targeted atom nuclei in MRI 
are usually the 1H protons. The density of protons in different tissues is quit unique leading to 
the high spatial resolution of MRI in the tens of micrometre range.[20] 
 
1.2.2  Contrast enhancement 
Although the morphological contrast originating from the 1H protons in MRI is often sufficient 
for diagnosis, in some cases more differentiation or contrast between different tissue types or 
areas is required. An increased contrast can be achieved by the injection of a contrast agent 
which alters the signal intensity of the 1H protons in its vicinity. Contrast enhancement 
induced by an injected agent may be explained based upon the Bloch equation 4[21], which 
describes the nuclear magnetization for a two-energy-level system: 
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𝑑𝑑 𝑀𝑀��⃗
𝑑𝑑𝑑𝑑
= 𝛾𝛾𝑀𝑀��⃗ ∙ 𝐻𝐻�⃗ 𝑎𝑎 − 𝑒𝑒𝑥𝑥 𝑀𝑀𝑥𝑥𝑇𝑇2∗ − 𝑒𝑒𝑦𝑦 𝑀𝑀𝑦𝑦𝑇𝑇2∗ − 𝑒𝑒𝑧𝑧 𝑀𝑀𝑧𝑧 −𝑀𝑀0𝑇𝑇1  
with 𝑀𝑀��⃗ : magnetisation of material, 
 𝐻𝐻�⃗ 𝑎𝑎: magnetic field, 
 𝑒𝑒𝑥𝑥/𝑦𝑦/𝑧𝑧: unit vector in x, y and z direction, 
 Mx/y/z: partial magnetization in x, y and z direction, 
 T2*: maximum transversal relaxation time, 
 T1: longitudinal relaxation time. 
T1 (also called spin-lattice relaxation time) and T2 (also called spin-spin relaxation time) are 
time constants that describe the relaxation of the excited nucleus, i.e. how the macroscopic 
magnetization returns to its equilibrium state. The displayed T2* in eq. 4 is a broader constant 
which includes static magnetic field effects in addition to T2. When the above differential is 
derived under the conditions of a standard MRI sequence like Spin Echo, the corresponding 
signal intensity (ISE) is given by equation 5[5]: 
𝐼𝐼𝑆𝑆𝑆𝑆 = 𝑁𝑁𝐻𝐻 ∙ 𝐾𝐾′ ∙ 𝑒𝑒− 𝑇𝑇𝐸𝐸𝑇𝑇2 ∙ 1 − 2𝑒𝑒− �𝑇𝑇𝑅𝑅− 𝑇𝑇𝐸𝐸2 �𝑇𝑇1 + 𝑒𝑒−𝑇𝑇𝑅𝑅𝑇𝑇1  
with 𝑁𝑁𝐻𝐻: number of hydrogen atoms per volume unit, 
 𝐾𝐾′: constant depending on extrinsic parameters, 
 𝑇𝑇𝑆𝑆: echo time between excitation pulse and echo maximum in ms, 
 𝑇𝑇𝑅𝑅: repetition time between successive RF excitation pulses in ms. 
While NH and K’ are constants, TE and TR are experimental parameters that can be modified 
by the operator. As shown by equation 4, the signal intensity can be modulated by shortening 
the longitudinal and/or transversal relaxation times: This is precisely how a MR contrast 
agent acts. Depending on the relaxation time that is reduced to a greater extend, contrast 
agents are divided into T1 or T2 agents. T1 contrast agents, for instance, are generally based 
upon paramagnetic ions like gadolinium, Gd(III). Due to its high magnetic moment as well as 
its slow electronic relaxation time, the Gd(III) ion is able to interact with the excited water 
protons in its vicinity, thus accelerating their spin-lattice relaxation and therefore the signal 
intensity (equation 4). As a consequence, T1 agents generate a bright spot on an MR image 
and are called positive contrast agents. 
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T2 relaxation agents, on the other hand, are mainly based upon iron oxide, which can show a 
super paramagnetic effect and induce a large magnetic susceptibility. This distorts the local 
magnetic field around the iron and leads to a faster dephasing of the nuclear spins in close 
proximity, therefore a shorter T2 and hence a signal loss in T2 weighted images. By this 
means, a dark spot is generated on the MR image obtained with such negative contrast 
agents. The weight of each individual term of equation 5 is directly correlated to the echo 
time (TE) and repetition time (TR) chosen by the operator. Therefore, T1 or T2 weighted 
images can be obtained depending on which effect has to be maximised. 
 
1.2.3 Contrast agents 
As mentioned above, compounds based on paramagnetic ions like gadolinium (III) or 
manganese (II)/(III) as well as super-paramagnetic iron oxide nanoparticles are in the main 
focus of current research or already in clinical routine use.[22] Since free gadolinium ions are 
highly toxic, their in vivo use is only possible if they are encapsulated in highly stable 
coordinated complexes. Two famous examples of clinical approved contrast agents for MRI 
are Gd-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (Gd-DOTA) [DOTArem®, 
Guerbet, France] and Gd-diethylenetriaminepentaacetatic acid (Gd-DTPA) [Magnevist® , 
Bayer Healthcare, Germany]. Both complexes possess very high thermodynamic stability 
constants (>1020) as well as a high kinetic inertness which avoids transmetallation reactions 
with endogenous cations. But even with such high complexation rates, complications are 
possible, like the rare syndrome of nephrogenic systemic fibrosis (NSF) in patients with 
kidney insufficiency. NSF was only observed with gadodiamide[23, 24], a previously FDA 
approved gadolinium contrast agent. Despite these possible serious side effects, gadolinium 
based contrast agents are still the almost exclusively used agents so far. 
The only FDA approved manganese(II) contrast agent is the manganese chelate N,N´-
dipyridoxal ethylenediamine-N,N´-diacetate 5,5´bisphosphate (Mn-DPDP) [Teslascan®, 
Takeda Pharmaceutical, Japan]. It should be noted that manganese(II) ions are often used in 
animal studies due to their sensitivity to a number of biological processes[25] which enables 
functional imaging in Manganese Enhanced MRI (MEMRI)[26] (see chapter 1.5.1). Several 
superparamagnetic iron oxide (SPIO) contrast agents were also approved and used in 
clinics, but only GastroMARK® [AMAG Pharmaceuticals, United States] and Lumirem® 
[Guerbet, France], an oral gastrointestinal imaging agent, are still in production. 
Unfortunately, most available contrast agents are highly unspecific. Extensive research is 
underway to develop new agents with explicit targeting moieties, also utilizing 
nanotechnology, to strengthen the contrast enhancing features even further.[27-33] Although a 
lot of research is going on in this field, and the scientific output is high, nearly none of the 
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newly developed contrast agents have been even taken to phase Ι clinical trials. A way to 
achieve this might be the use of PET and SPECT in combination with MRI and CT leading to 
multi-modal imaging. 
 
1.3 Emission tomography 
Positron-Emission Tomography (PET) and Single-Photon-Emission Computer Tomography 
(SPECT) are non-invasive medical imaging methods enabled by the radiotracer method 
described in chapter 1.1. They are used for in vivo research studies and diagnostics showing 
the distribution behaviour of radioactive molecules within a body.[2] The use of radiotracers in 
this field is still increasing due to the extremely low concentrations of radiotracers necessary 
which do not disturb the biological system in any kind.[34] 
In PET, the annihilation of a positron of a β+-emitting radionuclide, like 18F (half-life: 
109.8 min), is used to locate the place of the annihilation in a body. After its emission the 
positron travels a short distance ranging from 1 mm to up to several mm, depending on its 
energy and the interacting matter, until it is nearly at rest. The positron can now interact with 
an electron in the surrounding matter producing a highly unstable atom-like state: The 
positronium.[35] The spins of these combined positrons and electrons can be aligned parallel 
or anti-parallel termed as the ortho- or para -positronium. The ortho-positronium cannot be 
used in PET due to the emission of an uneven photon number in the annihilation process 
caused by the Lorentz invariance. Additionally, its life time is with 142 ns 103 times longer 
than that of the para-positronium and therewith the possibility of an annihilation negligible 
small.[36] The para-positronium annihilates after an average lifetime of 0.125 ns and emits two 
photons with energies of 511 keV each.[36] If the starting positron was completely 
thermalized, the photons are emitted in a 180° angle. Due to the weak interaction of γ-rays 
with matter, the emitted γ-rays will penetrate the whole body and can be measured externally 
with a suitable detector. The detectors consist usually of scintillation crystals coupled to 
photomultiplier tubes. These are generally arranged in the geometrical form of a ring around 
the body in current positron-emission tomographs (see Figure 1). Several other 
configurations were used earlier, but they show a significantly poorer coincident detection 
(<30%) which promoted the use of the full-ring configuration.[37] An event of decay is counted 
as coincident if both photons of the annihilation process hit the opposing γ-ray detectors 
within a time window of 6-12 ns[37]. Thus, if scattering and attenuation of the detected 
photons is neglected, each measured annihilation event must have occurred in a straight line 
between the two opposing detectors. 
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Due to the radial emission of radioactivity, the origin of the decay can be determined by 
superimposition of the straight decay lines produced by multiple decays in the same area. 
This basic principle of analytical image reconstruction is used in the filtered back-projection 
depicted in Figure 2.[38] 
 
Figure 1: Annihilation process and γ-ray detector assembly of a PET, adapted from 
Maus.[39 ]  
 
 
Figure 2: Example for reconstruction by superimposit ion of straight decay tubes 
between γ-detectors; adapted from Henkin et al. [38] .  
In a real two- or three-dimensional image, the scattering and attenuation cannot be neglected 
and have to be corrected to achieve a quantitative distribution image of the measured 
radionuclides. The correction can be done by independently measuring the scattering and 
attenuation with a body circling radioactive transmission source directly before or after the 
PET measurement, or by obtaining the attenuation and scattering map with CT. The result of 
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additional computation with this data is the two- or three-dimensional image of the 
quantitative distribution of the radionuclide with a resolution of approx. 5 mm with a clinical 
PET scanner.[40]  
An additional interpretation of the obtained radionuclidic distribution is necessary for the 
determination of the kinetic behaviour of a compound. Therefore, a bio-mathematical model 
based on differential equations is required, describing the velocity constants of a radioactive 
compound changing between different spatial and/or biochemical compartments in the body, 
e.g. blood, intra- and extracellular space.[41] If one biochemical parameter, e.g. the 
abundance of the radionuclide in the blood, is measured over time and used as an input 
function, the differential equation can be solved and other unknown kinetic parameters can 
be calculated. This is limited to simpler models with two or three compartments because no 
distinct assignment of the calculated coefficients is possible with more complex models. 
If the model conforms to the in vivo behaviour of a labelled compound, the arithmetical 
solution of these compartment models results in constants, depicting the in vivo local 
concentrations and kinetics of the labelled compound. With this method, a quantitative 
assessment of a specific biochemical function is possible with PET if a suitable labelled 
compound of known in vivo behaviour is available, matching a simple compartment model. 
The principle of SPECT is analogous to PET, but differs mainly in the used radioisotopes and 
the detection of directly emitted γ-rays from them. In SPECT, radioisotopes with a high 
intensity γ-ray in the energy region between 100 and 300 keV are used, like 99mTc (half-
life: 6 h). The radial emission of γ-rays originates from the place of the decayed 
radioisotopes, penetrates the body and is detected by a single or multiple NaI(Tl) scintillation 
detectors as depicted schematically in Figure 3. 
 
Figure 3: Schematic of the SPECT principle. 
This results in a 2D image of the radionuclide distribution from the specific angle. The 3D 
image is acquired by orbiting the detectors around the body, recording multiple 2D images of 
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adjacent planes and reconstructing them into true 3D images analogue to the reconstruction 
methods used in PET as discussed above. However, in contrast to PET the scatter and 
attenuation corrections necessary for a quantitation of radiotracers in SPECT are even more 
demanding and prone to errors, leading to strongly varying absolute values. This is caused 
by the unknown depth dependency of γ-ray emitters in tissue Only extensive computational 
processing of the raw imaging data can solve this issue and produce quantitative values.[42] 
This method is still experimental and not yet applicable for clinical routine use. 
Both imaging methods presented above have advantages as well as disadvantages. The 
main advantage of SPECT is strongly coupled with its most used single photon emitter 99mTc. 
It exhibits a convenient half-life of about 6 h and can easily be produced with a radioisotope 
generator. The generator can be used for several weeks 2-3 times a day. Additionally, the 
chemistry of 99mTc is so well known by now that a multitude of evaluated radiotracers are 
available by all-in-one synthesis kits at the place of use. For the production of a PET 
radiotracer, in contrast a large facility including a cyclotron, labs for radionuclide handling and 
highly qualified staff are necessary. Therefore, PET imaging can be realised in most cases 
only in close proximity to the radiotracer production facility because otherwise the necessary 
short lived radioisotopes would have decayed before reaching the imaging facility. 
The advantage of PET over SPECT is the 100 times higher detection sensitivity which leads 
to a higher time resolution and therefore enables more sophisticated dynamic studies. 
Additionally, clinical PET scanners have a higher spatial resolution of approx. 5 mm in 
comparison to SPECT with approx. 10 mm.[40] The most important advantage of PET is its 
superiority concerning the quantitation of radioactivity in vivo. Although the quantitation 
possibility of SPECT has been proved by now[42], it is still limited and in its infancy and by no 
means ready for clinical application. By now the quantitation of clinically applied radiotracers 
such as 2-deoxy-2-[18F]fluoro-D-glucose or o-(2-[18F]fluorethyl)-L-tyrosine with PET are 
routine diagnostic procedures. In conclusion, PET, in comparison to SPECT, is more 
expensive and locally bound to a large scale facility for radiotracer production, but PET is the 
technically more advanced method with better sensitivity, better spatial resolution and 
superior quantitation capabilities. These advantages can be further increased by introduction 
of multi-modal imaging by combination of PET with morphological imaging modalities like CT 
or MRI. 
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1.4 Multi-modal imaging and smart contrast agents 
Multi-modal imaging is the combination of two or more imaging methods to simultaneously 
measure complementary information. A new class of contrast agents utilizing the full 
potential of this multi-modal imaging is emerging and is called responsive or smart contrast 
agents.. Stand-alone, non-invasive imaging systems like MRI, PET, CT and SPECT have 
been in clinical routine use for decades now.[1, 2] In recent years more advanced systems 
were developed enabling the parallel measurement of diagnostically relevant information in a 
shorter time period. For example, PET/CT systems deliver higher morphological contrast in a 
shorter measurement time by use of the CT for the attenuation and scatter correction 
necessary for quantitation with PET making additional transmission source measurements 
redundant. After its introduction in 1998[43] and its commercial availability in 2001, the number 
of deployed systems rose exponentially to 500 worldwide within three years.[44] A similar 
approach was taken to combine PET and MRI systems pairing the high soft tissue contrast of 
MRI with the quantitative assessment of biochemical functions of PET. A first prototype for 
humans was developed in 2007[45] and a first commercial PET/MRI system has been 
available since 2011.[46] 
The longer development time was due to the high magnetic field interfering with the state of 
the arts photomultiplier tubes.[47, 48] Only the introduction of avalanche photodiodes[49] 
enabled the production of a PET inlay working inside of a MRI machine like the BrainPET 
inside a 3T MRI of the Forschungszentrum Jülich produced by Siemens Healthcare.[50] 
However, the question, if the combination of PET and MRI is advantageous for every clinical 
use or medical research, has not been completely answered until now.[44] The clear 
advantages of PET/MRI are the lower irradiation dose induced on patients, higher soft tissue 
contrast and the possibility to realise responsive bi-modal imaging probes combining the high 
spatial resolution with the quantitation capabilities of PET.[51] The major disadvantage of 
PET/MRI are the longer measurement times and the associated necessary movement 
corrections in addition to the still problematic attenuation and scatter correction necessary for 
PET quantitation.[44] 
The development of currently proposed responsive contrast agents[33] may tip the scales in 
favour of PET/MRI.[52] The concept of responsive or smart contrast agents is based upon 
chemical moieties which induce a varying contrast enhancement of the agents depending on 
a biochemical function or tissue state like redox condition, temperature or pH-value. In case 
of pH-sensitivity, the deprotonation of a contrast agent moiety leads to a partial blocking of 
water interaction with the complexed ion resulting in longer relaxivity times and hence a 
signal intensity loss in T1 or T2 weighted images. If the concentration of the contrast agent at 
the precise location of the signal loss is known, a correlation between relaxivity and pH can 
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be drawn and hence the pH can be determined in vivo. Another example is the redox state in 
tissue which is strictly regulated in healthy tissue, and changes can also be linked to several 
pathologies.[33] For redox responsive agents a redox couple like Mn2+/Mn3+ is needed which 
changes relaxivities depending on its oxidation state. The most difficult, but also most 
valuable approach, would be a responsive contrast agent for enzyme activity. A water 
exchange inhibiting moiety which possesses an enzyme cleavable link is needed at the 
contrast agent to achieve this. The specific enzyme activity could be determined by 
successive measurements due to increase of relaxivity and, hence, contrast. Unfortunately, 
all those approaches are still in development and in need of suitable radionuclides to enable 
simultaneous PET imaging for quantitation.[53] 
Another interesting approach is the utilization of clinically well-established SPECT. Since the 
development of new algorithms for image reconstruction and compensation techniques for 
photon attenuation and scattering corrections, the SPECT method is also viable for 
(quantitative) functional in vivo distribution studies.[42] The evaluation of newly developed MR 
contrast enhancing agents can therefore now also be conducted if a radionuclide suitable for 
SPECT is available. 
 
1.5 Radionuclides of interest for PET/MRI and SPECT 
In order to realise quantitation of multi-modal agents, several standard PET isotopes (18F, 
68Ga, 125I) can be considered for labelling purposes. Unfortunately, all of them are non-
isotopic and change the original contrast agent. The outcome may be an altered in vivo 
behaviour due to a deviating chemical structure (18F, 125I) and/or lipophilicity (68Ga), which 
would neglect the effort of providing a chemical analogue with an identical distribution in the 
body. Especially manganese has gained more attention in the last two decades due to its 
increasing use in MEMRI for novel studies to decipher several biological processes. 
Therefore, the focus of this work was on the production of PET or SPECT suitable isotopes 
of the previously described main T1 contrast enhancing elements manganese and 
gadolinium. 
 
1.5.1 Properties of radiomanganese 
Beside the research for new manganese chelate based contrast agents, the natural mono-
isotopic occurring 55Mn ion is currently increasingly used in animal studies with MEMRI as 
mentioned above. The element is an essential trace element in the human and animal body, 
however, higher doses have neurotoxic effects and lead to symptoms similar to Parkinson 
disease.[54] Therefore, MEMRI operates normally at the lowest mass of contrast agent 
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possible [25, 55-57], but it is still not approved for application in humans. Until now the 
visualization of activity in the brain and the heart, the trace of neuronal specific connections 
in the brain and also the enhancement of the brain cytoarchitecture after systemic dose 
application can be achieved by MEMRI in animals.[25] Additionally, work is done bringing 
MEMRI closer to human application [58], which calls for reliably stable new contrast agents as 
well as reliable in vivo distribution data[59]. The utilization of radioisotopes of manganese is 
another evaluation tool to achieve those goals. The available radioisotopes with half-lives 
between 20 min and one year are summarised in Table 1. The cross sections of proton 
induced reactions on natCr leading to 51,52g,mMn are depicted in Figure 4. 
Table 1: Properties of radiomanganese isotopes taken from ENSDF[60]  and 
possible nuclear reaction channels with corresponding threshold 
energies[61] without consideration of the coulomb barrier. 
 
Isotope 
 
Half-life 
 
β+-
abundance 
[%] 
 
Max. β+-
energy 
[MeV] 
 
γ-rays [keV] 
(intensity [%]) 
 
Nuclear 
reaction 
channel 
 
Threshold 
energy 
[MeV]  
 
51Mn 
 
46.2 min 
 
97.08 
 
2.186 
 
749.1 (0.26) 
 
52Cr(p,2n) 
53Cr(p,3n) 
54Cr(p,4n) 
 
16.3 
24.4 
34.3 
 
52gMn 
 
5.59 h 
 
29.6 
 
0.576 
 
744.23 (90.0) 
935.54 (94.5) 
1434.07 (100) 
 
52Cr(p,n) 
53Cr(p,2n) 
54Cr(p,3n) 
 
5.5 
13.4 
23.2 
 
52mMn 
 
21.1 min 
 
96.5 
 
2.633 
 
377.75 (1.7) 
1434.07 (98.3) 
 
52Cr(p,n) 
53Cr(p,2n) 
54Cr(p,3n) 
 
5.9 
13.8 
23.5 
 
54Mn 
 
312.3 d 
 
0 
 
- 
 
834.85 (99.98) 
 
54Cr(p,n) 
 
2.2 
 
56Mn 
 
2.58 h 
 
- 
 
- 
 
846.77 (98.9) 
1810 (27.2) 
 
55Mn(n,γ) 
 
0 
 
Two main production routes are available for suitable radiomanganese isotopes: The 
irradiation of elemental chromium or compounds of it with charged particles leading to 
51,52g,54Mn, or the irradiation of natural manganese with neutrons for production of 56Mn. Each 
radioisotope and production route has advantages and disadvantages. The positron emitting 
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isotopes 51,52gMn are available by cyclotron production[62-64] and enable in vivo quantitation 
with PET. The major downside is the need of excessive radiochemical work to separate the 
irradiated macroscopic mass of chromium from the produced radionuclides and the 
necessary radiosynthesis of the targeted compound afterwards.[65] 
The radionuclides 54Mn and 56Mn are both not applicable in emission tomography. The long 
lived 54Mn completely decays by electron capture which renders the isotope useless for PET. 
For extended laboratory or ex vivo animal studies with autoradiography (ARG), the isotope 
can be considered due to its high intensity γ-ray line. The β--emitter 56Mn, on the other hand, 
is directly produced by the neutron induced nuclear reaction on natMn[66] and can be used 
after the separation from ejected ions by the Szilard-Chalmers-effect. The amount of ejected 
ions is strongly dependent on the chemical bonding of the Mn atoms in the molecules or 
particles. No considerable radioactive by-products are produced with thermic neutrons due to 
the mono-isotopic abundance of 55Mn and no more complex nuclear reaction channels are 
available besides the 55Mn(n,γ)56Mn reaction at these neutron energies. The disadvantage of 
the neutron produced 56Mn is the low specific activity because of the direct irradiation of 
macroscopic masses of manganese, and that its application to imaging is limited to ARG. 
However, for preliminary and proof of principle in vitro and ex vivo experiments 56Mn is 
useful. 
 
Figure 4: Cumulative cross sections of proton induced nuclear reactions on natCr 
leading to 51,52g ,mMn adapted from a) Buchholz et al.[65 ] b) West et al.[64 ] 
c)  Klein et al. [62] d) Levkovskij et al. [67 ] e) Wing et al. [63] f) Skakun et 
al. [68]  g) Muminov et al. [69] h) Barrandon et al. [70].  
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The decay properties of the neutron deficient isotopes show high positron emitting 
probabilities for the shorter lived 51,52mMn making them promising for use in PET. 
Unfortunately, their maximal β+-energy is 2.2 and 2.6 MeV, respectively, which decreases the 
resolution drastically, and further on, their half-lives of 46 and 21 min are not feasible for 
observation of longer biochemical processes with PET. The shorter half-lives also limit their 
application for development of target separation and radiosynthesis. 
The most promising candidate for radiosynthetic development and initial PET studies is 52gMn 
due to its low maximal β+-energy and even lower average β+-energy of 245 keV, which is one 
of the lowest available. Even though, the lower positron-emission fraction of just 30 % and 
the high intensity γ-rays are problematic. The half-life of 5.6 d is also a limitation for repetition 
experiments in conjunction with the biological half-life of the respective compound, but 
allowing observation of slower biochemical processes otherwise. Comparing all available 
radionuclides of manganese different application areas become evident. While 52gMn seems 
to be the most suitable manganese radioisotope for the development of separation and 
radiosynthesis methods, it is also beneficial for first PET studies as shown by Topping et 
al.[71]. However, if target separation and the radiosynthesis are established, 51Mn seems the 
optimal radionuclide of manganese for a later in vivo application in PET. 
 
1.5.2 Properties of radiogadolinium 
Although there are no radiogadolinium isotopes with high β+-emission probabilities and 
suitable half-lives for PET, radiogadolinium isotopes are of high interest to investigate their 
potential for SPECT imaging. All of the relevant neutron deficient gadolinium isotopes and 
some of their respective properties are summarised in Table 2. 
Table 2: Decay properties of gadolinium isotopes[60]  with γ-rays suitable for SPECT 
(bold), complementary γ-rays for activity determination ( italic), possible 
nuclear reaction channels and corresponding thresholds[61] without 
consideration of the coulomb barrier.  
 
Isotope 
 
Half-life 
 
EC decay 
abundance [%] 
 
γ-rays [keV] 
(intensity [%]) 
 
Nuclear 
reaction 
channel 
 
Threshold 
energy 
[MeV]  
 
146Gd 
 
48.27 d 
 
100 
 
114.7 (44) 
115.5 (44) 
154 (46.6) 
 
151Eu(p,6n) 
151Eu(d,7n) 
153Eu(p,8n) 
153Eu(d,9n) 
 
40.0 
42.5 
54.9 
57.5 
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Table 2 cont.  
 
Isotope 
 
Half-life 
 
EC decay 
abundance [%] 
 
γ-rays [keV] 
(intensity [%]) 
 
Reaction 
channel 
 
Threshold 
energy 
[MeV]  
 
147Gd 
 
38.06 h 
 
99.74 
 
229.3 (57.7) 
370.0 (15.7) 
396.0 (31.4) 
 
151Eu(p,5n) 
151Eu(d,6n) 
153Eu(p,7n) 
153Eu(d,8n) 
 
32.6 
35.0 
47.5 
50.1 
 
149Gd 
 
9.28 d 
 
99 
 
149.7 (48.2) 
298.6 (28.6) 
788.9 (7.3) 
 
151Eu(p,3n) 
151Eu(d,4n) 
153Eu(p,5n) 
153Eu(d,6n) 
 
16.6 
18.9 
31.5 
34.0 
 
151Gd 
 
124 d 
 
99 
 
153.6 (6.2) 
174.7 (3.0) 
243.3 (5.6) 
 
151Eu(p,n) 
151Eu(d,2n) 
153Eu(p,3n) 
153Eu(d,4n) 
 
1.3 
3.5 
16.2 
18.6 
 
153Gd 
 
240.4 d 
 
100 
 
97.4 (29.0) 
103.2 (21.1) 
 
153Eu(p,n) 
153Eu(d,2n) 
 
1.3 
3.5 
 
All of the listed radionuclides exhibit β+ radiation emission probabilities below 1 % and 
therefore low background radiation for actual SPECT measurements. Further selection 
criteria for radioisotopes suitable with SPECT are high intensity γ-rays with energies in the 
efficiency maximum of NaI(Tl)-detectors at approximately 150 keV and suitable half-lives. 
These have to be long enough for precise measurement but short enough for timely 
excretion or decay to assure low radiation doses inflicted on animals or patients. In some 
cases half-lives allowing repetition experiments in a timely manner can be additionally 
favourable. Keeping this in mind, 146,151 and 153Gd have optimal γ-ray energies with more or less 
high intensities, but their physical half-lives are too long for in vivo application with humans in 
SPECT. The half-live of 147Gd of 38.06 h is suitable for in vivo studies. The high intensity γ-
rays of this isotope have higher energy than ideal but are still useful for SPECT as shown 
before by Denzler[72]. 
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The radionuclide 149Gd shows a more suitable γ-ray for SPECT at 149.7 keV with a high 
intensity of 48.2 %. The longer half-life makes it perfect for chemical development work. 
However, not only PET but also SPECT measurements are in need of radioisotopes with 
high radionuclidic purity due to the low resolution of NaI(Tl) γ-ray detectors (approx. <50keV). 
In detail, γ-rays with similar energy would produce overlapping photopeak areas in the 
measured γ-ray spectra. In case of a smaller overlap, no significant integration of the 
photopeak area is possible, and in case of a complete overlap the necessary decay 
correction becomes problematic which both lead to a distorted radioactivity determination. 
This is especially problematic for the isotopic pair 149Gd and 151Gd due to similar γ-ray and 
threshold energies for the proton and deuteron induced reactions on europium. Another 
important factor is the accumulation of radioactive daughter nuclides of gadolinium, namely 
147Eu (half-life: 24.1 d) with two prominent γ-rays (121 keV, 22.9 %, 197 keV, 27 %) and 149Eu 
(half-life: 93.1 d) with two minor intensity γ-rays (277 keV, 3.6 %, 327, 4.0 %)147,149Eu. 
Unfortunately, only few studies have examined the production[73-76] or separation[77-79] of 
147,149Gd until now, partly owed to the higher particle energies or uncommon projectiles 
needed for irradiation or partly owed to a necessary complex radiochemistry for separation. 
 
1.6 Production of radionuclides 
The production of radionuclides is a complex procedure based on several development 
steps.[1] At first, the decision has to be made which radionuclide could be suitable for the 
targeted application: A proton or a neutron deficient radioisotope (see chapter 1.5.1 and 
1.5.2). Further on, reaction channels have to be considered leading to this chosen 
radioisotope. Connected to those reaction channels is the search for a suitable target 
material which has to endure the partly harsh conditions of irradiation without suffering 
material loss. Also, an evaluation of the irradiation parameters based on cross section 
measurements and achievable thick target yields has to be conducted. The irradiation 
parameters should deliver suitable radioisotopic yields, purity and be cost efficient. Here, 
only low or non-isotopically enriched target materials are favourable. Additionally, a facile 
separation procedure from the target material has to be developed for most neutron deficient 
isotopes. The separation procedure should yield radiochemically pure, no-carrier-added 
(n.c.a.) radionuclides in a small volume of a medium suitable for the subsequent task. Also, 
the separation should be done in the shortest time possible to reduce loss of radioactivity by 
decay and the radiation exposure of an operator to a minimum. For imaging, an especially 
high isotopic and chemical purity combined with a high specific radioactivity is advanteagous. 
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1.6.1 Irradiation facilities 
As mentioned in chapter 1.5.1 the irradiation with neutrons or charged particles is mainly 
used for production of proton or neutron deficient radioactive isotopes. The major routes to 
produce neutrons for irradiation are the use of a nuclear reactor[2, 80], a neutron source[1] and 
secondary neutrons produced at a charged particle accelerator[81, 82]. 
In the present work the main focus was on neutron deficient radionuclides, so their 
production is discussed in more detail. The production route towards the neutron deficient 
radionuclides is generally based upon the acceleration of charged particles such as protons, 
deuterons, α-particles or heavier elements and the subsequent bombardment of a target with 
those. Three different concepts have been developed for the acceleration of charged 
particles: linear accelerators, cyclotrons and synchrotrons. The linear accelerator (linac) was 
the first machine developed for acceleration of electrons based on an idea of Leó Szilárd and 
developed by Rolf Widerøe[83] in 1928. Later on, the variety of accelerated particles was 
expanded to heavier charged particles like protons. 
The principle of a linac is a succession of cylindrical hollowed electrodes with small gaps 
between them within a larger cylindrical vacuum chamber. When an ion is introduced into the 
vacuum chamber, it is accelerated to the opposing charged first electrode. The electrode 
switches its polarity while the charged particle is passing through accelerating the particle 
further by repulsion after it exits the electrode. By alternation of polarity between the 
subsequent electrodes, the charged particle is further accelerated within the gaps between 
electrodes. The drawback of this acceleration system is the large space needed to reach 
higher velocities and a limited fractionated particle flux. Hence, the cyclotron, a spiral-
accelerator system, was developed by Ernest O. Lawrence[4] depicted in Figure 5. 
 
Figure 5: Original drawing of Ernest O. Lawrence from his patent in 1934 of the 
principle of a cyclotron. [4]  
After injection, the charged particle is accelerated towards one of the polarised hollowed Dee 
electrodes, named for its D shape. The accelerated particle is forced upon a circular orbit by 
 
18 
 
1. Introduction 
the Lorentz force by strong permanent magnets above and below the double Dees. Due to 
an applied high frequency electronic field the electrodes change their polarity with each 
transition of the charged particle between them, thereby accelerating it. With increasing 
velocity, but a constant magnetic field, the angular velocity of the particle stays the same 
forming a spiral-shaped orbit because of the centripetal force enabling the parallel 
acceleration of multiple particles at once. Thereby, a higher flux compared to linac´s is 
possible.[2] But the velocity is still limited due to occurrence of relativistic effects when nearing 
light speed. 
This can be corrected to some extent by focusing the beam with a azimuthal varying 
magnetic field at the outer rims of the cyclotron.[84, 85] Then it is possible to reach nearly 80 % 
of the speed of light (590 MeV protons) shown by the Ring cyclotron[86] located at the Paul 
Scherrer Institut in Switzerland. 
The only option to reach higher velocities is the application of larger synchrotron rings. The 
acceleration occurs similar to a linac accelerator, but with the addition of bending magnets 
guiding the particle beam onto a circular orbit. By synchronising the strength of the bending 
magnets, the circular orbit can be maintained with increasing velocity of the particle. 
Extremely high kinetic energies can be reached of presently up to 7 TeV protons in the Large 
Hadron Collider of CERN[87]. The kinetic energy is mainly limited by the loss of energy 
through synchrotron radiation formed by deflection of the particles within the bending 
magnets. However, the extremely high energies of a synchrotron are mainly interesting for 
particle physics and no reliable production of radionuclides is possible due to the low flux and 
the extremely complex nuclear reactions at these high energies with low reproducibility. 
Therefore, the optimal production route for short and longer lived pharmaceutical relevant 
radioisotopes is still the irradiation of a suitable target material at a level Ι to level ΙΙΙ sized 
cyclotron. The optimal energy range for production of specific radionuclides, and therefore 
the needed cyclotron size is strongly depending on each nuclear reaction, their possible by-
products and has to be experimentally determined for each single case. In case of the 
present work all neutron-deficient radioisotopes were produced at a small or medium sized 
cyclotron. 
 
1.6.2 Production parameters 
For a successful radioisotope production using charged particles the most important factor is 
the cross section of the nuclear reaction as shown in the activation equation 6[80]: 
𝐴𝐴𝑒𝑒𝑜𝑜𝑜𝑜 = 𝜎𝜎 ∙ 𝜙𝜙 ∙ 𝑁𝑁 ∙ 𝐻𝐻 ∙ �1 − 𝑒𝑒−𝜆𝜆𝑡𝑡𝑖𝑖𝑖𝑖𝑖𝑖� ∙ 𝑒𝑒−𝜆𝜆𝑡𝑡𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐
with A: half-life corrected activity at the end of bombardment (EOB), 
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 σ : nuclear reaction cross section at the corresponding particle energy, 
 φ : particle flux density, 
Ν : number of irradiated target atoms, 
Η: isotopic abundance of the targeted isotope, 
λ : decay constant of the radionuclide, 
tirr: irradiation time, 
tcool: time from the end of bombardment to the measurement. 
The particle flux density and the number of irradiated target atoms effects all produced 
radionuclides in the same way for proton and neutron irradiations, targeted radionuclides as 
well as by-products. The cross section of different nuclear reactions varies with the particle 
energy. Additionally, charged particles show a significantly higher energy transfer to matter 
than neutrons[2] as shown in Figure 6 due to their Coulomb interaction with the charges of 
shell electrons and atom nuclei. 
Therefore, selection of a suitable energy range can explicitly favour the production of one 
specific radionuclide, making precise cross section determination even more important. 
Cross sections of nuclear reactions induced by charged particles are mainly determined by 
the stacked foil technique[88, 89]. A foil stack is exemplary depicted in Figure 6. 
 
Figure 6: Stacked-foil technique and specif ic energy loss in matter for heavy ions. 
By alternating the actual targets, foils for energy degradation (absorber), foils for beam flux 
and energy determination (monitor foils) and foils catching eventually ejected radionuclides 
(catcher foils) a large energy range can be measured in one irradiation. Due to the strong 
interactions between charged particles, matter and the strong dependence of cross sections 
on particle energy, very thin targets are mandatory to determine accurate cross sections. 
This way cross sections can be measured at a rather precise particle energy and not as 
mean values over a broad energy range which differ dramatically. Generally speaking, 
targets for cross section measurements should degrade particle energy as little as possible 
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with the produced radionuclides still measurable after a reasonable irradiation time. A more 
detailed description of the exact target materials used and irradiation parameters for cross 
section measurements is given in chapter 3.2.1. With this basic approach, the production 
survey of the nuclear physical data necessary to produce above mentioned isotopes is 
possible as depicted for 51,52g,mMn in Figure 4. For further application, separation of the 
produced radionuclides from the bulk target material and purification with feasible procedures 
may be mandatory. 
 
1.7 Separation techniques 
Several physical-chemical separation techniques are applicable for the isolation of 
radionuclides from bulk target materials. This includes for example Thermochromatography 
(TC), Liquid-Liquid Extraction (LLX), Ion-Exchange Chromatography (IEC), Extraction 
Chromatography (EXC), High Pressure Liquid Chromatography (HPLC), co-precipitation 
methods and electrochemical methods. Some are more suitable for the task to separate 
picomolar amounts of radioactive material from millimolar amounts of the bulk targets than 
others. In general, the optimal separation method depends strongly on the composition of the 
target, the chemical nature of the irradiated material and the produced radionuclide. Also, the 
conditions for further processing are necessary to consider. In this work two chromatographic 
separation methods were of special interest (see chapter 3.4.1 and 3.5.2) due to their 
favourable separation performance and possible translation to semi-automated systems. 
1.7.1 Ion-exchange chromatography 
In general, the separation achieved with chromatographic methods is based upon the 
different distribution behaviour of two or more substances between a mobile and a stationary 
phase.[90] The classification of different chromatographic methods depends on the aggregate 
state of both phases. Ion-exchange chromatography is part of the liquid chromatography 
separation methods with a liquid mobile and a solid stationary phase. The stationary phase in 
most modern ion-exchange chromatography is made of a mesoporous polymer resin with ion 
exchanging groups bound to the surface. Depending on the charge of these exchange 
groups, the resins are affine to anions or cations. The scaffold of the resins is typically a 
matrix of polystyrene cross linked by co-polymerisation with divinyl benzene. Cross linkage 
varies normally between two and twelve percent and increases sturdiness, but decreases the 
ion-exchange capacity of the resins. After the polymerisation process, the matrix is 
functionalised with the exchange groups differentiating the resins into four groups: strongly 
basic (quaternary amino groups), strongly acidic (sulfonic acid groups), weakly basic 
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(primary, secondary and/or ternary amino groups) and weakly acidic (carboxylic acid groups) 
resins. These functional groups exchange charged ions with the mobile phase at different 
rates based on parameters such as ion size, charge and complexation rates in the mobile 
phase.[91] The exchange rates for different ions can deviate strongly from each other leading 
to different retention times when traveling through the stationary phase. The equilibrium state 
can vary between complete to no retention enabling the separation of two or more ions on 
one column. The quality of a separation can be expressed by Nernst´s distribution coefficient 
(KD) and the separation factor (SF) as[90]: 
𝐾𝐾𝐷𝐷𝑥𝑥/𝑦𝑦 = 𝑐𝑐𝑠𝑠𝑠𝑠𝑐𝑐𝑚𝑚𝑠𝑠 
𝑆𝑆𝑆𝑆𝑥𝑥/𝑦𝑦 = 𝐾𝐾𝐷𝐷𝑥𝑥𝐾𝐾𝐷𝐷𝑦𝑦 
with KDx/y: distribution coefficient of ion x and y, 
 csp: equilibrium concentration of ions in the stationary phase, 
 cmp: equilibrium concentration of ions in the mobile phase, 
 SFx/y: separation factor of substance x and y. 
Determining the SF of ion pairs in a mixture on a specific resin with a set of eluents enables 
the development of a separation method. In an ideal case (SFx/y -> ∞), one of the substances 
in the mixture would be completely adsorbed on the column (KDx = ∞) while the other is 
mobile (KDy = 0). In this ideal case the eluent is changed after removing the mobile 
component and the other bound substance eluted. For most ion pairs these basic ion 
exchange resins are sufficient to achieve a satisfying separation. In some cases, however, 
the commercially available ion exchange resins only lead to an incomplete separation and 
other chromatographic methods are more advantageous. 
 
1.7.2 Extraction chromatography 
Extraction chromatography (EXC) can be described as a specialised subgroup of Liquid-
Liquid-Extraction (LLX) for separation of metal ions.[92] In contrast to IEC organic complexing 
agents are used as hydrophobic stationary phase. Thus, it combines the selectivity of Liquid-
Liquid extractants with the functionality of a column chromatography. Commonly used 
extractants are Di-(2-ethylhexyl)-orthophosphoric acid (HDEHP), Tri-n-butylphosphate (TBP), 
long-chained aliphatic amines and crown ethers. These extractants are adsorbed by physical 
means to an inert supporting matrix mainly composed of mesoporous silica or organic 
polymers with bead sizes of 50-100 µm. The resin preparation involves the solvation of the 
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extractant in a volatile solvent, impregnating the support matrix with the mixture and 
evaporating the solvent. The capacity is limited by the amount of extractant absorbable on 
the supporting matrix. In general, the capacity is lower than that of an ion-exchange resin 
limiting its application to separations where the bulk target material is not extracted onto the 
resin. Additionally, due to the nature of physical absorption of the extractant on the target 
matrix a breakthrough of extractant is possible if high pressure chromatography conditions or 
specific organic solvents are applied. The capacity in combination with the distribution 
coefficients as well as the physical and chemical stability of the resin are therefore the major 
selection criteria for a feasible separation in this case.[93] 
Another difference of EXC to IEC is the chemical change of the extractants. While the 
functional groups of IEC undergo only minor chemical changes, extraction chromatography is 
governed by several complex chemical processes and exchange equilibria.[92] Hence, beside 
the most commonly used inorganic acids the utilization of complexing agents like oxalic acid 
in the mobile phase can be beneficial. Due to this complexity, more parameters need to be 
optimised for a separation procedure. The quality of separation is calculated identical to the 
ion-exchange approach by measurement of Nernst´s distribution coefficients and separation 
factors as described in equation 7 and 8. 
 
1.8 Separation of the lanthanides europium and gadolinium 
The separation methods of the lanthanide series are mainly based on two properties: The 
first is the lanthanide contraction which leads to a decreasing ion radius of their trivalent ions 
in course of the period and hence, a decreasing basicity. On that account the complexes of 
the lanthanides increase in stability with strong bases opposing to their own decreasing 
basicity. The second property is the differing stability of their oxidation states and their 
different redox potentials. While for europium the bivalent state is relatively stable, no 
bivalent state is known for gadolinium. 
While there are several approaches for near quantitative separation of europium and 
gadolinium using this two properties, they take too much time, are not practicable for n.c.a 
masses or need extremely specialised laboratory equipment[94-106]. The different separation 
methods involved are liquid-liquid extraction, ion-exchange, high pressure liquid 
chromatography, extraction chromatography, chemo-, and electro-reductive methods. 
Each method has its own advantages and problems. Liquid-liquid extraction, for example, 
yields good separation factors, but the used volumes tend to be relatively large which is 
highly impractical for n.c.a. material, later labelling and or injection. Ion-exchange only gives 
relatively low separation factors of up to 2.2[95] which is enough for a baseline separation of 
an europium and a gadolinium fraction, if both are present in nearly equal amounts. But 
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those separations take much time in addition to possible superimposition of europium and 
gadolinium fractions, in case of the ratio of 108 with one metal in n.c.a. amounts. The 
introduction of high pressure separation systems resolved the time problem, due to higher 
flow rates and also yields better separation factors.[105] However, preparative HPLC systems 
are highly technical demanding because of the need of acid resistance as well as sufficient 
loading capacities to separate the bulk target masses from n.c.a. radionuclides. 
On the other hand, the new generation of extraction resins yields superior separation factors 
and allows smaller separation volumes at the cost of their loading capacity.[107] DGA normal 
extraction resin (Triskem), for example, shows a capacity of 12 mg Eu/mL resin. This is 
optimal for pre-concentrations at trace amounts or a fine separation, but not suitable for bulk 
targets up to 500 mg and more due to the combination of high back pressure and 
decomposition of the resin under HPLC conditions described by the supplier which leaves 
large columns not viable. 
However, the selective reduction of europium to its bivalent or elemental state and a 
following separation seem to give good yields in a short time.[108] The difference of their redox 
potentials (see Table 3) is high enough for this selective reduction. 
Table 3: Redox potentials of Eu- and Gd-oxidation states, taken from Herman et 
al.[109 ]  
Element EIII/II [V] EIII/0 [V] 
Eu -0.30 -2.00 
Gd (-2.85) -2.27 
The reduction can be done by electrochemical or chemical reductive means. While 
electrochemical methods are time consuming[106], selective chemical reductions can be 
achieved within minutes.[77, 78, 108] The exact procedures will be described in chapter 3.4.1 and 
discussed in chapter 4.2. 
 
1.9 Nanotechnology 
The word “nanotechnology” was first used by Norio Taniguchi at a presentation on an 
international conference in 1974[110] and later on made publicly aware by the book of Eric 
Drexler “Engines of Creation: The coming Era of Nanotechnology”[111]. Drexler was inspired 
by the presentation: “There is plenty of Room at the Bottom” by Richard Feynman in 1959[112] 
proposing the direct manipulation of individual atoms as a new and more powerful form of 
synthetic chemistry. Nanotechnology was thereby defined to be “the manipulation of matter 
on an atomic, molecular, and supramolecular scale”.[111] Later on, a more general definition 
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was established by the National Nanotechnology Initiative[113], defining Nanotechnology as 
the manipulation of matter with at least one dimension sized from 1 to 100 nm. These 
nanometer scale materials or structures exhibit new physical properties or physical 
phenomena similar to newly found features in quantum mechanics. 
While a large amount of new nanoscale materials was produced, new tools for 
characterisation also emerged simultaneously, but not exclusively, for these materials. 
Among them are dynamic light scattering (DLS), scanning or transmission electron 
microscopy (SEM/TEM), x-ray diffraction (XRD) and x-ray photoelectron spectroscopy (XPS). 
Even with the newly established characterization methods, there may be still more unique 
and unknown properties of nanoscale materials not found until now.[114] This is especially 
problematic considering the widespread use of nanotechnology in today’s society. In many 
industrial as well as cosmetic products nanotechnology is an indispensable implement 
nowadays. Examples are the antibacterial coatings of refrigerators with silver nanoparticles, 
the application of TiO2 in white paint and many more. Additional cross-disciplinary work is still 
needed in the future to assess every aspect of these products to assure their safety. The 
present thesis also deals with nanoparticle based systems for possible contrast agents in 
MRI. Therefore, only corresponding information necessary for the synthesis and charact-
erization of nanoparticles will be displayed in the following. 
 
1.9.1  Synthesis methods 
Several synthesis routes leading to well-defined sizes, shapes and chemical compositions of 
nanosized particles have been established, but not all of them are completely understood. 
They can be classified in various ways, for example into the “top-down” and “bottom-up” 
approach.[114] The “top-down” approach which is in general an extension of lithography 
includes the breakdown or shaping of larger aggregates into smaller pieces or structures. 
The break down can be realised for example mechanically with grinding mills and the precise 
shaping with focused ion beams, atomic force microscope tips or by atomic layer deposition. 
“Bottom-up” approaches include every synthesis route, i.e. solid-, liquid-, vapour- and hybrid-
phase growth based methods, which starts building nanosized materials from atoms or 
molecules into colloidal dispersions. The advantages of the “top-down” methods is the 
industrial upscaling possibility while higher chemical purity as well as lesser defects and a 
higher short and long range crystal ordering can be achieved with “bottom-up” methods. 
The basic challenges of both approaches are the same: 
- Development of a reproducible synthesis method resulting in nanomaterials with desired 
chemical composition, crystallinity, morphology and size, hence, producing nanoscale 
materials with required physico-chemical properties. 
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- Overcoming the huge surface energy present due to the large surface to volume ratio of 
nanoparticles. 
- Sufficient stability to prevent coarsening by agglomeration or so called “Ostwald 
ripening”[115]. The latter is defined as a steady transfer of matter from smaller to larger 
particles decreasing the overall free energy of the system by lowering the surface tension 
of the resulting larger particles.  
Considering the actual production, the first synthetic step towards nanoscale particles can be 
achieved by either the kinetic approach or the thermodynamic equilibrium approach. The 
kinetic approach includes the use of a limited space or a amount of precursor available. A 
template-based deposition, aerosol pyrolysis or a microemulsion are examples for kinetically 
controlled nanoparticle synthesis. The basic principle of the thermodynamic equilibrium 
technique can be explained by the model of Victor La Mer[116] depicted in Figure 7. 
 
Figure 7: Simplif ied stages of nucleation and growth inside the La Mer diagram for 
an exemplary bottom-up nanoparticle synthesis; adapted from Murray et 
al.[117 ]  
 
The basic steps of the thermodynamic equilibrium technique are the generation of a 
supersaturation in a solution by various means, the homogeneous nucleation and a 
subsequent particle growth.[114] The main driving force of the nucleation and growth process 
is the reduction of the Gibbs free energy (∆G) towards an energetically lower system state by 
a phase transition. If the concentration of a substance is increased above the equilibrium 
concentration, the Gibbs free energy rises also. At this state, the formation of a new phase 
reduces the Gibbs free energy by removing the supersaturated compound from the solution 
into the second phase. But the creation of the new surface between the two phases requires 
a certain surface energy which counter balances the Gibbs free energy reduction. Hence, a 
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critical minimum size of a particle in a specific system can be deduced by the radius 
dependent Gibbs free energy. This radius is strongly correlated to the solvents and the level 
of supersaturation. 
In a subsequent step, the growth to the final size distribution has to be controlled. It is 
governed by a) generation of growth species, b) diffusion of the growth species from bulk to 
the growth surface, c) adsorption of the growth species onto the growth surface and d) 
surface growth through irreversible incorporation of growth species onto the solid surface.[114] 
The growth towards monodisperse nanoparticles can be influenced by several parameters 
like the overall mass and the controlled supply of growth species present in solution, the 
viscosity of the solvent as well as temperature and the application of a growth regulating 
diffusion barrier represented by a monolayer of surface capping agent. 
To achieve well-defined shapes and sizes for nanoparticles of different compositions, several 
synthesis methods can be used each with its unique requirements caused by the many 
adjustments possible. A more in-depth discussion about the advantages and disadvantages 
of each technique is far beyond the scope of this work and can be found in literature.[114, 118] 
More relevant is the characterisation of said nanomaterials and the used methods therefore. 
 
1.9.2 Characterisation of nanomaterials 
For a full description of a specific nanomaterial, several characteristic properties can be 
assessed such as melting point, crystal structure, lattice constants, mechanical properties, 
optical properties, electrical conductivity, ferroelectricity, dielectricity and superpara-
magnetism. The importance of each characteristic feature is depending on the field of 
application of the nanomaterial. The structural characterisation of nanomaterials is one of the 
most important assessments due to the high correlation between structure and already 
mentioned new physical phenomena. The structural characterisation includes the 
determination of the size distribution, the shape, the crystal structure and optionally a shell 
analysis if a surface functionalization has been done. 
A suitable method for a fast determination of the size distribution of colloidal nanoparticle 
dispersions is the dynamic light scattering[119]. DLS is based upon the time and space 
correlation of the interference pattern induced by the scattering of a laser beam by small 
particles within a dispersion. The pattern originates from the spherical scattering of light on 
small particles and the interference of those spheres. The time correlation occurs due to the 
Brownian motion of the particles which is dependent on their inertia and of course on the 
viscosity of the solvent, the temperature and their size. If both other parameters are known, 
the size can be computed with an autocorrelation function[119]. Unfortunately, the resolution 
for the differentiation of more than one sized particle is rather low. Additionally, only the 
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hydrodynamic radius of a particle can be measured by DLS, i.e. the particle enveloped by a 
solvent shell would lead to a larger apparent particle size. Therefore, complementary 
techniques for the size and shape determination have to be used like scanning or 
transmission electron microscopy (SEM/TEM). 
Normal optical microscopic techniques were limited by the wavelength of visible light for a 
long time. If the size of an object is considerably lower than the wavelength, it could not be 
depicted with the standard methods. Electron microscopy utilises the smaller wavelength of 
accelerated electrons for a superior resolution. In a scanning electron microscope, 
accelerated electrons range between 100 eV and 50 keV delivering a magnification of over 
300000. If a sample is scanned with such a focused electron beam, the electrons penetrate 
the sample and undergo a number of interactions leading to the emission of photons and 
secondary electrons. The emitted electrons are collected and combined into an image of the 
probed sample. Additionally to the morphology of a probe, SEM also delivers information 
about the composition of the compounds characterised by the emission of X-rays and Auger 
electrons from the excited atoms and molecules enabling the energy-dispersive X-ray 
spectroscopy (EDX). 
Another method to depict even smaller structures is TEM yielding point-to-point resolutions 
better than 0.2 nm.[114] In contrast to SEM, the electrons are accelerated further up to 
100 keV leading to even smaller electron wavelength. Those electrons pass through most 
thin objects (<200 nm), due to their higher energies. A picture can be constructed from the 
inelastic scattering taking place at grain boundaries, defects, and density deviations leading 
to a spatial intensity loss of the electron beam. But the shortcoming of TEM is the limited 
depth resolution induced by the projection of a three-dimensional object onto a two-
dimensional detector. On the other hand, the elastic scattering of electrons in a selected area 
produces an electron diffraction pattern which can be used for determination of the Bravais 
lattices of a single nanocrystal similar to XRD. This method is very time consuming due to 
problematic sample preparation and user interpretation of the lattice. Other diffraction 
methods are normally preferred for lattice determination like XRD or neutron diffraction. 
Beside the physical properties like size, shape and crystal lattice, the surface is also of 
utmost importance considering the impact on nanoparticle behaviour and dispersion stability. 
The composition of the surface or shell of a nanomaterial can be assessed by XPS, the 
Auger electron spectroscopy and the secondary ion mass spectrometry while the stability of 
a liquid dispersion can be determined by measurement of the ζ-potential which represents 
the electronic repulsion of two adjacent particles. 
However, whether all those analysis methods and the additionally available methods are 
necessary, is strongly depending on the field of application of the nanomaterial in question.  
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2. Aims of the thesis 
A major problem of MRI is the quantitation of contrast enhancing compounds which are 
mainly based on the paramagnetic elements gadolinium and manganese. The results of this 
work shall aid to solve this quantitation issue of MRI by application of PET/SPECT suitable 
radionuclides. The scope of the present work is activation and authentic radiolabelling of MR 
contrast agents. The precise evaluation of the in vivo behaviour of new contrast agents 
(intake, distribution, accumulation, excretion) can be achieved non-invasively with one of the 
emission tomographic methods in humans. Additionally, the connected concept of multi-
modal contrast agents opens up a new field of personalised medicine using the complete 
potential of PET/MRI hybrid scanners. 
The first goal of this work is the identification of suitable radionuclides of gadolinium and 
manganese for PET or SPECT . This includes the discussion of β+-emission probabilities, β+-
energies, half-lives and interfering γ-ray emission for the assessment if a radionuclide is 
suitable for PET. A similar discussion has to be done for the identification of radionuclides for 
SPECT. The most important parameter in case of SPECT is the high emission probability 
of γ-rays in the 100-300 keV range. Additionally, half-lives and interfering β+-emissions have 
to be discussed. 
The second goal is the production of the selected radionuclides. Nuclear reactions leading to 
those radionuclides have to be identified and assessed by cross section measurements, 
theoretical yield calculations and experimental yield measurements. Produced isotopic by-
products have to be considered and, if possible, avoided by selection of an optimal energy 
range for isotopic pure production and eventually the use of enriched target materials. Other 
suitable nuclear reactions have to be compared in search of the most beneficial one. 
The third goal is the separation of the produced radionuclide from the bulk of target material 
to enable the n.c.a. synthesis of a radiotracer. If no suitable separation is available from the 
literature, existing separations have to be adapted or new separations have to be developed 
to meet the current needs of the individual application. 
The fourth goal is a proof of principle application of the produced radionuclides. In case of 
gadolinium, it is the authentic labelling of a commercial MRI agent. Due to the current, 
worldwide research on manganese based MR nanosized contrast agents, the authentic 
labelling of a nanoparticle precursor should also be investigated. 
The fifth goal is the evaluation of an alternative tracing method of the nanosized contrast 
agents and their stability by activation experiments. Therefore, manganese nanoparticles 
have to be characterised after bombardment with neutrons and protons and their integrity 
and possible ion leaching have to be measured.  
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3.1 Chemicals and analysis equipment 
The chemicals used in this work, their properties and the respective suppliers are compiled in 
Table 4. If not mentioned otherwise materials were applied directly without further 
purification. The deionized water utilised in the experiments was HPLC-grade as a rule 
supplied by a purification plant (Purelab Classic, ELGA Labwater). 
Table 4: List of chemicals, properties and supplier 
 
Name 
 
Formula 
 
Properties 
 
Supplier 
acetic acid C2H4O2 purity >99.0 % 
 
Sigma-Aldrich Co. 
LLC. 
acetonitrile C2H3N purity 99.9 % 
Honeywell Riedel-
de Haën 
acetyl acetone C5H8O2 purity >99 % 
Sigma-Aldrich Co. 
LLC. 
aluminium foil Al 0.01 to 0.3 mm thickness; purity 99 % Goodfellow GmbH 
Amberlite CG-400-II - Cl- form, 200 - 400 mesh Fluka Chemie AG 
Amberlite IR 120 - H+ form, 20 - 50 mesh Merck KGaA 
ammonium hydroxide 
solution NH4OH 25 wt%, pro analysis Fluka Chemie AG 
bis(2-ethylhexyl) 
phosphate (HDEHP) C16H35O4P purity 97 % 
Sigma-Aldrich Co. 
LLC. 
butanol C4H10O purity 99.4 % 
Sigma-Aldrich Co. 
LLC. 
chromium plates Cr purity 99.9 % Goodfellow GmbH 
chromium(III) chloride 
hexahydrate CrCl3 ∙ 6 H2O purity >98.0 % 
Sigma-Aldrich Co. 
LLC. 
copper foil Cu 0.01 to 0.1 mm thickness; purity 99.9 % Goodfellow GmbH 
DGA normal - 50-100 µm particle size Triskem International 
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Table 4 cont. 
 
Name 
 
Formula 
 
Properties 
 
Supplier 
1,4,7,10-
tetraazacyclododecane-
1,4,7,10-tetraacetic 
acid (DOTA) 
C16H28N4O8 purity >97.0 % 
Sigma-Aldrich Co. 
LLC. 
ethanol C2H6O pro analysis 
Sigma-Aldrich Co. 
LLC. 
europium oxide Eu2O3 purity 99.9 % AlfaProducts 
hydrochloric acid HCl >37 wt%, pro analysis Sigma-Aldrich Co. LLC. 
nickel foil Ni 0.01 mm thickness; purity 99.95 % Goodfellow GmbH 
nitric acid HNO3 >69 wt%, pro analysis 
Sigma-Aldrich Co. 
LLC. 
manganese (II) acetate MnC4H6O4 purity 98 % 
Sigma-Aldrich Co. 
LLC. 
manganese (II) 
acetylacetonate MnC10H14O4 pro analysis 
Sigma-Aldrich Co. 
LLC. 
manganese (II) chloride 
tetrahydrate MnCl2 ∙ 4 H2O purity >98 % 
Sigma-Aldrich Co. 
LLC. 
mercury Hg purity >99.99 % Sigma-Aldrich Co. LLC. 
methanol CH4O pro analysis 
Sigma-Aldrich Co. 
LLC. 
oxalic acid C2H2O4 purity 98 % 
Sigma-Aldrich Co. 
LLC. 
phosphate buffered 
saline (PBS) 
KH2PO4, 
NaCl, 
Na2HPO4 ∙ 
7 H2O 
pH 7.4 life technologies 
polyvinylpyrrolidone 
(PVP) (C6H9NO)x 40.000 avg. molar weight 
Sigma-Aldrich Co. 
LLC. 
2-Propanol C3H8O purity 99.5 % Merck KGaA 
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Table 4 cont. 
 
Name 
 
Formula 
 
Properties 
 
Supplier 
sodium acetate NaC2H3O2 purity >99.0 % 
Sigma-Aldrich Co. 
LLC. 
sodium hydroxide NaOH pro analysis Merck KGaA 
sodium mercury 
amalgam Na,Hg 
20 wt% sodium content, 
purity >99.9 % 
Sigma-Aldrich Co. 
LLC. 
triethylene glycol C6H14O4 purity 99 % 
Sigma-Aldrich Co. 
LLC. 
 
The γ-ray measurements were conducted with five different ORTEC γ-ray spectrometers 
(AMETEK GmbH) which are listed in Table 5. They were efficiency and energy calibrated 
with the standard radiation point sources summarised in Table 6. 
Table 5: List of characteristics of employed γ-ray spectrometers (AMETEK GmbH) 
Detector model 
 
GEM- 
18190-P 
 
GEM- 
20190 
 
GEM-
20190 
 
GEM 
10P4-70 
HV 459 459 660 659 
MCA/ADC 919 E 919 E 919 E 919 Spectrum Master 
amplifier 672 672 672 672 
resolution (FWHM at 
1.33 MeV, 60Co) 1.70 keV 1.66 keV 1.68 keV 1.71 keV 
relative efficiency at 
1.33 MeV, 60Co 19.1 % 24.5 % 30 % 10 % 
peak-to-compton 
ratio, 60Co 51 : 1 61 : 1 64 : 1 43 : 1 
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Table 6: List of standard radiation point sources employed 
 
Nuclide 
 
ID 
 
Supplier 
 
60Co 
 
LY369 
 
Amersham 
133Ba 4081 Amersham 
133Ba LY366 Amersham 
137Cs 430-78 Physikalisch-Technische Bundesanstalt (PTB) 
152Eu 371-83 PTB 
152Eu 412-76 PTB 
152Eu 440-88 PTB 
226Ra 404-84 PTB 
226Ra DW539 Amersham 
multi element: 
241Am, 57Co, 60Co, 109Cr, 137Cs PK-151 PTB 
multi element: 
241Am, 57Co, 60Co, 109Cr, 137Cs PK-152 PTB 
241Am 430-78 PTB 
Several techniques such as Dynamic-Light-Scattering (DLS) and Transmission Electron 
Microscopy (TEM) were utilised for a characterisation of synthesised and commercial 
nanoparticles. The DLS measurements were done with a Zetasizer Nano S (Malvern). 
The instrument specifications for DLS measurements with a Zetasizer Nano S (Malvern) and 
TEM measurements with a LIBRA 120 (Zeiss) are listed in Table 7 and Table 8. Other 
special laboratory equipment used was a Biofuge Primo (Thermo Electron Fischer) 
centrifuge; a Discover (CEM) microwave oven; a DC scanner (Packard Instant Imager). 
Table 7: Specif ications of Zetasizer Nano S for DLS measurements 
Parameter Specification 
Measurement range 0.3 nm – 10.0 µm (diameter). 
Minimal sample volume 12 µl 
Measurement error +/-2 % for latex standards, traceable after NIST. 
Light source He-Ne-Laser, wave length: 633 nm, max. 4 mW. 
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Table 8: Specif ications of the used LIBRA 120 for TEM measurements 
Parameter Specification 
Electron Source LiB6-cristal 
Acceleration Voltage 80 and 120 kV 
Illumination System Koehler illumination system 
Objective Lenses Truly symmetrical type 
Resolution Point - Point 0.34 nm 
Information Limit <0.20 nm 
STEM <0.50 nm 
Spectrometer In-column OMEGA type 
Dispersion 1.17 µm/eV @ 120 kV 
Energy resolution <1.5 eV 
Imaging System 
Magnification zoom for imaging, diffraction 
and spectroscopy with 5 imaging lenses and 
OMEGA spectrometer. 
Magnification TEM 
STEM 
EELS 
8 - 630,000x 
50 - 1,000,000x 
20 - 315x 
System Control 
WinTEM™ Graphical User Interface (GUI) 
with Windows®XP 
 
3.2 Determination of nuclear reaction data for production of radio-
gadolinium 
As described in chapter 1.5.2 the two suitable candidates of gadolinium for SPECT imaging 
are 147Gd and 149Gd. Already available cross section data suggested higher production rates 
for deuteron and proton induced reactions on europium than those observed with the already 
established irradiation of enriched Sm isotopes with 3He and 4He by Denzler et al.[75] 
The cross sections, integral yields and some thick target yields were experimentally and 
arithmetically determined to evaluate if the production is worthwhile using deuteron and 
proton induced reactions on europium. 
 
3.2.1 Target preparation and stack assembly 
In general, cross sections of nuclear reactions are highly dependent on the particle energy. 
The energy degradation of charged particles in matter is rather high in comparison with 
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uncharged particles. Therefore, the earlier mentioned stacked-foil technique[89] was utilised to 
obtain several cross sections of nuclear reactions at different particle energies from one 
irradiation. Such stacked-foil targets consisted of 50 – 300 µm thin Al foils for particle energy 
degradation, 10 – 20 µm thin Al, Cu and Ni foils serving as monitors for determination of 
particle energy and beam current, as well as several sediments of the actual target material 
Eu2O3. Alternating the thickness of the Al degraders in the stack assembly lead to slightly 
different effective projectile energies in the individual target samples during each irradiation. 
These results in interleaved particle energy sets of the different irradiations and produces a 
cross section data over a broad but fine meshed energy spectrum. 
Due to this strong particle energy dependence, cross section determinations with charged 
particles are in need of thin cross section targets with a high homogeneity and well-defined 
elemental compositions to minimise the experimental uncertainty. This can be realised by 
using thin foils of the zero-valent oxidation state, i.e. the elemental metal, for many 
compounds. Unfortunately, elemental europium is one of the most reactive lanthanides. 
Already a contact with air at room temperature leads to oxidation which affects the area 
weight altogether with the energy degradation in the target noticeably. If heated to about 
180 °C, elemental europium self-ignites in the presence of air forming Eu2O3. Thus, handling 
an elemental europium target would need to be done under strictly inert conditions, whereas 
use of trivalent europium as Eu2O3 does not require any special precautions. It occurs as 
fine, slightly hygroscopic white powder and can be used for preparation of sediment targets 
with high homogeneity and well-defined area weights. 
The basic sedimentation technique used here was published by Rösch et al.[120] and was only 
adjusted in size to conform to the available target stations described below. Aluminium foils 
of 50 µm thickness and a diameter of 15 mm were used as sediment backings for a typical 
target for cross section measurements. This thickness was the optimal trade-off between a 
manageable stack assembly and additional interfering artefacts in the γ-spectrometric graphs 
from activation which is less in case of aluminium compared with other metals. 
Before sedimentation took place, the aluminium backings were etched for 1 min in a bath of 
6 M hydrochloric acid to increase adhesion of the sediments and cleaned thoroughly 
afterwards with pure water and 2-propanol. After weighing each foil three times, they were 
fixed in a Teflon sedimentation chamber with a volume of approx. 1.5 mL and an inner 
diameter of 13 mm. Europium oxide was then sedimented onto the aluminium foils from a 
finely dispersed ethanolic suspension. The thickness of sediments was carefully controlled 
by adjusting the concentration of europium oxide in the dispersion to achieve low energy 
degradation in the target, but still sufficient activities for measurement. The area mass 
density of a sediment was altered corresponding to its place in the stack from 0.0075 g/cm2 
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at lowest particle energies to 0.015 g/cm2 at the incident energy. After 2 to 4 h and nearly 
complete evaporation of ethanol the sediments were removed from the sedimentation 
chamber. The produced sediment discs were highly fragile and had to be handled with 
utmost care. If the evaporation time was too long, removal of discs from the sedimentation 
chamber was no longer possible as the sediments became too brittle and were destroyed in 
the process. 
Afterwards, the sediment discs were kept in an oven at 100°C as long as possible to assure 
complete dryness. After at least 6 h of drying the sediments were weighed threefold and 
carefully covered with aluminium foils of 20 µm thickness and a diameter of 18 mm. Figure 8 
shows different views of Eu2O3 sediments before and after wrapping. For storage, the 
sediments were kept in an oven at 100°C until the assembly of the stack took place. 
 
Figure 8: Uncovered (right) and covered (left) Eu2O3 sediment on 50 µm Al backing. 
 
Thick target preparation 
The sedimentation technique is limited by thickness. While very thin samples can be 
prepared with high quality, thick targets are very fragile and not fully homogeneous anymore. 
Considering this, thicker targets for measurement of the production rates and saturation 
yields were prepared differently. In this case europium oxide powder was pressed in a 
moulding (Supplier: ENERPAC) into pellets of varying thicknesses with a diameter of 10 mm. 
Application of 6.3 t/cm2 (62.5 kN/cm2) over 1-2 h was enough to produce pellets of sufficient 
stability and an area density of 1.01 g/cm2 or 1.72 g/cm2. The prepared pellets were dried in 
an oven for at least 6 h at 100°C before weighing. Afterwards they were completely wrapped 
in 10 µm thick copper foil on top of a 50 µm thick copper backing which was 13 mm in 
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diameter. Such prepared thick targets were stable enough to endure beam currents up to 
0.5 µA without weight loss or visible physical change. 
 
3.2.2 Irradiation facilities and irradiations 
Two different target stations of the cyclotron JULIC were used for irradiations. The deuteron 
bombardments were all done at the internal target system while the proton bombardments 
took place at the new external target system depicted in Figure 9. 
The schematics of the stacked-foil target support systems are shown in the lower right and 
upper left corner of Figure 10. In the internal target system, the deuteron beam was extracted 
with a stripper foil, guided through an aperture and directly let onto the target. The deuteron 
incident energy was 75.0 ± 0.4 MeV and the nominal beam current was 200 nA which was 
maintained for 4 h. 
The prime advantage of the external target is the additional focusing of the particle beam 
with a quadrupole magnet in combination with a 4 sector aperture for the individual beam 
modulation in close proximity of the target. The simpler target handling, the improved cooling 
system, including a helium-gas cooled injector foil as well as a larger cooling area compared 
to the internal target system is furthermore more suitable for irradiating fragile targets or for 
irradiations with higher beam currents of up to 3 µA. 
 
Figure 9: Picture of the external target system of cyclotron JULIC with 4 sector 
aperture, cooling and vacuum system. 
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Figure 10: Scheme of the internal and external target system of the JULIC cyclotron 
as well as standard stack composition. 
A further important point for introduction of the new target system was the problematic 
modulation of the proton beam which could not be sufficiently focused in the internal target 
system (see chapter 3.2.3). Therefore, proton cross section experiments were carried out at 
the external target system with proton incident energies of 45.1 ± 0.3 MeV and a nominal 
beam current of 200 nA over 2 h. 
 
3.2.3 Beam profile, beam current and particle energy analysis 
For the reliability of the experiments, and hence, reliability of the determined nuclear reaction 
data, several parameters had to be analyzed carefully for each irradiation. These were the 
final beam position, the beam spreading throughout the target, the particle energy 
degradation, and the beam current or particle flux density. 
The final beam position and eventual spreading of the beam in the target were checked by 
measuring the first and last monitor foils with a DC scanner (Packard Instant Imager) after 
the irradiations. Due to the lack of a graphical overlay with a real time picture, the foils were 
placed on a target matrix consisting of two circles, whose physical dimensions (diameter: 16 
and 20 mm) were marked with 4 dots of 22Na each. The scanner revealed the activation 
profile of the monitor foils with the necessary spatial orientation from the target matrix (see 
Figure 11). Therewith the dimensions and the position of the beam spot could be assessed 
by investigating the activation profile of the monitor foils relative to the 22Na spots. 
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Figure 11: Beam position in a proton test irradiation at the internal target with a 
circular area of 15 mm in diameter to i l lustrate the monitor foil position 
and dimension. 
While the nominal beam current can be easily determined by a faraday cup, the effective 
beam current on the target foils can be quite different due to beam absorption or spreading. 
Therefore, the actual beam current as well as the particle energy was experimentally 
determined from the already mentioned Al, Ni and Cu monitor foils in front of every Eu2O3 
sediment target. 
The general principle behind the use of those monitor foils is based on the evaluated nuclear 
monitor reactions, namely natAl(d,x)22,24Na, natNi(p,x)57Ni, natCu(p,x)62,63,65Zn, and their well-
defined excitation functions which are summarised and published in IAEA-TECDOC-
1211[121]. If both the effective particle energies of the monitor foils within the target stack and 
the cross section of the respective monitor reactions are known, only a simple mathematical 
conversion of the above mentioned activation equation 6 is needed to calculate the beam 
flux or current: 
𝜙𝜙 = 𝐴𝐴
𝜎𝜎 ∙ 𝑁𝑁 ∙ (1 − 𝑒𝑒−𝜆𝜆𝑡𝑡𝑖𝑖𝑖𝑖𝑖𝑖) ∙ 𝑒𝑒−𝜆𝜆𝑡𝑡𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 
with: φ : particle flux density, 
A: half-life corrected activity of the produced monitor nuclide at EOB, 
σ : cross section of the monitor nuclide at the corresponding particle energy, 
Ν : number of irradiated, inactive monitor atoms, 
λ : decay constant of the produced monitor nuclide, 
tirr: irradiation time, 
tcool: time from the end of bombardment to the γ-ray measurement. 
The calculation of the particle energy degradation which is needed for measurement of the 
beam current and for determination of the reaction cross section was realised with the Excel-
routine STACK which is based on arithmetical calculations from Bethe and Bloch[122] with a 
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numerical adjustment from Williamson[123]. Additionally, the particle energy was experi-
mentally determined by using the cross section ratio of two independent nuclear reactions. 
The theoretical calculated particle energies were used for planning of the cross section 
interleave between different irradiations beforehand and corrected with the experimentally 
determined particle energies afterwards. An example of the calculated energy degradation 
for the proton irradiation by STACK is shown in Table 9. 
Table 9: STACK calculation of the proton irradiation of Eu2O3 sediment targets. 
 
 
Legend
Projectile data copper monitor foil
Name
Proton 
number
Molar 
nass
Incident 
energy
Eu2O3 sediment target
opr upr startener precision nickel monitor foil
H 1 1.0079 45 100 aluminium absorber
Target-Daten
No.: Target
Protons 
target
Mass Weight Diameter Area density
Average 
energy
Incident 
energy
Exit energy
Energy 
absorption
1 Cu 29 63.546 0.041 15.0 2.319E-02 44.90 45.00 44.80 0.20
2 Eu 63 151.96 0.01367 13.0 1.030E-02 44.66 44.80 44.53 0.26
3 Al 13 26.982 0.04527 15.0 2.562E-02 44.40 44.53 44.26 0.27
4 Ni 28 58.7 0.03907 15.0 2.211E-02 44.16 44.26 44.05 0.21
5 Eu 63 151.96 0.01570 13.0 1.183E-02 43.91 44.05 43.77 0.28
6 Al 13 26.982 0.04553 15.0 2.576E-02 43.63 43.77 43.50 0.28
7 Al 13 26.982 0.04536 15.0 2.567E-02 43.36 43.50 43.22 0.28
8 Cu 29 63.546 0.0411 15.0 2.324E-02 43.11 43.22 43.01 0.21
9 Eu 63 151.96 0.01362 13.0 1.026E-02 42.87 43.01 42.74 0.27
10 Al 13 26.982 0.04565 15.0 2.583E-02 42.59 42.74 42.45 0.28
11 Al 13 26.982 0.04555 15.0 2.578E-02 42.31 42.45 42.17 0.28
12 Ni 28 58.7 0.03853 15.0 2.180E-02 42.06 42.17 41.96 0.21
13 Eu 63 151.96 0.01439 13.0 1.084E-02 41.81 41.96 41.67 0.28
14 Al 13 26.982 0.04554 15.0 2.577E-02 41.53 41.67 41.38 0.29
15 Cu 29 63.546 0.041 15.0 2.318E-02 41.28 41.38 41.17 0.22
16 Eu 63 151.96 0.01480 13.0 1.115E-02 41.02 41.17 40.88 0.29
17 Al 13 26.982 0.04553 15.0 2.576E-02 40.73 40.88 40.59 0.29
18 Al 13 26.982 0.04555 15.0 2.578E-02 40.44 40.59 40.29 0.29
19 Ni 28 58.7 0.03898 15.0 2.206E-02 40.18 40.29 40.07 0.22
20 Eu 63 151.96 0.01371 13.0 1.033E-02 39.93 40.07 39.78 0.29
21 Al 13 26.982 0.11962 15.0 6.769E-02 39.39 39.78 38.99 0.79
22 Al 13 26.982 0.11973 15.0 6.775E-02 38.59 38.99 38.19 0.80
23 Al 13 26.982 0.04543 15.0 2.571E-02 38.04 38.19 37.88 0.31
24 Cu 29 63.546 0.041 15.0 2.319E-02 37.77 37.88 37.65 0.23
25 Eu 63 151.96 0.01509 13.0 1.137E-02 37.50 37.65 37.34 0.31
26 Al 13 26.982 0.11990 15.0 6.785E-02 36.92 37.34 36.51 0.83
27 Al 13 26.982 0.11975 15.0 6.776E-02 36.09 36.51 35.66 0.85
28 Al 13 26.982 0.04538 15.0 2.568E-02 35.50 35.66 35.34 0.32
29 Ni 28 58.7 0.03902 15.0 2.208E-02 35.22 35.34 35.09 0.25
30 Eu 63 151.96 0.01554 13.0 1.171E-02 34.93 35.09 34.76 0.33
31 Al 13 26.982 0.11992 15.0 6.786E-02 34.32 34.76 33.88 0.88
32 Al 13 26.982 0.11964 15.0 6.770E-02 33.43 33.88 32.99 0.90
33 Cu 29 63.546 0.041 15.0 2.320E-02 32.86 32.99 32.73 0.26
34 Eu 63 151.96 0.01398 13.0 1.053E-02 32.56 32.73 32.39 0.34
35 Al 13 26.982 0.11990 15.0 6.785E-02 31.92 32.39 31.46 0.93
36 Al 13 26.982 0.11990 15.0 6.785E-02 30.98 31.46 30.51 0.95
37 Ni 28 58.7 0.04004 15.0 2.266E-02 30.37 30.51 30.23 0.28
38 Eu 63 151.96 0.01650 13.0 1.243E-02 30.05 30.23 29.88 0.34
39 Al 13 26.982 0.11990 15.0 6.785E-02 29.39 29.88 28.89 0.99
40 Al 13 26.982 0.04549 15.0 2.574E-02 28.70 28.89 28.51 0.38
41 Al 13 26.982 0.04544 15.0 2.571E-02 28.31 28.51 28.12 0.39
42 Cu 29 63.546 0.0425 15.0 2.403E-02 27.97 28.12 27.82 0.30
43 Eu 63 151.96 0.01596 13.0 1.202E-02 27.64 27.82 27.46 0.36
44 Al 13 26.982 0.11990 15.0 6.785E-02 26.93 27.46 26.39 1.06
45 Al 13 26.982 0.04542 15.0 2.570E-02 26.19 26.39 25.98 0.41
46 Al 13 26.982 0.04545 15.0 2.572E-02 25.77 25.98 25.57 0.42
47 Ni 28 58.7 0.03894 15.0 2.203E-02 25.41 25.57 25.25 0.31
48 Eu 63 151.96 0.01362 13.0 1.026E-02 25.07 25.25 24.88 0.37
49 Al 13 26.982 0.11990 15.0 6.785E-02 24.31 24.88 23.73 1.15
50 Al 13 26.982 0.04543 15.0 2.571E-02 23.51 23.73 23.28 0.45
51 Cu 29 63.546 0.041 15.0 2.321E-02 23.11 23.28 22.95 0.34
52 Eu 63 151.96 0.01265 13.0 9.532E-03 22.75 22.95 22.56 0.39
[MeV] [MeV][g/mol] [g] [mm] [g/cm2] [MeV] [MeV]
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The disadvantage of the STACK software is its inability to calculate the energy degradation 
of chemical compounds like europium oxide directly. The routine is only designed to iterate 
the degradation in elemental materials, hence, for calculation in a compound the composing 
elements have to be handled separately. It was possible to simulate a homogenous 
compound by adding up the degradation of nearly infinitesimal thin layers of the alternating 
elements (see Table 10). 
Table 10: STACK calculation of Eu2O3 sediments for layer simulation. 
 
The mass of the corresponding layers was calculated by formula 10: 
𝑚𝑚𝑆𝑆𝐸𝐸/𝑂𝑂 = 𝑚𝑚𝑠𝑠𝑒𝑒𝑠𝑠𝑠𝑠𝑚𝑚𝑒𝑒𝑠𝑠𝑡𝑡 ∙ 𝑀𝑀𝑠𝑠𝑎𝑎𝑝𝑝𝑡𝑡𝑙𝑙 ∙ 𝑀𝑀𝑆𝑆𝐸𝐸2𝑂𝑂3  
with 𝑚𝑚𝑆𝑆𝐸𝐸/𝑂𝑂: mass of corresponding element in one simulated layer, 
𝑚𝑚𝑠𝑠𝑒𝑒𝑠𝑠𝑠𝑠𝑚𝑚𝑒𝑒𝑠𝑠𝑡𝑡: mass of the complete sediment, 
𝑀𝑀𝑠𝑠𝑎𝑎𝑝𝑝𝑡𝑡: molar weight part of Eu / O in Eu2O3, 
𝑙𝑙: number of layers, 
𝑀𝑀𝑆𝑆𝐸𝐸2𝑂𝑂3: molar mass of Eu2O3. 
Projectile data
Name
Proton 
number
Molar nass
Incident 
energy
No. of 
foils  
opr upr startenergy precision
H 1 1.0079 44.87 100
Target-Daten
No.: Target
protons 
target
Mass Weight Diameter Description Area density
average 
energy
incident 
energy
Exit energy
Energy 
absorptio
n
[g/mol] [g] [mm] [g/cm2] [MeV] [MeV] [MeV] [MeV]
otrg utrg weight dfolie flweight energy_in energy_out
1 Al 13 26.98154 0.00726 18.0 2.853E-03 44.86 44.87 44.84 0.03
1 Eu 63 151.96 0.00137 13.0 1.030E-03 44.84 44.84 44.83 0.01
2 O 8 15.9994 0.00022 13.0 1.626E-04 44.83 44.83 44.83 0.00
4 Eu 63 151.96 0.00137 13.0 1.030E-03 44.83 44.83 44.82 0.01
5 O 8 15.9994 0.00022 13.0 1.626E-04 44.82 44.82 44.82 0.00
6 Eu 63 151.96 0.00137 13.0 1.030E-03 44.82 44.82 44.82 0.01
8 O 8 15.9994 0.00022 13.0 1.626E-04 44.81 44.82 44.81 0.00
9 Eu 63 151.96 0.00137 13.0 1.030E-03 44.81 44.81 44.81 0.01
10 O 8 15.9994 0.00022 13.0 1.626E-04 44.81 44.81 44.80 0.00
11 Eu 63 151.96 0.00137 13.0 1.030E-03 44.80 44.80 44.80 0.01
12 O 8 15.9994 0.00022 13.0 1.626E-04 44.80 44.80 44.80 0.00
13 Eu 63 151.96 0.00137 13.0 1.030E-03 44.79 44.80 44.79 0.01
14 O 8 15.9994 0.00022 13.0 1.626E-04 44.79 44.79 44.79 0.00
15 Eu 63 151.96 0.00137 13.0 1.030E-03 44.78 44.79 44.78 0.01
16 O 8 15.9994 0.00022 13.0 1.626E-04 44.78 44.78 44.78 0.00
17 Eu 63 151.96 0.00137 13.0 1.030E-03 44.77 44.78 44.77 0.01
18 O 8 15.9994 0.00022 13.0 1.626E-04 44.77 44.77 44.77 0.00
19 Eu 63 151.96 0.00137 13.0 1.030E-03 44.76 44.77 44.76 0.01
20 O 8 15.9994 0.00022 13.0 1.626E-04 44.76 44.76 44.76 0.00
21 Eu 63 151.96 0.00137 13.0 1.030E-03 44.76 44.76 44.75 0.01
22 O 8 15.9994 0.00022 13.0 1.626E-04 44.75 44.75 44.75 0.00
23 Al 13 26.98154 0.02353 15.0 1.332E-02 44.68 44.75 44.61 0.14
sum 0.09
sim layer 4
sim layer 5
sim layer 6
sim layer 7
cover foil
backing
sim layer 1
sim layer 8
sim layer 9
sim layer 10
sim layer 2
sim layer 3
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Two nuclear reactions induced in the same monitor foil are needed for the experimental 
determination of the particle energy.[124] The particle energy was therefore determined 
independently of the beam current and particle flux density by calculating the cross section 
ratios of the natAl(d,x)22,24Na reactions and the natCu(p,x)62,63Zn reactions known from 
literature[121]. In Figure 12 these calculated ratios are plotted against the corresponding 
particle energy for the deuteron and proton induced reactions. 
A unique particle energy to cross section ratio assignment was achieved by dividing the 
energy range into subsets and fitting each subset with precise functions using the software 
TableCurve 2D. The fitted functions were used to determine the particle energy in each 
monitor foil as the calculated cross section ratio is equivalent to the experimentally measured 
activity ratio at the end of bombardment (EOB). 
  
Figure 12: Cross section ratio of deuteron induced 27Al(d,x)22,24Na (left) and proton 
induced na tCu(p,xn)62,63Zn (r ight) nuclear reactions derived from the 
recommended data of the data collection IAEA-TECDOC-1211[121 ].  
The incident energy as well as the degradation throughout the stacks derived from the 
STACK software was checked and eventually corrected this way. The monitor foils were 
measured twice with γ-ray spectrometers: One short measurement directly after irradiation 
and one extended measurement for long-lived monitor nuclides, i.e. 22Na  and 65Zn. Activities 
were calculated using γ-ray intensities given by IAEA-TECDOC-1211[121], even if they 
deviated from most recently published γ-ray data[60] (see Table 11). This was done to 
maintain the internal integrity between the recommended and our measured data. 
Unfortunately, no other recommended cross section data of monitor reactions suitable for the 
experimental particle energy determination will be available in literature until the next revised 
version of IAEA-TECDOC-1211 is published. 
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Table 11: Half-l ives, γ-ray energies and intensities of used monitor radionuclides 
from the electronic version of IAEA-TECDOC[121] and ENSDF[60] . 
Isotope Half-life 
γ-ray [keV] 
(intensity [%]) 
IAEA-TECDOC 
γ-ray [keV] 
(intensity [%]) 
ENSDF 
22Na 2.602 a 1274.5 (99.94) 1274.6 (99.94) 
24Na 14.650 h 1368.6 (100) 1368.6 (99.99) 
57Ni 35.60 h 
127.2 (12.9) 127.2 (16.67) 
1377.6 (77.9) 1377.6 (81.7) 
62Zn 9.193 h 
548.4 (15.2) 548.4 (15.34) 
596.7 (25.7) 596.6 (26.0) 
63Zn 38.47 min 
669.8 (8.4) 669.6 (8.2) 
962.2 (6.6) 962.0 (6.48) 
65Zn 244.26 d 1115.5 (50.75) 1115.5 (50.04) 
 
3.2.4 Cross section measurements and calculations 
Due to high dose rates after irradiation of the target stacks some cool down time of at least 
1 h was allowed after EOB for the decay of short-lived activation by-products, such as 13N 
and 15O, produced by natO(p,x) or natO(d,x) reactions, before first measurements took place. 
Non-destructive measurements of all targets were done after separating the monitor foils and 
sediments. Samples were measured several times with different time intervals after the EOB 
using γ-ray spectrometers for a quantitative registration of the radioactivity. Thereby, 
measurements of both shorter- (147,149Gd) and longer-lived (146,151,153Gd) radioisotopes were 
appropriately performed over the investigated energy range. Every investigated radionuclide 
possesses at least two separate γ-ray energies (see Table 2) which were both used for 
identification and determination of absolute radioactivity at EOB. The decay rates were 
individually calculated from the photo peak areas for each γ-ray by equation 11[125]: 
𝐴𝐴𝐸𝐸𝑠𝑠𝑢𝑢𝑜𝑜𝑝𝑝𝑝𝑝 = 𝐶𝐶𝑑𝑑𝑙𝑙𝑠𝑠𝑙𝑙𝑒𝑒 ∙ 𝜀𝜀 ∙ 𝑒𝑒𝑒𝑒
with Auncorr: decay rate of a radionuclide specific γ-ray without half-life correction in 
 decays/s, 
C: counting events in a photo peak of a γ-ray integrated by a Gaussian bell 
curve with baseline correction, 
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tlife: active measurement time of the γ-ray detector corrected for dead time in sec, 
ε: efficiency of the detector at given distance and geometry, 
ep: emission probability of the specific γ-ray. 
This decay rate had to be corrected for the decay occurring during the time of measurement 
(eq. 12)[125] as well as the time elapsed since EOB (eq. 13)[125]: 
𝐴𝐴𝑜𝑜𝑒𝑒𝑏𝑏𝑠𝑠𝑠𝑠 𝑚𝑚𝑒𝑒𝑎𝑎𝑠𝑠𝐸𝐸𝑝𝑝𝑒𝑒𝑚𝑚𝑒𝑒𝑠𝑠𝑡𝑡 = 𝐴𝐴𝐸𝐸𝑠𝑠𝑢𝑢𝑜𝑜𝑝𝑝𝑝𝑝 ∙ 𝜆𝜆 ∙ 𝑑𝑑𝑝𝑝𝑒𝑒𝑎𝑎𝑙𝑙(1 − 𝑒𝑒−𝜆𝜆∙𝑡𝑡𝑖𝑖𝑟𝑟𝑟𝑟𝑐𝑐)  
𝐴𝐴𝑢𝑢𝑜𝑜𝑝𝑝𝑝𝑝 𝑆𝑆𝑂𝑂𝐸𝐸 = 𝐴𝐴𝑜𝑜𝑒𝑒𝑏𝑏𝑠𝑠𝑠𝑠 𝑚𝑚𝑒𝑒𝑎𝑎𝑠𝑠𝐸𝐸𝑝𝑝𝑒𝑒𝑚𝑚𝑒𝑒𝑠𝑠𝑡𝑡 ∙ 𝑒𝑒𝜆𝜆∙𝑡𝑡𝑖𝑖𝑟𝑟𝑟𝑟𝑐𝑐 
with Abegin measurement: corrected activity at the starting time of the measurement, 
 treal: real time elapsed during measurement, 
 λ: decay constant of corresponding radionuclide, 
 Acorr EOB: corrected activity at the end of bombardment. 
This resulted in the absolute activity Acorr of the produced radionuclides at the EOB. Cross 
sections were subsequently calculated with these absolute activities and the experimentally 
determined beam current using the converted activation equation 14[80]: 
𝜎𝜎 = 𝐴𝐴𝑢𝑢𝑜𝑜𝑝𝑝𝑝𝑝 𝑆𝑆𝑂𝑂𝐸𝐸 ∙ 𝑀𝑀
𝜙𝜙 ∙ 𝑎𝑎𝑑𝑑 ∙ 𝑁𝑁𝐴𝐴
∙ 1028 
with: σ : cross section of the monitor nuclide at the given particle energy in barn, 
Acorr EOB: absolute activity of the corresponding radionuclide at EOB in Bq, 
M: molar mass of the target nuclei in gram/mol, 
φ : particle flux density in particles/cm2, 
ad: area density of the target g/cm2, 
NA : Avogadro’s constant. 
 
3.2.5 Integral and experimental thick target yield measurements and 
calculations 
The radionuclide production yields from proton induced reactions on elemental Eu were 
determined experimentally as well as calculated by the integral yield approach. For the latter, 
increments of 1 MeV projectile energy degradation were chosen for the compilation. The 
respective area densities needed for this energy degradation of 1 MeV were calculated up to 
the incident particle energy with STACK. Additionally, excitation functions were derived from 
the measured cross sections by iterating curve trend with the program TableCurve 2D (see 
Figure 13). 
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Figure 13: Iterated curve progression by the program TableCurve 2D for the 
determination of the excitation function of natEu(p,xn)147Gd. 
Based on the derived cross section values for each energy increment and the corresponding 
area density, the radioactivity produced in the chosen 1 MeV intervals was calculated using 
the activation equation. The integral production rates per hour (IntYprod) and the integral 
saturation yields (IntYsat) described in equation 15 were calculated by integrating the 
produced activity over all intervals. 
𝐼𝐼𝐼𝐼𝑑𝑑𝐼𝐼𝑠𝑠𝑝𝑝𝑜𝑜𝑠𝑠/𝑠𝑠𝑎𝑎𝑡𝑡 = �  𝑚𝑚𝑆𝑆𝑀𝑀 ∙ 𝑁𝑁𝐴𝐴 ∙ 𝜎𝜎𝑆𝑆 ∙ �1 − 𝑒𝑒−𝜆𝜆𝑡𝑡𝑝𝑝𝑖𝑖𝑐𝑐𝑝𝑝/𝑠𝑠𝑟𝑟𝑠𝑠�1𝜇𝜇𝐴𝐴𝑆𝑆=𝑚𝑚𝑎𝑎𝑥𝑥
𝑆𝑆=𝑚𝑚𝑠𝑠𝑠𝑠
 
with E = max: maximal available projectile energy of measured cross sections, 
 E = thrs: minimal available projectile energy of measured cross sections, 
 me: mass of corresponding increment, 
tprod/sat: 1 h / 10 times half-life of the corresponding nuclide in sec. 
The experimental thick target yields were determined by irradiating targets of Eu2O3-pellets 
with a diameter of 10 mm and area densities of 1.01 or 1.72 g/cm2. The area densities were 
chosen to include the complete production of 147Gd in the higher and to cover the first 
maximum of the 149Gd excitation function in the lower energy range. 
A non-destructive measurement of the irradiated Eu2O3-pellet was not possible because of 
the large amount of produced radioactivity in the pellets. Therefore, irradiated pellets were 
completely dissolved in 3 - 4 mL 6 M hydrochloric acid overnight. Afterwards two 100 µl 
aliquots were prepared in 1.5 mL Eppendorf vials to assure near point-source geometry for γ-
ray spectroscopy. The γ-ray measurements were conducted as described above. The whole 
procedure is illustrated in Figure 14. 
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Figure 14: Partial measurement technique for highly radioactive Eu2O3 targets. 
 
The incident and exit energy in the target as well as the respective beam current were 
confirmed via the monitor reactions natCu(p,x)62,63Zn as described in chapter 3.2.3. Thereafter, 
the production rates per hour (TTYprod) and the saturation yields (TTYsat) were arithmetically 
obtained by equation 16: 
𝑇𝑇𝑇𝑇𝐼𝐼𝑠𝑠𝑝𝑝𝑜𝑜𝑠𝑠/𝑠𝑠𝑎𝑎𝑡𝑡 = 𝐴𝐴𝑢𝑢𝑜𝑜𝑝𝑝𝑝𝑝 𝑆𝑆𝑂𝑂𝐸𝐸 ∙ �1 − 𝑒𝑒−𝜆𝜆∙𝑡𝑡𝑝𝑝𝑖𝑖𝑐𝑐𝑝𝑝/𝑠𝑠𝑟𝑟𝑠𝑠�𝐼𝐼 ∙ (1 − 𝑒𝑒−𝜆𝜆∙𝑡𝑡𝑖𝑖𝑖𝑖𝑖𝑖)  
with Acorr EOB: corrected activity at EOB in Bq, 
λ: decay constant of the corresponding nuclide in 1/sec, 
tprod/sat: 1 h / 10 times half-life of the corresponding nuclide in sec, 
Ι: charged particle induced current in µA, 
tirr: irradiation time in sec. 
 
3.3 Separation of n.c.a 147/149Gd from bulk natEu with a Na-Hg amalgam 
extraction 
A macroscopic separation method for the removal of the bulk europium target material was 
tested and optimised. The separation of samarium and n.c.a europium from gadolinium was 
previously developed by Malan and Munzel[108] and later on successfully used by Denzler et 
al.[78]. An adaptation of the procedure of Malan and Munzel was used to separate europium 
from gadolinium by Lebedev et al.[77]. For a nearly quantitative removal of europium from 
n.c.a. radiogadolinium the separation had to be adapted and optimised. Therefore systematic 
studies were conducted and new optimised separation parameters determined. 
The separation apparatus of Denzler et al. was adapted with slight modifications and is 
shown in Figure 15. The separations were assessed with a self-synthesised 149Gd stock-
solution to which inactive Europium was added in order to achieve target-like conditions. For 
the preparation of the 149Gd solution Eu2O3-pellets with area densities of 0.83 g/cm2 and a 
diameter of 13 mm were irradiated at the cyclotron JULIC for 2 - 3 h with a nominal beam 
current of 1 µA. The targets were dissolved overnight in 4 mL 6 M hydrochloric acid. An 
inactive Eu3+ solution (25 wt%) was prepared by dissolving Eu2O3 powder in 6 M hydrochloric 
acid within 5 min. The solution for aqueous separation was prepared by mixing appropriate 
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amounts of the 149Gd/147Eu solution and of the europium stock-solution (20 wt% Eu2O3), 
heating it to dryness and re-dissolving the white, solid residue in 25 mL of a 1 M saline 
solution buffered with 0.4 M sodium acetate. Afterwards the pH of the solution was adjusted 
to 2 – 3 using 0.5-0.8 mL concentrated hydrochloric acid. 
Sodium mercury amalgam with 20 wt% of sodium was obtained from Sigma-Aldrich Co. The 
solid amalgam was diluted with elemental mercury in a small glove box under inert 
atmosphere yielding a liquid amalgam with 0.4 wt% sodium content. The diluted amalgam 
was stable for some weeks, when it was covered by dry ethanol under inert atmosphere in a 
tightly sealed glass bottle. The saline solution was added into the separation funnel first and 
the amalgam added directly afterwards. 
 
Figure 15: Extraction apparatus, adapted from Denzler et al.[78] .  
 
Three main separation parameters were systematically studied: The influence of europium 
mass, the sodium mercury amalgam mass, and the influence of the separation time. The 
europium mass was stepwise increased from 50 to 500 mg. The amount of amalgam was 
also stepwise increased from 5 to 10 mL with 500 mg europium present at the beginning of 
the separations. The time dependence of extraction was determined over 30 min with 
500 mg europium and 10 mL amalgam. 
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In the assessment of the influence of europium and amalgam mass on the extraction, the 
residual 149Gd and 147Eu in solution were analysed by γ-spectrometric measurements of 1 mL 
aliquots before and after the separation. In order to measure the progress of the separation 
after different time intervals an on-line sampling of 0.5 mL aliquots with subsequent γ-
spectrometric measurement was done over the course of the separation. ICP-MS analysis 
was utilised complementary to the γ-spectrometry for low europium concentrations. 
The separations can be compared by calculation of the distribution coefficients as described 
in eq. 7 with the stationary phase corresponding to the amalgam phase and the mobile 
phase corresponding to the aqueous solution. 
 
3.4 Preparation of 147/149Gd-DOTA and biodistribution measurements 
in and ex vivo on rats 
As a proof of principle the applicability of 147/149Gd for authentic labelling of MRI contrast 
agents was tested with the already existing and FDA approved 1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) ligand as complexing agent. For 
this labelling 147/149Gd was separated from the irradiated bulk of target material Eu2O3, the 
complex was synthesised, the complex stability was measured under varying conditions, and 
the labelled compound injected into a tumour bearing rat. 
 
3.4.1 Separation of 147/149Gd from Eu2O3 
A 500 mg pellet of natural europium oxide was prepared as described above and irradiated 
at the cyclotron JULIC for 3 h with a beam current of 2 µA. The pellet was dissolved in 4 mL 
6 M hydrochloric acid and evaporated to dryness. The newly determined optimal 
experimental parameters of the sodium-mercury amalgam separation described in detail in 
chapters 3.3 and 4.2 were used for the preparation of n.c.a. 147/149Gd with trace amounts of 
Eu. Therefore, the white residue was dissolved in 25 mL of a 1 M NaCl solution buffered with 
0.4 M NaOAc. The solution was adjusted to a pH of 2, purged with Ar in an ultrasonic bath 
for 15 min and added to the separation funnel which was already flooded with Ar. After an 
additional 5 min Ar purge of the solution, 10 mL Na-Hg amalgam was weighed and added 
rapidly into the funnel. The binary mixture was intensely stirred for 20 min while a steady 
stream of Ar was bubbled through the solution. 
From the resulting solution sodium acetate and sodium chloride (ca. 0.7 g) were removed 
with the extraction resin DGA normal. A column was prepared by packing 0.4 g previously 
soaked and sonicated DGA normal resin under 3 bar pressure into a column with a diameter 
of 0.5 cm. The separation solution was acidified with 65 % nitric acid to a 1 M nitric acid 
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concentration. The residual traces of europium and radioactive gadolinium were 
quantitatively bound on the DGA normal resin in 1 M nitric acid and eluted with approx. 
25 mL of 0.1 M hydrochloric acid with a flow speed of 2 mL/min. The resulting fractions were 
evaporated to dryness, and the residues were dissolved in 2 mL of H2O. The europium 
content was determined by ICP-MS. 
 
3.4.2 147/149Gd-DOTA complex synthesis and stability tests 
Two approaches for the formation of the DOTA complex with Sc or Gd known from literature 
were tested for the n.c.a and c.a. synthesis of 147/149/natGd-DOTA.[126, 127]. 
In the first method, 100 µL of the stock-solution was added to 0.5 mL of a 0.1 M sodium 
acetate puffer solution with 30 mg DOTA ligand dissolved. The pH of the solution was 
adjusted with 1 M sodium hydroxide solution to 5.0 and the solution stirred at 40°C for 24 h. 
Then the solution was analysed with a radio thin layer chromatographic (TLC) system 
adapted from Huclier-Markai et al.[127]. The mobile phase consisted of a 2:1:1 volume mixture 
of NH4OH(25 %):MeOH:H2O and the stationary phase of silica gel with a manganese 
activated zinc oxide as fluorescence indicator. After an exposure time of 30 – 45 min the thin 
layer plate was measured in an Instant imager. Free ionic Gd3+ showed a retention factor of 
Rf = 0 and Gd-DOTA of Rf = 1. 
In the second method, 100 µL of the stock-solution was added to 0.5 mL of a 1 M sodium 
acetate puffer solution with 5 mg dissolved DOTA ligand. The carrier added synthesis was 
tested with the same method by addition of 0.19 mg (0.1 eq) inactive Gd3+ carrier to the 
starting solution. Both mixtures were heated to 90°C for 20 min. After 5 min and 20 min 
radio-TLC was performed as described above. 
The stability tests were conducted with the n.c.a as well as the c.a. Gd-DOTA complex. For 
this, 10 µL of the Gd-DOTA complex solution was added to 0.5 mL of a PBS puffer system. 
The solution was stirred for 24 h at 40°C and then analysed by radio TLC. The procedure 
was repeated with 0.5 mL human blood serum (HBS) by addition of 10 µL c.a. or n.c.a. Gd-
DOTA solution and shaking for 56 h and also 144 h at 37°C in a ThermoMixer (Eppendorf). 
The analysis method had to be slightly adapted for HBS. The protein content of the HBS had 
to be denaturated with 1 mL of acetonitrile. The suspension was centrifuged to separate the 
clear liquid which was then used for radio TLC with the parameters described above. 
 
3.4.3 In and ex vivo imaging of the 147/149Gd-DOTA complex 
The previously described complex was injected into F98 glioma bearing male Wistar rats by 
colleagues at the Institute of Neuroscience and Medicine, INM-4: Medical Imaging Physics, 
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but are mentioned here for complete description of all experiments done. For comparison the 
rats were first injected with inactive DOTArem™ and measured in a 3T MRI camera and 
afterwards injected with the radioactive natEu/147,149Gd cocktail. The tumour was measured by 
autoradiographic methods. The experiments were done once with an n.c.a. and once with a 
c.a. preparation of 147,149Gd-DOTA. 
The n.c.a experiment was conducted 8 days and the c.a. experiment 2 weeks post 
implantation of the glioma. In both experiments 0.3 mmol/kg of the commercial contrast 
agent was injected intravenously and T2-weighted SPC Inversion Recovery (similar to clinical 
“FLAIR – Fluid Attenuated Inversion Recovery”[128]) measurements as well as T1-weighted 
Magnetization Prepared Rapid Gradient Echo (MP-RAGE)[128] before and after the 
application of contrast agent were done. 
The ex vivo imaging was done with the 147,149Gd-DOTA complex synthesised at 90°C in 
0.5 mL of a 0.1 M sodium acetate puffer solution. After the synthesis the pH of the solution 
was adjusted to 7 with 1 M sodium hydroxide solution. In the experiment without carrier 
approx. 30 MBq of n.c.a. 149Gd-DOTA in 1 mL solution was injected into the rat intravenously. 
In the carrier added experiment, approx. 40 MBq of a 1:1 mixture of 147/149Gd-DOTA in 0.6 mL 
solution was mixed with 0.2 mL commercial available DOTArem™ to simulate carrier added 
conditions similar to the previous contrast enhanced MRI measurement. The mixture was 
also injected intravenously into a tumour bearing rat. For the ex vivo measurements the rat 
was sacrificed 10 min later and dissected. The rat’s brain was cut into 30 µm thick 
cryosections and the radioactivity measured by a cellulose acetate covered film (FUJI BAS-
IP MS) for ca. 15 h. A histological staining with the DNA fluorescent stain 4',6-diamidino-2-
phenylindole (DAPI) of the adjacent sections was concluded for comparison. 
 
3.5 Production of n.c.a. manganese-52g 
In a previous study[129] the proton induced reactions on natural chromium leading to 
radiomanganese and its separation from the bulk of target material were examined. For a 
better assessment of the production capabilities the thick target and integral yields had to be 
determined. Also, the isolation of the radionuclide had to be optimised because of the 
necessary complete removal of chloride ions. 
 
3.5.1 Integral and experimental thick target yields of radiomanganese 
For measurements of thick target yields and the development of an isolation of 52gMn from 
the target material natCr, circular targets (thickness: 1 mm, diameter: 13 mm) were wire 
eroded from cast disks of natCr (Goodfellow Ltd., purity 99.9 %). 
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Stacks of one cast chromium plate, copper monitor foils (10 µm thickness) and a copper 
beam stop for adequate thermal conductivity were irradiated at the Baby Cyclotron BC1710 
to measure experimental production rates and to determine saturated thick target yields. The 
irradiations were done with a beam current of 1 µA for 1 minute. 
The thick target yield over the proton energy range of 16.9 MeV to 8.2 MeV was 
experimentally determined to cover the full excitation function maximum of the nuclear 
reactions natCr(p,x)52g,mMn (see Figure 4). The targets were repeatedly measured non-
destructively with a γ-ray spectrometer, beginning approx. 60 min (three half-lives of 52mMn) 
after EOB. The production rates for a one hour irradiation as well as the saturation thick 
target yields were calculated by equation 16. The theoretical integral yields were calculated 
with the previously measured excitation functions[65] using the same approach described 
above in chapter 3.2.5. The results of calculations were compared with the experimental 
values. 
 
3.5.2 Development of a radiochemical separation of 52gMn and Cr 
52gMn was produced for development of a radiochemical separation method by irradiation of 
cast chromium disks with protons in the energy range of 16.9 → 8.2 MeV. 
First, a separation procedure of 54Mn and natCr found in literature[130] was tested for its 
applicability. The Cr target was therefore dissolved in conc. HCl, the solution evaporated to 
dryness and the residue dissolved in 5 mL 5 % oxalic acid. This solution was again 
evaporated to dryness and the residue re-dissolved in 50 mL of 5 % oxalic acid. This solution 
was loaded onto an Amberlite IR-120 column 1 cm in diameter and 2 cm long which was 
prewashed with ten column volumes of 5 % oxalic acid. The column was washed with 5 % 
oxalic acid for Cr elution. HPLC-grade pure water was passed through the column and 
afterwards the residual radioactivity eluted with 1M HCl. Stepwise several parameters of the 
separation were optimised which are discussed in chapter 4.4.2. 
The optimisation experiments of the known separation yielded no good results and the 
development of a new separation procedure was conducted by a two-step approach. At first 
a screening of distribution coefficients regarding an anion (Amberlite CG400™) and a cation 
exchange resin (DOWEX 50WX8™) with different eluents was performed searching a 
separation system. Secondly, eluents with promising distribution coefficients were used in 
chromatographic separations, and their capability evaluated to isolate 52gMn. 
For measurement of the distribution coefficients, the resins were dried in an oven overnight 
and 50-100 mg of it was weighted into a 2 mL Eppendorf reaction vial. The resins were 
conditioned with 1.5 mL of the eluents by joggling the mixture with a vortex shaker (Vortex-
Genie 2, Scientific Industries) for at least 24 h. 50 µL of a radioactive mixture consisting of 
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52gMn, 51Cr and non-radioactive chromium were then injected into the resin-eluent mixtures. 
Additionally, reference samples were prepared by diluting 50 µL of the same radioactive 
mixture with the respective eluent. Both were equilibrated for 1 h by joggling in a vortex 
shaker. After the liquid-solid separation a 500 µL aliquot was taken from the liquid phase of 
the mixtures and the reference samples for γ-spectrometric determination of the 
radionuclides present in the liquid phase. The reference samples were used for 
measurement of the absolute radioactivity of the injected radionuclides. The advantage of 
this reference based method is the reduction of deviations induced by the volume contraction 
of binary solvent mixtures and by differing γ-spectrometric geometries, both leading to 
smaller or larger values of radioactivity. Finally, the KD value of each system was calculated 
with the distribution coefficient equation 7 adapted to: 
𝐾𝐾𝐷𝐷 = �𝐴𝐴0 − 𝐴𝐴𝑒𝑒𝑒𝑒𝐴𝐴𝑒𝑒𝑒𝑒 � ∙ 𝑉𝑉𝑎𝑎𝑙𝑙𝑠𝑠𝑒𝑒𝐸𝐸𝑜𝑜𝑡𝑡𝑚𝑚𝑝𝑝𝑒𝑒𝑠𝑠𝑠𝑠𝑠𝑠  
with A0: complete activity in liquid phase before equilibrium, 
 Aeq: activity in liquid phase in equilibrium, 
 Valiquot: volume of measured aliquot in mL, 
 mresin: mass of resin in g. 
Promising solvent combinations with separation factors >100 were tested for 
chromatographic separations. The resins were soaked in the starting eluent for at least 24 h. 
Columns were prepared with varying diameters (0.5 to 2 cm) and varying length (3 to 10 cm). 
A portion of the “bulk” chromium-radiomanganese stock-solution was evaporated to dryness 
and dissolved in ethanol, methanol or a methanol/acetic acid mixture. Additional inactive 
chromium chloride hexahydrate was added to achieve target like conditions with an inventory 
of approx. 480 mg elemental chromium. The radioactive cocktail was introduced slowly onto 
the top of the column and a constant pressure and/or temperature of 55°C was applied 
depending on the experimental set-up. The eluent was collected manually in 3-10 min 
fractions depending on the flow rate, reduced to dryness and measured by γ-ray 
spectrometry for radioactivity. 
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3.6 Isotopic labelling of manganese nanoparticles 
3.6.1 Synthesis of MnO nanoparticles 
Radioactive precursor synthesis for isotopic labelling of MnO-nanoparticles 
The precursor 52g/55Mn(acac)2 was produced batch-wise for each single nanoparticle 
synthesis. The synthesis was adapted from literature[131] for significant smaller amounts. The 
reaction is shown in equation 18: 
𝑀𝑀𝐼𝐼𝐶𝐶𝑙𝑙2 ∙ 4 𝐻𝐻2𝑂𝑂 + 2 𝐶𝐶5𝐻𝐻8𝑂𝑂2 → ↓ 𝑀𝑀𝐼𝐼(𝐶𝐶5𝐻𝐻8𝑂𝑂2)2 ∙ 2 𝐻𝐻2𝑂𝑂 + 𝑁𝑁𝑎𝑎+ + 𝐶𝐶𝑙𝑙−
 
In a typical precursor synthesis, the 52gMn2+ eluent fraction from the radiochemical separation 
was transferred into a 15 mL glass centrifuge tube, reduced to dryness and 0.4 g (2.0 mmol) 
MnCl2 ∙ 4 H2O were added. The solid was dissolved in 2 mL HPLC-grade H2O and the 
solution degassed for 15 min under a steady argon stream in an ultrasonic bath. The 
centrifuge tube was sealed and wrapped in aluminium foil for light exclusion. 0.39 g 
(3.9 mmol) acetyl acetone in 4 mL 1 M NaOH was also degassed under inert atmosphere in 
an ultrasonic bath for 15 minutes and then slowly injected into the sealed centrifuge tube with 
a syringe. The directly formed intensively yellow precipitate was separated from the mother 
solution by centrifugation at 6000 rpm for 3 min and the resulting powder washed two times 
with HPLC-grade water. The compound was completely submerged in a sand bath and 
heated at 110°C for 1 h under a steady argon stream in order to remove water of 
crystallisation. The resulting light tan powder was weighed with the centrifuge tube, and the 
radioactivity was measured by γ-ray spectrometry. Afterwards it was used without further 
purification. In the development procedure of the synthesis the inactive precursor was 
additionally analysed by electrospray ionisation mass spectrometry (ESI-MS). 
Inactive microwave assisted MnO-nanoparticle synthesis 
Several published synthesis routes for MnO-nanoparticles were tested[132-135] and adapted for 
microwave use in order to achieve sufficiently short preparation times. 
One adapted synthesis route yielded a reproducible nanosized dispersion, stable in 2-
propanol for at least 72 h. The synthesis was conducted with 0.0828 g (0.33 mmol) of 
previously synthesised Mn(acac)2. A mixture of Mn(acac)2, 0.24 g polyvinyl pyridine (PVP) 
with an avg. molar weight of 40000 g/mol and 5 mL triethylene glycol were degased under a 
steady Ar stream in an ultrasonic bath for 15 min. The closed vial was then rapidly heated in 
a microwave oven at 280°C for 5 min and the temperature monitored by an external infrared 
sensor. The reaction mixture was cooled externally with an air jet to 250°C and then kept at 
that temperature for 1 h in a microwave oven. The resulting opaque, dark green solution was 
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precipitated with acetone under Ar atmosphere and centrifuged for 20 min at 8500 rpm. The 
precipitate was re-dispersed and washed with 2-propanol and precipitated again with 
acetone and centrifuged for removal of precursor, triethylene glycol and PVP. The washed 
compound was dispersed in 2-propanol and the clear, brown-black dispersion analysed with 
DLS and TEM as described in chapter 3.6.3. 
 
3.6.2 Activation studies with water dispersible Mn3O4-nanoparticles 
For activation studies of nanoparticles, water-soluble Mn3O4 particles with a mean crystal 
size of 25 nm were purchased from Nanograde, a company specialised in the production of 
nanosized composites. Different direct activation methods were tested and the properties of 
the nanoparticles before and after irradiations compared. 56Mn and 13N were produced by 
means of neutron and proton activation of 55Mn and 16O, respectively, and ion leaching of 
neutron irradiated particles was assessed. 
Activation of Mn3O4-nanoparticles with charged particles 
At the available irradiation facilities no liquid target system was accessible throughout the 
course of this study. Instead, solid targets of Mn3O4 nanoparticle were prepared by slowly 
evaporated 0.75 mL of an aqueous 2 wt% nanoparticle solution in a sedimentation chamber 
onto a 50 µm thick Al backing, 13 mm in diameter. The sediments were 10 mm in diameter 
and carefully covered by a 10 µm thick Al foil which was 16 mm in diameter. The targets 
were irradiated at the BC1710 cyclotron of the INM-5 with proton energies of 8.2 MeV to 
exclude proton induced reactions on manganese leading to long living impurities such as 
54Fe (half-life: 2.7 a) or 54Mn (half-life: 314 d). Ten minutes after EOB the target was 
disassembled, the cover foil removed, and the material partly dispersed in 2 mL of distilled 
water with an ultrasonic bath. The brown dispersion was measured in a Capintec 
Radioisotope Calibrator CRC-10BC (Capintec) every 5 minutes until complete decay. The 
measured, logarithmized activity was plotted against the elapsed time since EOB and the 
half-life determined by fitting a linear function to the data. After complete decay the 
nanoparticles were analysed with TEM and DLS to check for morphologic or crystallographic 
deviations induced by charged particle bombardment. 
Activation of Mn3O4-nanoparticles with neutrons 
Two 1.5 mL probes of aqueous 2 wt% Mn3O4 nanoparticle solution in 2 mL Eppendorf vials 
were irradiated at the TRIGA research reactor of the Johannes Gutenberg University Mainz. 
Together with an additional 1 mL probe of an aqueous 1 wt% solution of manganese (II) 
acetate they were irradiated for 15 min in the rotary specimen rack with thermic neutrons and 
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a flux density of 0.7 ∙ 1012 neutrons per cm2 and s. The produced 56Mn (half-life: 2.579 h) was 
measured by γ-ray spectroscopy with no distance to the γ-ray spectrometer. The γ-ray 
spectrometer was energy and efficiency calibrated with standard point sources (133Ba, 137Cs, 
152Eu , 241Am) and a correction factor had to be implemented for the differing measurement 
geometry of the liquid leaching probes. The Mn(ac)2 probe served as geometric calibration 
standard by measuring a 20 µl aliquot in the tip of an Eppendorf vial for point-like geometry. 
The aliquot was diluted to 500 µl and measured again to provide the correction factor for later 
measurements. The Mn(ac)2 probe was additionally used as calibration standard for the 
measurement of the manganese content in the irradiated nanoparticles. 
Stability and leaching experiments with activated Mn3O4-nanoparticles 
Four parallel leaching test-series were conducted with the irradiated Mn3O4 nanoparticles. 
Two series with HPLC grade water and two with a medical standard phosphate buffered 
saline (PBS) at pH 7.4. For each series, 0.5 mL irradiated Mn3O4 nanoparticle solution was 
introduced in a 15 mL glass centrifuge tube and the particles precipitated with 5 mL 2-
propanol and 5 mL n-hexane. The 2-propanol was mandatory to achieve solubility between 
water and n-hexane and, hence, the precipitation. After precipitating the nanoparticles were 
separated from the solution by centrifugation at 8500 rpm for 10 min. A 0.5 ml aliquot was 
taken from the top of the solution and the residual supernatant discarded. It was measured 
by γ-ray spectroscopy for activity quantification. This first aliquot was not used for calculation 
of released inactive manganese due to high content of the neutron recoil nuclide 56Mn due to 
the Szilard-Chalmers-Effect. 
The solid Mn3O4 residue was dispersed in 1 mL HPLC grade water or PBS by means of 
3 min treatment in an ultrasonic bath. The resulting dispersion was moved for 2 h with 200 
motions per min by a shaker (IKA Labortechnik). Afterwards the particles were again 
separated from the solution by precipitation, centrifugation, and a 0.5 ml aliquot was taken 
from the top solution. After discarding the supernatant the procedure was repeated several 
times until the leached activity was below the detection limits of the used γ-ray 
spectrometers. 
 
3.6.3 Characterisation of nanoparticles 
The size distribution of commercial and synthesised nanoparticles were analysed using TEM 
and DLS, while the results of the SAED were used in a direct comparison to check for 
crystallographic changes. 
The TEM and DLS measurements complemented each other because TEM only produces 
images of the naked nanoparticle core and DLS measures size distributions including coating 
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and/or a solvent shell, but without differentiation between bigger particles or agglomerates. 
Machine specifications of the different methods for analysis are given in chapter 3.1. 
Samples for TEM and SAED were prepared by dilution of the samples and dipping a 
3.05 mm diameter 200 mesh copper grid bearing a 10 -15 nm carbon film (PLANO GmbH) 
for 10-15 seconds into the solution. After removing supernatant liquid from the top of the 
tweezers with filter paper, the copper grids were placed in a petri dish and dried inside an 
oven at 50°C for 5 minutes. In each TEM measurement at least three different grid cells were 
scanned to reveal a more general image of the contained nanoparticles in the sample. 
The size of nanoparticles in the resulting images were assessed with a graphic program 
(ImageJ), collected for all corresponding images and then arithmetically averaged. The size 
uncertainty was assumed to be the standard deviation. 
For DLS measurements the samples were also diluted and macroscopic dust particles 
removed by a 0.22 µm syringe filter (MILLEX-GP®, MILLIPORE Ireland Ltd.) if no aggregates 
were apparent. The diluted solution was injected in a disposable polystyrene cuvette (Kartell) 
and measured by a Zetasizer Nano S (Malvern Instruments) with a standard measurement 
procedure. 
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4. Results and Discussion 
The development of bi-modal probes and the linked authentic labelling of MR contrast agents 
include a multitude of research tasks. These concern the field of nuclear physics, nuclear 
chemistry or organic chemistry. This work, however, concentrated only on the basic 
questions of the production of the suitable radionuclides 52gMn and 147,149Gd to build a 
foundation for future more detailed studies on actually labelled compounds. Different 
radionuclide production routes as well as separation procedures are discussed in the 
following chapters and evaluated in prospect for a later application. Also, some proof of 
principle tests were done to demonstrate the applicability of the developed radionuclides. 
Additionally, some work was done considering the new field of nanoparticles. However, 
before these tests can be performed the radionuclides have to be produced. 
4.1 Production of radiogadolinium 
The cross sections of proton and deuteron induced nuclear reactions for the production of 
the isotopes 146,147,149,151,153Gd were measured with deuteron energies of up to 70.9 MeV (see 
Table 12) and proton energies of up to 44.8 MeV (see Table 13). If no radioactivity was 
detected and no cross section could be determined, the respective spaces are left blank in 
these tables. 
Cross sections for the natEu(d,xn)146Gd and natEu(p,xn)147Gd reactions were determined for 
the first time. For other measured radioisotopes three data sets up to 50 MeV can be found 
in literature[74, 76, 136]. The data of West et al.[74] were arithmetically converted to the natural 
abundance of the corresponding target isotope 151Eu: 47.8 % or 153Eu: 52.2 % [137] in order to 
allow a comparison. 
Table 12: Experimentally determined cross sections of deuteron induced reactions 
on na tEu. Uncertainties are given according to chapters 4.1.6  and 4.1.7. 
 
Energy 
[MeV] 
 
Cross section [mb] 
146Gd 147Gd 149Gd 151Gd 153Gd 
 
70.9 ± 0.4 
 
77.7 ± 5.8 
 
169.5 ± 17.8 
 
176.6 ± 16.1 
 
72.1 ± 5.6 
 
8.2 ± 0.6 
68.4 ± 0.4 92.0 ± 6.9 152.5 ± 16.5 186.9 ± 19.2 74.9 ± 14.6 13.5 ± 4.9 
65.2 ± 0.5 56.8 ± 4.3 159.3 ± 23.0 199.6 ± 21.9 76.7 ± 8.3 9.1 ± 0.9 
62.2 ± 0.5 55.2 ± 4.0 160.6 ± 14.2 242.3 ± 24.4 82.9 ± 7.9 23.4 ± 3.2 
56.3 ± 0.5 19.8 ± 1.2 190.1 ± 19.0 327.4 ± 32.0 103.2 ± 9.8 16.7 ± 1.8 
52.0 ± 0.6 1.6 ± 0.1 128.7 ± 12.5 278.2 ± 30.2 100.9 ± 10.0 14.0 ± 1.1 
51.8 ± 0.5 4.5 ± 0.4 141.7 ± 16.0 281.5 ± 30.8 95.5 ± 8.2 13.0 ± 2.2 
50.0 ± 0.6 - 92.0 ± 10.7 262.3 ± 28.9 124.3 ± 10.1 16.3 ± 1.3 
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Table 12 cont. 
 
Energy 
[MeV] 
 
Cross 
section 
[mb] 
 
Energy 
[MeV] 
 
Cross 
section [mb] 
 
Energy 
[MeV] 
 
Cross 
section 
[mb] 
 
46.2 ± 0.6 
 
- 
 
41.0 ± 4.6 
 
207.6 ± 27.3 
 
137.5 ± 12.2 
 
17.0 ± 1.3 
43.6 ± 0.7 - 13.6 ± 1.3 211.5 ± 15.3 175.9 ± 17.9 22.0 ± 1.5 
39.1 ± 0.7 - 0.6 ± 0.1 230.8 ± 24.9 229.4 ± 19.0 21.9 ± 1.7 
37.9 ± 0.8 - - 311.6 ± 23.3 307.5 ± 29.9 26.2 ± 1.8 
32.6 ± 0.8 - - 327.1 ± 34.2 358.5 ± 31.5 39.6 ± 3.7 
26.6 ± 1.2 - - 202.3 ± 19.1 265.9 ± 19.9 43.4 ± 3.8 
23.3 ± 0.9 - - 96.7 ± 12.7 156.6 ± 13.8 53.2 ± 4.0 
22.6 ± 1.5 - - 67.7 ± 6.2 130.5 ± 9.9 59.7 ± 4.3 
 
Table 13: Experimentally determined cross sections of proton induced reactions on 
natEu. Uncertainties are given according to chapters 4.1.6 and 4.1.7. 
 
Energy 
[MeV] 
 
Cross section [mb] 
147Gd 149Gd 151Gd 153Gd 
 
44.8 ± 0.4 
 
179.2 ± 25.6 
 
332.3 ± 36.0 
 
66.4 ± 5.8 
 
6.4 ± 0.5 
44.0 ± 0.4 171.3 ± 13.5 330.9 ± 21.8 74.2 ± 4.6 6.9 ± 0.4 
43.0 ± 0.4 143.1 ± 15.5 310.4 ± 26.7 76.5 ± 5.3 8.4 ± 0.6 
41.9 ± 0.4 105.3 ± 9.5 246.9 ± 15.1 73.8 ± 4.4 7.7 ± 0.5 
41.2 ± 0.4 80.6 ± 10.8 228.5 ± 20.0 75.9 ± 4.9 7.8 ± 0.5 
40.1 ± 0.5 52.3 ± 4.6 188.7 ± 12.2 77.5 ± 4.6 7.5 ± 0.4 
37.6 ± 0.5 11.6 ± 1.0 139.0 ± 9.8 99.5 ± 5.8 7.9 ± 0.4 
35.1 ± 0.5 0.39 ± 0.03 156.8 ± 9.5 138.0 ± 8.2 8.3 ± 0.5 
32.7 ± 0.6 - 241.3 ± 21.0 212.3 ± 11.8 9.0 ± 0.5 
30.2 ± 0.6 - 364.4 ± 23.7 319.1 ± 17.7 9.7 ± 0.5 
27.8 ± 0.6 - 425.6 ± 32.2 407.3 ± 22.6 10.5 ± 0.6 
25.3 ± 0.7 - 432.3 ± 26.4 429.7 ± 23.9 11.8 ± 0.6 
23.0 ± 0.7 - 342.0 ± 30.4 342.7 ± 19.1 12.5 ± 0.7 
20.4 ± 0.8 - 215.9 ± 14.4 223.1 ± 12.4 16.3 ± 0.9 
18.0 ± 0.8 - 23.8 ± 1.4 40.9 ± 2.3 16.6 ± 0.9 
15.5 ± 0.9 - - 22.3 ± 1.2 25.4 ± 1.4 
 
Modelled cross section data from the TENDL-2013 library [138, 139] which is based on the 
computer code TALYS[140] were used for comparison with the experimental data and are 
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4. Results and Discussion 
 
The published excitation functions of the recommended proton monitor reactions are not 
suitable for the determination of the experimental particle energy in the investigated energy 
range. The cross section ratios of the recommended deuteron monitor reactions are either 
poorly distinguishable above 50 MeV (see Figure 17), or the cross sections are too low to 
generate sufficient activity for adequate counting statistics. 
Therefore, measurement of the beam energy was done by determining it for the more 
reliable lower energy region of the target and then extrapolating it up to the incident energy 
using STACK. This revealed a deviation between the incident energy in different irradiations 
which resulted in the incident energy uncertainty of deuteron irradiations as discussed below 
in chapter 4.1.6. 
 
Figure 17: Recommended cross sections of the deuteron induced nuclear reaction 
27Al(d,x)22Na, 27Al(d,x)22Na and individual li terature data taken from IAEA-
TECDOC-1211.[121]  
 
4.1.2 Cross section of main product 147Gd 
For both proton and deuteron induced reactions leading to the formation of 147Gd, the 
experimental thresholds (see Tables 12 and 13) are higher than their theoretical values (see 
Table 2). They are, however, still in good agreement with previously published deuteron 
cross section measurements by Takács et al.[76], even if they are partly higher in value. 
The experimental cross section data of the reactions with deuterons is depicted in Figure 18 
showing a first maximum at about 57 MeV which is due to the 151Eu(d,6n)-nuclear reaction.  
A second increase above 70 MeV indicates another maximum at higher particle energies 
which corresponds to the 153Eu(d,8n)-reaction channel. However, the expected second 
maximum seems to be located at even higher deuteron energies than available in this work 
(see Figure 18). The theoretical values given by the TENDL-2013 library seem to be shifted 
to lower particle energies by an offset of approx. 5 MeV. The cross sections of proton 
induced reactions leading to the formation of 147Gd are given in Figure 19. 
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Figure 18: Cross sections of 146,147Gd formation by deuteron induced reactions on 
natEu and theoretical cross section data from TENDL-2013[138,  139] . Eye 
guides drawn through own data points. 
 
Figure 19: Cross sections of 147Gd formation by proton induced reactions on natEu 
and theoretical cross section data from TENDL-2013[138 ,  139] .  
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Again, the theoretical calculation shows a slightly shifted excitation function to lower particle 
energies by approx. 2.5 MeV. Due to comparable cross sections, but with lower reaction 
thresholds, proton induced reactions seem to be superior for the production of 147Gd. 
The radionuclide production yield is not the only relevant parameter regarding the medical 
application of Gd radioisotopes. For absolute quantitation in SPECT a high isotopic purity is 
even more important[141]. Problematic impurities to be considered with the application of 147Gd 
are 149Gd and 151Gd. This is due to interfering γ–rays of 147Gd: 229.3 keV (57.7 %), 149Gd: 
272.3 keV (3.2 %) and 151Gd: 243.3 keV (5.6 %). The impact of those impurities is discussed 
in detail together with a comparison of production rates in chapter 4.1.5. 
 
4.1.3 Cross section of main product 149Gd 
Both, the excitation functions of the deuteron and proton induced reactions leading to 149Gd 
show two maxima (see Figures 20 and 21) which corresponds well to the reaction channels 
151Eu(d,4n), 153Eu(d,6n), 151Eu(p,3n) and 153Eu(p,5n). 
After converting the data of West et al.[74] to the natural abundance of the respective 
europium isotopes, there was a very good agreement of the shape of the excitation functions 
with the other literature data[76] and the measurements done in this work. 
 
Figure 20: Cross sections of 149Gd formation by deuteron induced reactions on na tEu 
and theoretical cross section data from TENDL-2013[138 ,  139] . 
* Data adapted to natural abundance. 
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Figure 21: Cross sections of 149Gd formation by proton induced reactions on natEu 
and theoretical cross section data from TENDL-2013[138 ,  139] . 
* Data adapted to natural abundance. 
 
However, a clear deviation in magnitude at the maxima of the curves is apparent. In the 
region of the maximum of deuteron induced reactions at approx. 35 MeV the measured cross 
section values are up to 30 % lower and in case of proton induced reactions at 26 MeV up to 
20 % lower in comparison with the literature[74, 76]. 
Other proton cross section data[136] deviate not only in magnitude (up to 30 % higher/lower) 
but also in the shape of the excitation function. This deviation cannot be explained by 
outdated half-life values or γ-ray intensities as their differences were found to be negligible. 
Also no significant error in the described measurement technique was found in retrospective. 
The data published by West et al.[74] and Takács et al.[76] agree more with the data measured 
in this work. 
The theoretical cross section values from the TENDL-2013 library for nuclear reactions 
leading to the formation of 149Gd show a similar trend as discussed for 147Gd above. In this 
case, not the whole theoretical excitation function is shifted to lower particle energies. The 
experimental data in the lower deuteron energy region up to 25 MeV and in the lower proton 
energy up to 22.5 MeV are well described by the theoretical calculations. On the other hand, 
the theoretical maxima appear to be too narrow in comparison with the experimental data 
causing a shift of the excitation function in the higher energy region towards lower values. 
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This is clearly an effect of the already implemented older literature data[136] in the TALYS 
code parameters. In the higher energy region where no data is available the code differs 
again from reality. 
 
4.1.4 Cross section of isotopic impurities 146,151,153Gd 
As depicted in Figure 18, production of 146Gd was only observed for deuteron energies above 
52 MeV. The formation of 146Gd near its reaction threshold is apparently too small and cannot 
be distinguished from the background of the γ-ray detectors used. The same seems to be 
true for the proton irradiations because in the energy range of 45 to 15 MeV no 146Gd could 
be observed at all. In addition to higher cross section values, the cross sections calculated 
with the TALYS computer code taken from the TENDL-2013 database also indicate a small 
maximum at approx. 65 MeV deuteron energy which could not be confirmed experimentally. 
Further investigations would be necessary to explain the reason of this. 
Concerning 151Gd, only the cross section maxima of the 153Eu(d,4n)151Gd (see Figure 22) and 
153Eu(p,3n)151Gd (see Figure 23) reactions are recognizable at approx. 34 MeV and 25 MeV, 
respectively. The slope of the experimental curve points to the theoretical thresholds of their 
corresponding reactions (153Eu(d,4n): 18.6 MeV; 153Eu(p,3n): 16.2 MeV). More than a rough 
extrapolation is not possible here. This is due to overlap with reactions of lower threshold 
energies (151Eu(d,2n), 151Eu(p,n)). 
 
Figure 22: Cross sections of 151Gd formation by deuteron induced reactions on na tEu 
and theoretical cross section data from TENDL-2013[138 ,  139] . 
* Data adapted to natural abundance. 
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Figure 23: Cross sections of 151Gd formation by proton induced reactions on natEu 
and theoretical cross section data from TENDL-2013[138 ,  139] . 
 * Data adapted to natural abundance. 
The shape of the excitation function, including the transition from the end of the first 
maximum to the beginning of the second one (see Figure 22), agrees well with previous 
data[74, 76]. However, the magnitudes of West’s data[74] differ in the peak area by up to 18 % 
for deuteron and up to 15 % for proton induced reactions. An even higher value for the cross 
section maximum for deuteron induced reactions was measured recently by Takács et al.[76] 
which is up to 40 % higher. 
Regarding the data of West et al.[74], it is interesting to notice that contrary to the EXFOR 
classification, no highly enriched 151Eu or 153Eu target material was used. Instead, the cross 
sections were extrapolated to 100 % enrichment from irradiation of natural europium. While 
this is acceptable in some cases, a problem arises in the overlapping area (33 → 18 MeV) of 
lower and higher reaction orders of 151,153Eu. A clear assignment of 151Gd activity originating 
from one or the other reaction is simply not possible above 20 MeV. 
Therefore, the cross section data had been deduced by adjusting a normalised polynomial fit 
from the first order 153Eu(p,n)153Gd and 153Eu(d,2n)153Gd reactions to the cross section data 
of the second order 151Eu(p,n)151Gd and 151Eu(d,2n)151Gd reactions below 17 MeV proton and 
22 MeV deuteron particle energy, respectively, in order to yield the cross sections in the 
overlapping energy region. Cross section data for the higher order reactions 153Eu(p,3n)151Gd 
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and 153Eu(d,4n)151Gd was then obtained by subtraction of those deduced data from the 
experimentally measured data. It is questionable, if this approach is reliable because 
excitation functions[142] show only similar, but never exactly equal shapes of the curve tail. 
Thus, only the data for natEu is shown here. Therefore, the cross section data of West et al. 
for the production of 151Gd should be neglected in future evaluations. Regarding the results of 
TENDL-2013, the same trend as already discussed in the previous chapter is also found for 
deuteron and proton induced reactions, namely a good match to the experimental data in the 
lower energy region and larger deviations in the higher energy region. 
The deuteron cross section data for the formation of 153Gd measured in this work (see Figure 
24) increasingly deviate by up to 42 % from previous measurements[74, 76] with decreasing 
particle energy, but they agree with the publication of Nichols[136] in the small overlapping 
area (27 → 23 MeV). The theoretical data below 30 MeV agree well with previous 
measurements of Takács et al.[76] and West et al.[74] and above 30 MeV with the data 
measured here. 
 
Figure 24: Cross sections of 153Gd formation by deuteron induced reactions on na tEu 
and theoretical cross section data from TENDL-2013[138 ,  139] . 
 * Data adapted to natural abundance. 
 
The proton induced reaction cross sections measured in this work (Figure 25) are identical 
with the available data[74] within the uncertainties. The theoretical values from TENDL-2013, 
on the other hand, differ strongly from the experimental results above 10 MeV and show a 
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maximum lower in energy as well as in height. In general, the overall trend of a complete or 
partial energy shift between the theoretical excitation functions from the TENDL-2013 library 
and experimentally available data persists throughout all measured reactions. This clearly 
demonstrates the need for experimental nuclear data to further improve the empirical 
adjustment of reaction parameter in the nuclear models as mentioned in the beginning of 
chapter 4.1. 
 
 
Figure 25: Cross sections of 153Gd formation by proton induced reactions on natEu 
and theoretical cross section data from TENDL-2013[138 ,  139] . 
* Data adapted to natural abundance. 
 
4.1.5 Experimental thick target and calculated integral yields 
The integral production rates and saturation yields of the radionuclides 147,149Gd and isotopic 
impurities were determined for proton and deuteron bombardment using the measured cross 
sections shown above (see Tables 12 and 13) and are summarised in Table 14. 
The shapes of the integral curves for deuteron and proton induced reactions (see Figures 26 
and 27) are very similar, but the deuteron integral curves shift to higher energies by an 
amount of about 7.5 MeV. This corresponds to the higher energy thresholds for deuteron 
induced reactions. 
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Figure 26: Calculated integral yields of 146 ,147,149,151,153Gd based on the 
experimentally determined excitation functions (eye guides) of deuteron 
induced reactions on natural europium. 
 
Figure 27: Calculated integral yields of 147,149,151,153Gd based on the experimentally 
determined excitation functions (eye guides) of proton induced reactions 
on natural europium. 
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Table 14: Calculated production rates using elemental europium for thin targets 
integrated over the measured energy range. 
Uncertainties given are calculated according to chapter 4.1.7.  
Isotope 
 
IntYprod a) 
(deuteron) 
[MBq/µAh] 
 
IntYprod b) 
(proton) 
[MBq/µAh] 
 
146Gd 
 
1.51 ± 0.27 
 
- 
147Gd 177.33 ± 19.71 43.30 ± 4.39 
149Gd 81.59 ± 8.51 61.83 ± 4.94 
151Gd 3.96 ± 0.42 2.11 ± 0.27 
153Gd 0.26 ± 0.04 0.59 ± 0.004 
 
a) Integral production rates calculated for 71 → 22 MeV deuteron energy. 
b) Integral production rates calculated for 45 → 15 MeV proton energy. 
The thick target yields of proton bombardments were also experimentally determined (see 
Table 15). These measured values are 20 – 25 % lower than the calculated integral yields. 
Some deviation of approx. 5-30 % is to be expected due to experimental artefacts, e.g. 
thermal effects within thick targets during irradiation which influence the actual area weight 
among others. 
Table 15: Comparison of experimentally determined thick target yields and 
calculated integral yields of proton induced reactions on na tEu and 
percentages of integral yields for corresponding energy ranges. 
Uncertainties given are calculated according to 4.1.7. 
Isotope 
 
45 → 31 MeV 
TTYprod 
[MBq/µAh] 
IntYprod 
[MBq/µAh] 
IntYprod 
fraction [%] 
 
147Gd 
 
27.89 ± 1.53 
 
34.15 ± 3.45 
 
81.7 
149Gd 19.63 ± 0.99 23.74 ± 1.89 82.7 
151Gd 0.79 ± 0.04 0.96 ± 0.12 82.0 
153Gd 0.025 ± 0.003 0.0337 ± 0.0005 75.5 
 
 
36 → 18 MeV 
 
147Gd 
 
- 
 
- 
 
- 
149Gd 27.10 ± 1.37 33.43 ± 3.88 81.1 
151Gd 1.83 ± 0.07 2.33 ± 0.30 78.6 
153Gd 0.037 ± 0.003 0.0494 ± 0.0009 75.9 
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Proton and deuteron yields of the 147Gd production were found to be considerably higher 
than for the previously reported 3He- and α-particle reactions with incident energies of 
27.1 MeV and 35.8 MeV, respectively.[75] The proton and deuteron induced production of 
147Gd show integral yields of (177.33 ± 19.71) MBq/µAh and (43.30± 4.39) MBq/µAh, 
respectively. In comparison, Denzler et al.[75] reported 9.5 MBq/µAh for 3He and 4.8 MBq/µAh 
for α-particle induced processes. Those earlier values were also extrapolated to 100 % 
enrichment of the target material 144Sm (used: 86.6 %, nat.: 3.07 %) and 147Sm (used: 
96.5 %, nat.: 14.99 %), while here values are calculated with natural abundances. 
These lower production rates are mainly caused by stronger energy degradation of doubly 
charged particles (4He2+, 3He2+) in matter. Therefore, a lower mass of target material was 
used by Denzler et al.[75]. However, they achieved a significantly higher isotopic purity 
employing targets of enriched samarium than obtained here by use of natural europium. In 
case of natural europium, the formation of the longer lived isotopic impurities 146,151,153Gd is 
calculated to be rather low (<5 %) and not of primary concern for SPECT measurements. 
More problematic is the simultaneous production of 147Gd and 149Gd interfering with each 
other (see Figure 27). 
Thus, employing europium, highly enriched targets are required to achieve a high isotopic 
purity. Albeit, enrichment of either stable europium isotope is much cheaper compared to 
samarium due to almost equal proportions of 151Eu (47.8 %) and 153Eu (52.2 %) in the natural 
isotopic composition. Hence, application of enriched europium would not only yield 
considerable higher amounts of 147Gd or 149Gd but also be more beneficial than application of 
enriched Sm, considering its high production costs due to the low natural abundances of 
144,147Sm (see above). 
Another important factor for the application of radiogadolinium in SPECT is the presence of 
impurities resulting from the decay products of gadolinium like 147Eu (T1/2: 24.1 d, γ-rays: 121 
keV (23%), 197 keV (27 %)) or 149Eu (T1/2: 93.1 d, γ-rays: 277 keV (3.6 %)). While this 
problem is the same for the production by proton or deuteron bombardment as well as 
production by α-particles, the direct formation of those isotopes is much higher if europium is 
applied as target material. In this context, irradiation of samarium would be more favourable 
due to the more efficient radiochemical separation methods presently available which would 
be needed to remove those decay products. Rapid separation of gadolinium from bulk 
europium is possible, but needs excessive effort[78, 108]. Unfortunately, this cannot be easily 
circumvented, or ignored, due to the similar γ-ray energies of the decay products. Therefore, 
as part of this study a fast and facile separation of radiogadolinium and europium was 
developed. 
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4.1.6 Particle energy uncertainties 
Two factors were taken into account for the uncertainty determination of the individual 
particle energies of cross sections: The degradation in the Eu2O3 targets and the energy 
dependent uncertainty of the incident energy. This uncertainty was calculated by iteration of 
the foil-stack energy degradation with the maximal and minimal possible incident energy (+/- 
∆Eincident). Half of these deviations between upper and lower energies were used as 
dependent uncertainty of the incident energy at the corresponding target energy. The 
Gaussian propagation (root mean square) of this general uncertainty of the incident projectile 
energy and the uncertainty of the energy degradation in the specific target yielded the 
particle energy uncertainty for each individual target in the foil stacks. 
This results in an overall uncertainty for deuterons from 0.4 MeV at 75 MeV up to 1.5 MeV at 
20 MeV. For proton irradiations it ranges from 0.32 MeV at 45 MeV up to 0.60 MeV at 
18 MeV. The overall uncertainties are given together with the experimental cross section 
data in Tables 12 and 13 above. 
 
4.1.7 Cross section and yield uncertainties 
Several further sources of uncertainties besides that of particle energy have to be considered 
for the measured cross sections and thick target yields and are as follows: 
- area weight determination, 
- particle flux determination, 
- detector efficiency, 
- peak fitting, 
- counting statistics for γ-ray energy, 
- γ-ray intensity. 
The individual uncertainties of the area weight determination of foils and sediments derived 
from weighing and uncertainty of area determination ranged from 1.7 to 4.8 %. The total 
uncertainty in particle flux determination ranged between 3.5 to 8.8 %, due to uncertainties in 
activity measurement, particle energy and in monitor reaction cross sections taken from 
literature[121]. The uncertainty of detector efficiencies lay between 2.8 and 8.6 % depending 
on γ-ray energy, due to the limited coverage with standard radiation sources over the 
investigated energy region. The statistical uncertainty ranged from 0.05 up to 12 % in peak 
areas, due to Gaussian-shaped peak fitting with strongly varying counting statistics 
dependent on activity, γ-ray intensity and efficiency of detectors for the γ-ray energy. The γ-
ray intensity uncertainty of 0.5 to 5 % was taken from literature[60]. 
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Considering additional minor uncertainties, e.g. in molar weight, half-life etc., the individual 
uncertainties of the final cross section data were calculated according to Gaussian error 
propagation (root mean square). In total, the resulting absolute uncertainty of cross sections 
measured in this work ranges between 6.0 and 17.1 %. 
 
4.2 Separation of n.c.a 147/149Gd from bulk natEu with a Na-Hg amalgam 
extraction 
For the separation of a lanthanide mixture of europium and gadolinium a promising approach 
was tested based on a liquid sodium-mercury amalgam and a buffered saline solution.[78, 108] 
After a test run with a minimal target mass of 0.5 mg Eu2O3 and the separation conditions 
determined by Denzler et al.[78], the need for an optimization became clear when dealing with 
macroscopic europium masses. The parameters with the strongest influence on the 
reduction and selective extraction of one particular lanthanide are the pH-value as well as the 
sodium content in the amalgam and the solution, hence, its reductive potential and extraction 
capacity. There are some restrictions to both parameters and their adjustment. Sodium 
mercury amalgam gets solid at room temperature above a sodium content of about 0.7 wt%. 
Therefore, the capacity can only be changed significantly by increase/decrease of the used 
mass of amalgam. The pH range is limited by the decomposition of sodium mercury 
amalgam below a pH-value of 1.5 and the precipitation of lanthanide hydroxides above a pH 
of 8. Unfortunately, the pH-value of the solution increases gradually during the extraction 
because of the steady production of H2 and OH- by the competing reaction 19: Na + H2O → Na+ + OH− + 12 H2 
A buffer solution has to be introduced and the starting pH has to be low enough that the pH-
value stays below 8 until the end of separation. The already published process of Lebedev et 
al.[77] mentions the use of a starting pH of 4.5 which makes a strong buffer solution 
mandatory or it cannot yield satisfying results. With the goal in mind to label an 
organometallic complex and to inject it into an animal or even human, any additionally 
introduced ion or compound can lead to complications. Thus, the reported separation was 
assessed anew and the optimal separation parameters were determined systematically. 
At first the capacity of the amalgam separation conditions determined by Denzler et al.[78] 
was assessed by increasing the europium mass. Other parameters were kept constant at: 
- 1 M saline solution buffered with 0.4 M sodium acetate, 
- starting pH = 2, 
- 5 mL (67.72 g) amalgam, 
- 0.4 % sodium content, and 
- 5 min reaction time. 
 
72 
 
4. Results and Discussion 
The results are shown in Figures 28 and 29 for a first extraction (E1) and a subsequent 
second extraction (E2) with a new batch of amalgam. Inductively coupled plasma – mass 
spectrometry (ICP-MS) was necessary beside the γ-spectrometric measurements (γ-spec.) to 
assess low Eu concentrations with a sufficient accuracy. 
 
Figure 28: Extraction coefficients of europium of varying amounts. 
 
Figure 29: Extraction yield of varying amounts of europium and 149Gd with varying 
content in percent. 
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The residual mass of Eu3+ in solution increased as expected with the Eu3+ mass after the first 
extraction. A second extraction with a new batch of amalgam was therefore appended 
directly after the first extraction. This should lead to a suitable Eu reduction as described by 
Denzler et al.[78]. However, the subsequent second extraction only reduced the amount of 
residual Eu3+ to approx. 14 mg with a 500 mg Eu2O3 target. This 97 % reduction could be 
further improved by more extraction repetitions, but with the disadvantage of decreasing 
yields of the Gd radioactivity. While no significant extraction of radiogadolinium can be 
observed into the amalgam, a yield reduction can easily occur due to physical loss of fluids 
caused by not optimised solution handling. 
Next, the volume of used amalgam was increased step-by-step to find the minimal mass of 
amalgam necessary for the separation of the complete 500 mg Eu2O3 within one extraction 
step. The other parameters were kept constant as described above. The results are depicted 
in Figures 30 and 31. 
The fluctuating results of the radioactivity derived determinations seen in all diagrams are 
measurement artefacts due to the statistical decay uncertainty. The extraction capacity 
increases nearly linearly, corresponding to the elemental sodium content present during the 
extraction. Correspondingly, the distribution coefficients stay nearly the same until a volume 
of 9 mL amalgam was reached and the capacity of the used amalgam was high enough to 
extract nearly all Eu from the solution. The constant sodium concentration in the amalgam 
was 0.4 wt% which corresponds to 542 mg of elemental sodium in 10 mL amalgam. 
 
Figure 30: Extraction coefficients of varying amounts of europium and 149Gd with 
varying sodium mercury amalgam masses. 
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Figure 31: Extraction yield of macroscopic europium and 149Gd in dependence of 
varying sodium mercury amalgam volumes in percent. 
With a europium content of 431 mg Eu3+ to be extracted, an excess Eu:Na ratio of 1.25 was 
achieved. However, only approx. 98 % of europium was extracted into the amalgam with a 
residual Eu3+ content of 9 – 12 mg in the solution. 
An extraction dependence on the reaction time was assumed as a possible reason for the 
incomplete reduction of europium. Hence, the kinetic influence was examined with the 
optimised parameters of Denzler et al.[78] for a 500 mg Eu2O3 pellet. 
 
Figure 32: Distribution coefficients of the kinetic extraction behaviour of europium 
within the course of 30 min with and without the exclusion of air.  
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Figure 33: Kinetic extraction yield of macroscopic europium and 149Gd within the 
course of 30 min with and without exclusion of air given in percent. 
The extraction behaviour at different time intervals is depicted in Figures 32 and 33. Within 
the first few minutes of the extraction under room atmosphere the europium content in 
solution decreases rapidly to 33 % (141 mg Eu3+), but increases afterwards back up to the 
starting concentrations. This phenomenon can be clearly attributed to the re-oxidation of 
elemental europium by oxygen dissolved in the solution. The gadolinium content stays more 
or less at maximum levels and negative values of the distribution coefficients are caused by 
measurement uncertainties. 
When the kinetic extraction behaviour was investigated employing 10 mL amalgam under 
inert atmosphere and after 15 min argon purge in an ultrasonic bath to remove oxygen 
solved in the solution, the re-oxidation was strongly reduced (also see Figures 32 and 33). 
This way the europium content in the solution can be reduced to 0.09 % (0.4 mg Eu3+) after 
20 min without noticeable reduction of radiogadolinium activity. A further reduction of the 
europium content down to tracer levels may be possible by use of oxygen scavengers like 
Cr2+. However, the introduction of additional metal ions would complicate the system 
immensely and would render it unsuitable for a quick and facile separation of radio-
gadolinium. 
In summary, this extraction method can be used as an effective way to remove macroscopic 
amounts of europium in order to prepare a precursor for a quantitative Gd separation, for 
example with a specialised extraction resin, like TRU[107] (Triskem), with a low capacity. In 
case of labelling a standard MRT contrast agent in order to show the application of 147/149Gd, 
the separation is sufficient, due to the analogous chemical complex behaviour of europium 
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and gadolinium. The low amounts of inactive europium should not interfere in vivo. A more 
detailed discussion about the in/ex vivo behaviour is given in chapter 4.3.3. 
 
4.3 Preparation of 147/149Gd DOTA and its in and ex vivo comparison 
Gd-DOTA was synthesised with two different methods as assessment for the suitability of the 
separation and the applicability of 147/149Gd as a MRT contrast marker. The in vivo stability of 
the complex was tested in PBS and HBS. Also, a distribution comparison of an inactive MR 
contrast agent and its labelled analogue in the brain of a tumour bearing rat was carried out. 
The in vivo images of the rat brain taken by a 3T MRI scanner were compared to the ex vivo 
images prepared by autoradiography. 
 
4.3.1 Separation of Na and 147/149Gd 
The bulk amount of europium was removed by the amalgam separation procedure described 
in the previous chapter. Additionally, the sodium, chloride and acetate content in the solution 
had to be drastically reduced prior to stability tests and an in vivo injection. This was 
necessary to achieve a suitable small volume and to assure an analogous model for the 
measurements of the commercial and synthesised compound. A chromatographic column 
extraction with the DGA normal resin was used for the removal of excess sodium, chloride 
and acetate ions. 
The capacity and distribution factors of several elements on the extraction resin DGA normal 
were measured in different media by Horwitz et al.[107]. They determined a log KD of >3 and 
>4 in nitric acid for europium and gadolinium, respectively, while sodium was not adsorbed at 
all. In 0.1 M hydrochloric acid the log KD values were approx. 0.5 for both Eu and Gd. 
Therefore, an elution with 1 M nitric acid should lead to a concentration of the Eu/147/149Gd 
mixture on the column and an elution of sodium, chloride and acetate simultaneously. 
Horwitz et al.[107] also suggested a simultaneous separation method for 33 elements, 
however, no separation of europium and gadolinium was observed. 
Hence, the separation was simplified and focused on the separation of sodium from both 
lanthanides using a DGA normal column. After the solvent change from 1 M nitric acid to 
0.1 M hydrochloric acid, about 87.4 % of the starting activity of 149Gd was eluted in approx. 
17.0 mL of it. 
Approx. 12.6 % of the starting Gd radioactivity is lost in solution transfers between different 
containers or glass ware of the amalgam procedure and the DGA separation. Yet, the yield 
was still high enough for the subsequent tasks and no transfer optimization was necessary. 
The fractions containing radioactivity were united and evaporated to dryness. A different 
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eluent may lead to smaller volumes containing the Gd, but the radioactive fractions 
evaporated within 1-3 h so that no additional optimization was necessary. Only a slight 
residue of presumably Eu or Na salt was observed after the evaporation of the solvent. 
However, the mass of the residue was within the weighing uncertainty of the available 
balance (± 0.1mg) and the residue used without further purification. It easily resolved in a 
minimal solvent volume of at least 0.5 mL. 
 
4.3.2 147/149Gd DOTA complex synthesis and stability tests 
Two previously described synthesis routes[126, 127] for the n.c.a and c.a. 147/149Gd labelling of 
DOTA were tested. The conditions and results of the complexing tests performed in this 
thesis are summarised in Table 16. 
Table 16: Reaction condit ions, reaction time and yields for Gd-DOTA synthesis 
Solution pH Carrier Reaction time [min] 
Temperature 
[°C] 
Radio TLC 
yield [%] 
0.1 M NaOAc 5,0 n.c.a. 1440 40 >99 
1 M NaOAc 5,6 n.c.a. 5 90 >99 
1 M NaOAc 5,6 n.c.a. 20 90 >99 
1 M NaOAc 5,6 0.1 eq 5 90 >99 
1 M NaOAc 5,6 0.1 eq 20 90 >99 
The first tested synthesis route by Vanasschen et al.[126] was chosen for its low reaction 
temperature and therefore mild reaction conditions. It was confirmed by TLC that the 
chemical reaction was quantitative. Unfortunately, the reaction time of 24 h was rather long 
and about 36 % of the starting radioactivity of 147Gd decayed during the DOTA complexation. 
An alternative synthesis was found in literature[127] with harsher temperature conditions of 
90°C but a significantly shorter reaction time of 20 min. The synthesis was originally 
designed for the DOTA complexation of the 44Sc3+ ion. The chemistry of Sc(III) and Gd(III) 
are rather similar, due to the lanthanide contraction. Therefore, it was not farfetched to 
assume similar complexation behaviour with DOTA. The results of the synthesis confirmed 
this assumption. A reaction time of 5 min was sufficient to complete the reaction with no 
precursor present in solution which was confirmed by radio TLC. The temperature test 
showed that even after 20 min at 90°C the complex was still intact and no precursor or free 
Gd3+ ions were detected by radio TLC. Accordingly, a quantitative reaction was achieved 
here within 5 min which is considerable shorter than the previously followed concept of 
Vanasschen et al.[126] The same quantitative reaction within 5 min was observed with 0.1 eq. 
inactive Gd carrier. 
 
78 
 
4. Results and Discussion 
The stability of the synthesised complex was examined to exclude distribution deviations 
caused by free Gd(III) in the in vivo comparison to DOTArem™. The stability was previously 
tested in a phosphate buffered saline (PBS) to check for possible ion exchange between the 
solution and the complex. Subsequently, the complex was further tested in human blood 
serum (HBS) at 37°C to simulate in vivo conditions as best as possible. The HBS of four 
different donors was pooled to exclude possible unique behaviour of a single sample. The 
results of the stability tests in PBS and HBS are listed in Table 17 and an exemplary TLC 
instant imager measurement is depicted in Figure 34. 
Table 17: Results of the c.a. and n.c.a. stabil ity tests with 147/149Gd-DOTA in PBS 
and HBS at 37°C. 
Solution Carrier Incubation time [h] 
Stable complex 
[%] 
HBS c.a. 56 >99 
HBS c.a. 144 >99 
HBS n.c.a. 56 >99 
HBS n.c.a. 144 >99 
PBS n.c.a. 24 >99 
 
 
Figure 34: Instant Imager measurement of a TLC plate with Gd-DOTA after a 6 d 
incubation time in HBS (left) and corresponding radioactivity prof ile of the 
red stripe (right). Depicted circles are the reference points (green), the 
TLC start l ine ref. point (purple), the TLC end line ref. point (orange), and 
the 147,149Gd-DOTA complex (black). 
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The reference spots on the TLC plate (green, orange, purple circles) were marked after the 
separation and were used for “orientation purposes” in the Instant Imager. 
No de-complexation of n.c.a. or c.a. Gd-DOTA was observed with TLC measurements in the 
PBS solution in a time period of 24 h or in the HBS solution in time periods of 56 h and 
144 h. As indicated by its high thermodynamic stability constant (>1024) determined from 
measurements in water by Cacheris et al.[143], the complex shows sufficient chemical 
inertness in HBS. The radiochemical equivalence of this synthesised 147/149Gd-DOTA is 
thereby proven to be the same as the commercially available Gd-DOTA complex 
DOTArem™. The enzymatic metabolization of the complex is chemically very unlikely 
because all acetic acid groups of DOTA are bound to the central Gd ion and no vantage 
point is exposed for enzymatic cleaving. 
 
4.3.3 Comparison of in and ex vivo imaging of the 147/149Gd DOTA complex 
and commercial DOTArem™ 
For first comparison experiments the in vivo distribution of the contrast agent DOTArem™ 
was measured by MRI in a tumour bearing F98 rat model. One day later the here prepared 
147/149Gd-DOTA was injected, the rat sacrificed, brain sections prepared and measured with 
autoradiography as described in chapter 3.4.3. A histology of the neighbouring brain sections 
was done with the dye DAPI (4’,6-diamindino-2-phenylindole). Some of these coronal brain 
sections of the tumour area are depicted in Figures 35 and 36. 
In the autoradiographic measurements the radioactivity distribution of 147/149Gd is shown (left 
column in Figures 35 and 36). The histological staining with the fluorescence marker DAPI 
shown in the middle column displays the DNA in cell nuclei and therefore the cell density. 
Denser tissues, like the implanted tumour cells, appear darker in the staining than normal 
brain tissue or brain liquor. 
The MRI sections are the subtraction of images measured before and after an injection of the 
contrast agent. The difference in contrast is depicted in white. A perfect mapping of the MRI 
images onto the brain sections is not possible because the size of the brain is different in 
each method. While the shape of the brain is fixed by the cranial bone in the MRI in vivo 
measurements, it is strongly deformed after its extraction in the ex vivo histology or 
autoradiography. This distortion is most likely caused by the tumour, leading to a larger right 
hemisphere. In the comparison of the different imaging techniques, this leads to a 
problematic localisation of the MR sections in relation to the coronal orientation of the 
histological and autoradiographical images. An approximate localisation can be done with the 
help of characteristic anatomical structures. However, in the present case those are mostly 
not significant enough to achieve a perfect match for each section. The identified details, 
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however, are sufficient for a close assignment and comparison of most sections. Due to this 
and the limited number of experiment repetitions all stated interpretations are highly 
preliminary and still in need of confirmation by further testing. 
 
Figure 35:  Coronal autoradiographic ( left side), histologic (middle) and magnet 
resonance sections (right side) of the rat brain after the successive 
administration of n.c.a. 147/149Gd-DOTA (ARG) and commercial 
DOTArem™ (MRI) with the tumour tissue marked red and the lateral 
ventricles marked yellow. 
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Figure 36: Coronal autoradiographic ( left side), histologic (middle) and magnet 
resonance sections (right side) of the rat brain after the successive 
administration of c.a. 147/149Gd-DOTA (ARG) or commercial DOTArem™ 
(MRI) with the tumour tissue marked red, the lateral ventr icles marked 
yellow and the right hemispheric striatum labelled blue. 
The n.c.a. 147/149Gd-DOTA experiment was done 14 days after the implantation of the F98 
tumour cells and the tumour was considerably larger than in the c.a. 147/149Gd-DOTA 
experiment which was conducted 8 days after implantation. The tumour dimensions of the 
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histological staining were marked red in the images and these markings were transferred to 
the autoradiography sections. The dimensions of the radioactivity distribution, the histological 
staining as well as the tumour tissue shown by the MR images of the n.c.a. 147/149Gd-DOTA 
experiment correspond with each other and only smaller deviations occur which might be 
explained by freezing and fixating the sections. 
But, before any comparison of the non-radioactive and radioactive compounds can be 
discussed, it has to be stated that the Gd complex with DOTA exhibits a purely unspecific 
behaviour in the brain and cannot cross the intact blood brain barrier. An accumulation can 
only occur if the blood brain barrier is disturbed and an enhanced permeability and retention 
effect is present in the tissue. This is the case for most brain tumours. Another accumulation 
site beside the brain tissue is the choroid plexus in the ventricle system and every region with 
a significant high abundance of blood. 
This in mind, all three methods were successful in giving an approximate localization of the 
implanted tumour cells in both experiments. They reveal different fine structures of the brain 
and the tumour tissue and also show a deviating accumulation of the contrast agent. The 
differences which will be discussed in more detail are the accumulation in the central tumour 
regions and the highly metabolically active border regions as well as the difference in the 
general size of the tumour between the three imaging methods. 
At first the fine structures show an interesting difference in the central region of the tumour 
(see Figure 35). The used F98 glioma cells grow considerably faster than new blood vessels 
can be constructed from the body to sustain the tumour cells, leading to necrotic tissue. 
When the tumour grows further, this necrotic tissue is encapsulated preventing any blood 
supply. Only the outer regions of such fast growing tumours are highly metabolically active 
and supplied with blood. Thus, the outer regions typically show the highest contrast in MRI 
which is additionally enhanced in the living animal by the increased amount of blood in the 
border region of the tumour. This is seen in the histological staining as well, because no 
living cells with DNA are left in the necrotic regions. 
In this study, however, autoradiographic measurements show an accumulation of 
radioactivity in these necrotic regions in the centre of the tumour. This implicates a high 
concentration of contrast agent in the necrotic tissue which cannot be seen in the MRI 
images. The observed deviation between MRI images and autoradiographic measurements 
may be caused by an increasing magnetic susceptibility in the tissue which is induced by a 
rising concentration of T1 contrast agent leading to the annihilating of the positive T1 contrast 
by the negative T2* contrast above a certain contrast agent concentration.[144] 
Even though the cause for the deviation of MRI and autoradiography might thus be 
understood, the reason for the accumulation of the contrast agent in the necrotic region 
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cannot be explained yet. A uniform background radiation could be caused by diffusion of the 
compound, but an accumulation is contrary to the previously observed behaviour of glioma. 
Also, the accumulation can not be caused by the unlikely decomposition of the Gd-DOTA 
ligand because free 147/149Gd3+ ions cannot reach the necrotic regions. Thus, no conclusive 
explanation can be given thus far, and further studies are needed to explain the mismatch. 
Another difference is evident at the highly metabolically active border regions of the glioma. 
While a strong contrast change is observed in the MR sections, no accumulation can be 
seen in the autoradiograms. This can be based upon the unspecific nature of Gd-DOTA and 
the contrast enhancement originating from the blood in the blood vessels. On the one hand, 
no trapping of the contrast agent occurs in the tumour cells due to the disrupted blood brain 
barrier. After death of the rat the compound can diffuse into the surrounding tissue over time. 
The preparation of the sections and the acquisition of the autoradiograms took long enough 
for this phenomenon to occur. On the other hand, the preparation of the brain slices was 
done by shock freezing the brain only after its removal from the animal. Therefore, the blood 
with the excess of contrast agent probably has drained from the brain and the tissue shows a 
much lower accumulation of 147/149Gd-DOTA than in vivo. It can be assumed that these 
artefacts are additionally amplified by the considerable higher detection limit of 
autoradiography in comparison with MRI. This effect can also be seen in the c.a. 147/149Gd-
DOTA experiments. 
Completely similar histological and magnetic resonance images are obtained in the brain 
sections after the administration of c.a. 147/149Gd-DOTA (see Figure 36). For all three methods 
the same distribution of contrast agent is seen in the plexus coroideous, lateral ventricles 
(yellow) as well as at the implantation point of the glioma cells (red). In contrast to this, the 
radioactivity distribution in the region of the main tumour is considerably larger than the 
tumour tissue depicted by the histology or MR. The radioactivity is distributed nearly 
uniformly in the complete striatum which is marked blue for reference in Figure 36. A minor 
blurring of the autoradiogram is to be expected due to the γ-rays of 149Gd with higher 
energies. But as mentioned above, the most likely explanation for this is the combination of 
the different detection limits and the diffusion of contrast agent from the glioma into the 
striatum after the death of the rat. 
The limitation of the radioactivity within the striatum is most probably caused by the 
detachment of the striatum from the rest of the brain by the corpus callosum and the ventricle 
system. This explanation might be supported by the structures seen in brain section #370 
and #371 in Figure 36. It is possible that a small part of the glioma has grown into the 
striatum on the left hemisphere of the rat brain. The diffusion of the contrast agent is 
hindered by the separation of the striatum from the rest of the brain except for the leakage at 
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the metastasised tumour cells growing to the left hemisphere. In the left hemisphere the start 
of the diffusion originating from the tumour cells is seen. Another explanation for the 
observed structure in the brain section #370 and #371 could also be the right interventricular 
foramen which is displaced in the strong distortion of the brain by the expanding tumour. 
Either way the diffusion artefact depicted with the higher detection sensitivity of the 
autoradiography and the artefact induced by the absence of blood seem to be the basic 
problems of the measurement arrangement in the ex vivo comparison of the commercial 
DOTArem™ contrast agent and the synthesised 147/149Gd-DOTA. It is unlikely that other 
effects exist which would influence the distribution of the applied chemically identical 
compounds. Hence, the used method seems not to be applicable for a conclusive 
comparison of the distribution of radioactive and non-radioactive Gd-complexes. 
One solution may be shock freezing the whole animal before the brain is removed and 
therewith preserving the original blood distribution. Another solution of the distribution 
deviations between in and ex vivo measurements could be the subsequent in vivo imaging 
with SPECT and MRI with the same contrast agent cocktail. The great disadvantage of this 
would be the lower spatial resolution achieved with small animal SPECT scanners of 0.5 -
 2 mm in comparison to 50 – 100 µm with autoradiography.[37] The advantage is the 
avoidance of possible artefacts by dissection, freezing and cutting the brain in sections as 
well as diffusion of the compound until the autoradiogram is performed. 
Additionally, while Gd is momentarily the most used element in contrast agents in MRI, the 
use of the new PET/MRI hybrid scanners may tip the scales towards new bi-modal probes 
based on the Gd alternate Mn(II). This would allow a simultaneous in vivo evaluation with 
both modalities, if a PET suitable radiomanganese isotope is at disposal.  
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4.4 Production of n.c.a. 52gMn 
Given the emerging combination of PET and MRI scanners as well as emerging bi-modal 
probes, the radioisotopes of manganese suitable for PET measurements, namely 51,52gMn, 
and their production routes have to be re-evaluated. Cross sections of the promising proton 
induced reactions on natural chromium leading to 52gMn have been measured earlier [62-65, 67, 
68, 70, 145] and indicate an optimal production energy range at the maximum of the excitation 
function between 5 and 20 MeV (see Figure 4). While the cross sections of said reaction 
have been adequately measured, data on the production rates or thick target yields are only 
scarcely available.[69, 146, 147] In addition, more suitable separation methods have to be 
developed to establish a reliable supply of highly radionuclidically pure radiomanganese for 
those purposes. 
4.4.1 Integral yields and experimental thick target yields 
All production rates (TTYprod), derived saturation thick target yields (TTYsat) and theoretically 
assessed integral yields (IntYprod/sat) covering the maximum of the excitation function of the 
natCr(p,x)52g,mMn reaction were measured and calculated as described in chapter 3.2.5 and 
are shown in Table 18. Additionally, the integral yields of 52g,mMn are depicted in Figure 37. 
Some TTYs found in the literature are listed in Table 19. These were arithmetically converted 
into the TTYsat in GBq/µA for comparison as described by equation 16. 
Table 18: Experimental production rates, calculated saturation thick target yields 
and respective integral yields of main radioisotopes produced. 
 
 
 
 
 
Table 19: Literature thick target yields converted to saturation yields. 
 
 
 
 
Isotopes 
 
EP = 16.9 → 8.2 MeV 
TTYprod 
[MBq∙µA-1∙h-1] 
IntYprod 
[MBq∙µA-1∙h-1] 
TTYsat 
[GBq∙µA-1] 
IntYsat 
[GBq∙µA-1] 
 
52gMn 
 
13.1 ± 1.6 
 
13.7 ± 1.6 
 
2.55 ± 0.31 
 
2.74 ± 0.30 
52mMn 5990 ± 490 6910 ± 760 6.96 ± 0.57 8.03 ± 0.88 
51Cr 1.60 ± 0.16 1.73 ± 0.19 1.53 ± 0.15 1.66 ± 0.18 
Isot. 
TTYsat [GBq∙µA-1] 
Muminov[69] 
(12 MeV → threshold) 
Abe[147] 
(16 MeV → threshold) 
Dmitriev[146] 
(22 MeV → threshold) 
 
52gMn - 0.98 4.07 ± 0.47 
52mMn 7.25 - - 
51Cr - - 5.66 ± 0.67 
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Figure 37: Integral yield curves of 52g,mMn. 
The measured cumulative saturation yields in the proton energy range of 16.9 to 8.2 MeV 
amount to 2.55 ± 0.31 and 6.96 ± 0.57 GBq/µA for the ground state and the metastable state 
of 52Mn, respectively. With these new experimental data the activity contribution of the 
metastable state to the ground state was calculated to approximately 4.7 % in a saturated 
thick target. The calculated integral saturation yields of 52gMn and 52mMn are approx. 0.19 
GBq/µA (8 %) and 1.07 GBq/µA (15 %) higher than the experimentally determined yields, 
representing acceptable variances within one standard deviation for 52gMn and two standard 
deviations for 52mMn. This variance is analogous to the experimental yield diminution in the 
thick target measurements with radiogadolinium discussed in chapter 4.1.5. Again, in 
comparison to the integral yields a reduction of 5-30 % for the experimental yields is to be 
expected due to the earlier mentioned experimental artefacts, e.g. thermal effects, which 
influence the actual area weight among others. 
In the literature, only one determination of the thick target yield for 52gMn (16 → threshold) 
exists from Abe et al.[147] for the optimal proton energy production range (0.98 GBq/µA)[147]. 
This is only 38.5 % of the experimental result and 36.6 % of the theoretical calculation found 
in this study here. No details about the process of yield calculation, efficiency calibration, γ-
rays used for radioactivity calculation or their exact branching ratios are given by Abe et 
al.[147]. Therefore, no scientifically justified reason for this deviation can be given. Other 
reported thick target yields are either covering a too narrow (12 MeV → threshold[69]) or a too 
large energy region (22 MeV → threshold[146]), where more radioactive impurities (e.g. 
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48,49,51Cr) are produced. Therefore, a comparison of the measured data with those literature 
values is not seriously possible. 
In conclusion, the irradiation of a natural chromium disk is sufficient for laboratory scale 
separation tests, subsequent synthesis and initial PET studies. The shorter lived isotope 
52mMn decays too quickly into 52gMn (1.75 %) and 52Cr (98.25 %) before further experiments 
can be performed. The longer-living chromium impurities will be removed together with the 
macroscopic amount of target material. However, irradiations for more sophisticated in vivo 
PET studies should be done with enriched 52Cr targets to minimise isotopic impurities by 
51,54Mn. The investigation of these co-products was not part of this work, because for the 
development of a radiochemical separation 51Mn decayed too fast with a half-life of 46.2 min 
while the production of 54Mn was too low to be detected in presence of 52gMn and was 
therefore not interfering. 
 
4.4.2 Optimised radiochemical separation 
A number of different methods for the separation of manganese and chromium have been 
reported in literature so far.[148-150] Unfortunately, none of them is directly suitable for an 
authentic radiolabelling of MR contrast agents, because of the carrier used, too long 
separation times, a problematic transfer into an automated system or a chemical form, 
unfavourable for the subsequent synthesis steps. 
As mentioned in chapter 3.5, a separation of Mn from Cr was previously developed[65] which 
eliminates most of the problematic disadvantages of the available separation procedures. In 
this separation an irradiated chromium target was dissolved in fuming hydrochloric acid and 
separated by ion-exchange chromatography, utilizing DOWEX 50WX8 and 0.067 M 
ammonia citrate solution (pH 7.2) for elution of manganese. Unfortunately, a complete 
removal of chloride ions is absolutely mandatory for the chromatographic step of the 
separation. The time consuming removal is quite impractical considering that the chromium 
is dissolved in hydrochloric acid and the resulting product needs to be converted into MnCl2 
for further processing. Additionally, the volume of the eluted radiomanganese is rather large 
with 10 – 15 mL. Russel et al.[130] suggested a different n.c.a. chromatographic separation 
method, which uses oxalic acid as eluent for Cr and 1 M HCl for the elution of 
radiomanganese. The separation was originally designed for the separation of 54Mn from 
macroscopic amounts of Cr, but should be easily adaptable for 52Mn. Therefore, the 
separation was carried out according to the described procedure (see chapter 3.5.2) and the 
separation parameters were optimised aiming at a more suitable separation of 52Mn from Cr. 
The elution profile of this separation is depicted in Figure 38. 
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Figure 38: Elution profi le of the *Mn separation from Cr taken from Russel et al.[130]    
(resin: Amberlite IR120, Cr eluent: 0.56M oxalic acid, Mn eluent: 1 M HCl) 
The elution profile shows a clearly separated Cr as well as a 52Mn fraction of approx. 75 mL 
volume with an additional small loss of approx. 1.2 % of starting 52Mn radioactivity in the Cr 
fractions. A small amount of Cr (<1 %) is absorbed on the column and eluted in the Mn 
fractions, unless a large amount of oxalic acid is used for the elution of Cr or a successive 
repetition of the separation procedure is performed. The original separation procedure is not 
optimal due to the far too large volume of the eluent fractions of both Cr and Mn which is 
impractical for a subsequent radiolabelling. Therefore, the parameters of the separation were 
further changed. 
The loading solution was reduced from 50 mL 5 % oxalic acid to 5 mL 1 % oxalic acid to 
achieve smaller chromium fractions for more efficient reprocessing of the target material. The 
resin was changed from Amberlite IR120 to DOWEX 50WX8, due to availability reasons. The 
column temperature was increased to 80°C, enhancing the elution, in order to obtain smaller 
chromium and manganese fractions. The column dimension was increased for reduction of 
manganese break through. The elution profile of the resulting optimised separation thus 
developed is depicted in Figure 39. 
Even yet, with optimised parameters a small amount of approx. 1.4 % radiomanganese was 
still lost in the chromium fractions, and it was found that the adsorption of the Cr on the 
column is strongly dependent on the residual chloride concentration from the solvation of the 
elemental chromium target. The addition of 0.05 to 0.15 M hydrochloric acid leads to a 
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complete Cr elution with the necessary concentration depending on the employed Cr mass. 
However, the concentration window of added hydrochloric acid is rather small, since a 
concentration above 0.2 M HCl will already lead to a substantial manganese breakthrough. 
Lower concentrations are leading to Cr impurities within the manganese fractions. Because 
of this strong dependence on the hydrochloric acid concentration for the complete elution of 
chromium, a simple translation of the separation procedure for varying chromium masses is 
not possible. For this, the separation method is too complex and not favourable. 
 
Figure 39: Elution prof ile of a *Mn separation from Cr with optimised parameters 
(resin: DOWEX 50WX8, Cr eluent: 0.11M oxalic acid / 0.15 M HCl, Mn 
eluent: 3M HCl, T=80°C). 
Another separation method investigated was based on the selective extraction of chromium 
from an ion exchange resin by an organic extractant. A suitable one for the selective 
extraction of trivalent ions is di-(2-ethylhexyl)phosphoric acid (HDEHP) which is also used in 
the DAPEX[151] procedure for uranium extraction. Distribution coefficients were measured for 
varying concentrations of HDEHP in EtOH with an anion and cation exchange resin after a 
1 h and a 72 h equilibration time period. The resulting KD-values and separation factors (SF) 
are summarised in Table 20.  
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Table 20: KD and SF values of 51Cr, 52Mn in different solutions. Bold marked 
solution combinations were used in column separations discussed below. 
 
Resin / incub. time 
 
Solution 
 
KD 51Cr 
 
KD 52Mn 
 
SF 52Mn/51Cr 
 
DOW. 50WX8 / 1 h 
 
 
2.2 % HDEHP / 
97.8 % EtOH 
 
9.0 ± 2.6 
 
1335 ± 138 
 
149 ± 15 
DOW. 50WX8 / 1 h 
4.4 % HDEHP / 
96.6 % EtOH 
9.2 ± 2.6 746 ± 77 81 ± 8 
DOW. 50WX8 / 1 h 
6.6 % HDEHP / 
93.4 % EtOH 
7.5 ± 2.5 790 ± 82 106 ± 11 
DOW. 50WX8 / 1 h 
8.8 % HDEHP / 
91.2 % EtOH 
5.1 ± 2.3 691 ± 72 137 ± 14 
DOW. 50WX8 / 72 h 
2.2 % HDEHP / 
97.8 % EtOH 
14.8 ± 2.3 1916 ± 186 129 ± 13 
DOW. 50WX8 / 72 h 
4.4 % HDEHP / 
96.6 % EtOH 
11.6 ± 2.1 1541 ± 150 133 ± 13 
DOW. 50WX8 / 72 h 
6.6 % HDEHP / 
93.4 % EtOH 
9.7 ± 2.0 1378 ± 134 143 ± 14 
DOW. 50WX8 / 72 h 
8.8 % HDEHP / 
91.2 % EtOH 
6.7 ± 1.9 1330 ± 129 197 ± 19 
 
Amb. CG 400 / 1 h 
 
0 % HDEHP / 
100 % EtOH 
 
1.1 ± 1.7 
 
506 ± 47 
 
460 ± 43 
Amb. CG 400 / 1 h 
0.25 % HDEHP / 
99.75 % EtOH 
2.2 ± 2.2 796 ± 59 358 ± 27 
Amb. CG 400 / 1 h 
0.5 % HDEHP / 
99.5 % EtOH 
0.91 ± 1.70 461 ± 43 508 ± 48 
Amb. CG 400 / 1 h 
1 % HDEHP / 
99 % EtOH 
2.3 ± 2.1 671 ± 50 291 ± 22 
 
Amb. CG 400 / 1 h 
 
2.2 % HDEHP / 
97.8 % EtOH 
 
0.77 ± 1.70 
 
418 ± 55 
 
544 ± 72 
Amb. CG 400 / 1 h 
4.4 % HDEHP / 
96.6 % EtOH 
2.5 ± 1.8 577 ± 76 235 ± 31 
Amb. CG 400 / 1 h 
6.6 % HDEHP / 
93.4 % EtOH 
2.0 ± 1.8 490 ± 65 242 ± 32 
Amb. CG 400 / 1 h 
8.8 % HDEHP / 
91.2 % EtOH 
2.1 ± 1.8 700 ± 92 338 ± 44 
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Table 20 cont. 
 
Resin / incub. time 
 
Solution 
 
KD 51Cr 
 
KD 52Mn 
 
SF 52Mn/51Cr 
 
 
Amb. CG400 / 1 h 
 
 
MeOH 
 
 
-0.22 ± 0.59 
 
 
154 ± 24 
 
 
1537 ± 244 
Amb. CG400 / 1 h EtOH 1.4 ± 1.1 329 ± 34 239 ± 25 
Amb. CG400 / 1 h iPrOH -0.26 ± 1.00 24.3 ± 3.1 243 ± 31 
Amb. CG400 / 1 h BuOH -0.051 ± 0.601 56.7 ± 9.6 567 ± 96 
 
Amb. CG400 / 1 h 
 
 
1 % HCl / 
99 % MeOH 
 
0.36 ± 0.61 
 
141 ± 23 
 
395 ± 63 
Amb. CG400 / 1 h 
5 % HCl / 
80 % MeOH 
2.2 ± 0.7 203 ± 32 93.2 ± 14.7 
Amb. CG400 / 1 h 
20 % HCl / 
80 % MeOH 
1.4 ± 0.6 163 ± 26 118 ± 19 
 
Amb. CG400 / 1 h 
 
 
1 % AcH / 
99 % MeOH 
 
-0.19 ± 0.97 
 
93.0 ± 8.6 
 
930 ± 86 
Amb. CG400 / 1 h 
5 % AcH / 
95 % MeOH 
-0.41 ± 0.97 106 ± 10 1064 ± 98 
Amb. CG400 / 1 h 
20 % AcH / 
80 % MeOH 
-0.29 ± 1.09 211 ± 27 2111 ± 273 
Amb. CG400 / 1 h 
30 % AcH / 
70 % MeOH 
-0.65 ± 0.99 292 ± 31 2924 ± 305 
Amb. CG400 / 1 h 
50 % AcH / 
50 % MeOH 
-0.43 ± 0.59 563 ± 87 5632 ± 872 
Amb. CG400 / 1 h 
70 % AcH / 
30 % MeOH 
4.3 ± 0.8 1123 ± 173 261 ± 40 
Amb. CG400 / 1 h 
90 % AcH / 
10 % MeOH 
14.5 ± 2.2 836 ± 86 57.5 ± 5.9 
 
In case of KD-values showing a negative value, what can emerge due to the uncertainties in 
radioactivity and volume, the separation factors were calculated with a KD-value of 0.1, taking 
conservatively a minimal physical absorption into account. The corresponding KD values and 
separation factors for varying HDEHP concentrations from Table 20 are graphically depicted 
in Figures 40 and 41. 
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Figure 40: Comparison of KD values with varying DEHP extractant concentrations on 
DOWEX 50WX8 and Amberlite CG400 after 1h and 72h equilibration time. 
 
Figure 41: Separation factors of Cr and 52gMn with varying DEHP concentrations on 
DOWEX 50WX8 and Amberlite CG400 after 1h and 72h equil ibration time. 
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No conclusive trend leading to an optimal HDEHP concentration was observed with the 
distribution coefficients. The highest separation factor after a 1h equilibration time was found 
to be 543 ± 71 for a 0.064 M (2.2 wt%) HDEHP solution on the anion exchange resin 
Amberlite CG400. Therefore, a proof of principle column separation was conducted using an 
ethanolic 0.064 M (2.2 wt%) HDEHP solution with the corresponding elution profile as 
depicted in Figure 42. 
 
Figure 42: Elution profi le of a *Mn separation from Cr on an anion exchange resin 
(resin: Amberlite CG400, Cr eluent: EtOH with 2.2 wt% HDEHP 
extractant, Mn eluent: H2O. 
Again, the elution profile shows a broad Cr elution peak as well as chromium impurities in the 
manganese fractions of approx. 13 % in total. This is not tolerable for a subsequent n.c.a. 
labelling application. But no manganese breakthrough was detected in the chromium 
fractions. For quantitative elution of radiomanganese pure water was sufficient which 
simplifies processing for the subsequently planed radiolabelling. 
Due to the inconclusive influence of the HDEHP concentration on distribution coefficients 
another KD-value screening was done, testing MeOH, EtOH, 2-PrOH and BuOH as solvents 
without the addition of any extractant (see Figure 43). Those alcohols were furthermore 
selected for their varying alkyl chain length, to investigating their possible different 
complexing behaviour with Cr or Mn. 
The distribution coefficients as well as SF are showing that no extractant is needed for the 
successful absorption of 52Mn2+ on the anion exchange resin Amberlite CG400 (see Figure 
43). Additionally, the binding affinity of Cr3+ towards the resin decreases with shorter alkyl 
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chains, making MeOH the most promising solvent. The elution profile of the *Mn separation 
from Cr using MeOH as loading and elution solvent for Cr is depicted in Figure 44. 
 
Figure 43: KD values and separation factors of 51Cr and 52Mn with MeOH, EtOH,      
2-PrOH and BuOH on Amberlite CG400. 
 
 
Figure 44: Elution prof ile of a *Mn separation from Cr with MeOH as eluent (resin 
Amberlite CG400, Cr eluent: MeOH, Mn eluent: H2O). 
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The elution peak of Cr is considerably smaller than for the separation with ethanol, however, 
as soon as the concentration of Cr in the eluent drops below 1.2 mg/mL, about 18 % of the 
absorbed Mn activity is slowly eluted before the change to pure H2O as eluent. As a result 
only about 1 % of Cr impurity is found within the radiomanganese fractions. 
Still, another investigation of KD-values was done to evaluate the utilisation of an additive to 
either suppress the manganese leaching or to accelerate the elution of weakly adsorbed Cr. 
Especially to achieve the latter, acetic acid and hydrochloric acid were tested as additives 
and the KD-values and SF were determined and are shown in Figures 45 and 46. 
 
Figure 45: KD values of the Amberlite:MeOH system with addit ion of acetic and 
hydrochloric acid for the suppression of chromium retention. 
 
 
Figure 46: Separation factors of the Amberlite:MeOH system with addit ion of acetic 
and hydrochloric acid for the suppression of chromium retention. 
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The addition of acetic acid shows the greatest effect on the ion exchange behaviour of Cr 
and Mn. The Mn absorption rises steadily until an acetic acid concentration of 12.24 M is 
reached. However, at the same concentration a simultaneous absorption of chromium can be 
observed. Therefore, the optimal acetic acid concentration for a high radiomanganese 
absorption and low Cr retention is at 8.74 M. The elution profile of a separation executed with 
8.74 M acetic acid in MeOH for the elution of Cr is depicted in Figure 47. 
 
Figure 47: Elution profi le of the *Mn separation from Cr with the Amberlite: 
MeOH:AcH system (resin: Amberlite CG400, Cr eluent: 1:1 MeOH:AcH, 
Mn eluent: H2O 1. Mn peak, 3 M HCl 2. Mn peak). 
The elution peaks of Cr and Mn are well separated and no radiomanganese breakthrough is 
detected in the acetic acid eluent. But now, the bound Mn species shows such a high affinity 
towards the resin that pure water is not enough for a quantitative elution of radiomanganese. 
Only 77.2 % radiomanganese were eluted with pure water. However, the residual 52Mn can 
be quantitatively eluted with 3 M HCl; shown in Figure 47 as a second 52Mn elution peak. 
Therefore, the 52Mn eluent was changed to 3 M HCl in the subsequent separations. 
A further optimization was done by increasing the column temperature. The higher 
temperature accelerates the ion exchange rate between the mobile and stationary phase 
which influences the eluent volume size necessary for quantitative elution of Cr and Mn. The 
temperature was increased after the main mass of Cr was passed through the column to 
minimise a negative effect on the mass of absorbed Cr. The elution profile of a separation of 
52Mn conducted at 50°C and 3 M HCl is depicted in Figure 48. 
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The separation was completed within 3 to 4 h after the disassembly of the target. The elution 
fraction volume of Cr was reduced by the factor of two while 99.5 % of 52Mn was eluted with 
2.1 mL of eluent. No radioactive 51Cr was anymore measured in the 52Mn fractions over a 
counting period of three days. Should trace amounts of chromium still be present in the 
resulting 52Mn fraction, the procedure could be repeated within a short period of time 
because the small elution volume of 52Mn could be evaporated quickly. This volume can be 
optimised further by use of columns with smaller diameters. However, for the purpose of the 
present work the elution volume was suitable. 
 
Figure 48: Elution profile of the optimised *Mn separation from Cr (resin: Amberlite 
CG400, Cr eluent: 1:1 MeOH:AcH, Mn eluent: 3 M HCl). 
 
In conclusion, the optimised procedure seems to be feasible for the separation of 52Mn in a 
much smaller eluent volume than in the previously developed separation methods. The final 
procedure can be summarised as follows: 
Optimised radiochemical separation procedure for n.c.a. 52Mn 
- dissolution of 470-500 mg elemental Cr in 5 mL conc. HCl at 70°C, 
- evaporation to dryness and re-solvation in 5 mL of 50 % acetic acid and 50 % MeOH, 
- loading of the solution onto a previously conditioned Amberlite CG400 column with a 
diameter of 1 cm and a height of 2 cm, 
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- elution of bulk Cr and residual impurities at an elevated temperature of 50°C with 
45 mL of 50 % acetic acid and 50 % MeOH, 
- elution of n.c.a. radiomanganese in 2-3 mL of a 3 M HCl solution at 50°C. 
The final solution can be evaporated to dryness and the residue completely re-dissolved in 
pure water for further processing. The resulting solution was found to be slightly acidic due to 
residual hydrochloric acid. The produced n.c.a. 52Mn was used in this form for the radioactive 
synthesis of the MnO nanoparticle precursor Mn(acac)2 as described below. 
 
4.5 Authentic manganese nanoparticle labelling 
In recent years a strong focus in MR contrast agent research was on the development of new 
nanosized contrast agents. Two main advantages of nanosized contrast agents are 
postulated in literature.[152] The first is the increased volume concentration of the contrast 
enhancing element in nanoparticles leading to an even higher contrast enhancement in 
comparison to single chelates. The second is a possible functionalization of the nanoparticle 
shell with tumour or disease targeting moieties or groups prolonging blood circulation time of 
the particles.[153] 
Considering this beneficial translation of MR contrast agents into nanosized compounds, 
divalent manganese is the most promising element besides trivalent gadolinium. Its five 
unpaired electrons lead to a high T1 relaxivity change in MRI. Several water-soluble 
manganese based nanoparticle concepts exist, but none was completely evaluated for a use 
in vivo. Even though the potential of nanosized diagnostic or therapeutic agents is high, a 
critical assessment of the advantages of nanosized compounds over already existing drugs 
is essential. The authentic labelling of manganese based nanoparticles might be an excellent 
in vivo analytical means to facilitate another step towards the realisation of nanosized 
contrast agents with a useful application, because of the low detection limits and precise bio-
distribution studies possible with the PET systems. 
 
4.5.1 MnO nanoparticle synthesis 
Radioactive precursor synthesis for authentic labelling of MnO-nanoparticles 
As described in the introduction (chapter 1.9.1), most synthesis routes of nanoparticles are in 
need of a suitable precursor. Therefore, efficient authentic labelling of a nanosized 
compound can only be realised with an authentic labelled precursor as starting material. The 
isotopic labelling of an already known MnO nanoparticle precursor was performed here as 
proof of principle. When the separation was done as described by Graddon et al. [131], a dark 
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brown precipitate was formed as by-product which is most likely MnO2. This was prevented 
by performing the separation process in the dark and in an inert atmosphere. 
The adapted precursor synthesis (see section 3.6.1) resulted in a radioactively determined 
yield of 73.9 ± 5 % and a weighing yield of 78.7 ± 5 %; results coinciding within one standard 
deviation. These deviations mainly originate from the slightly altered detection geometry in 
the radioactivity measurements compared to the radioactive reference point sources used for 
the efficiency calibration of the γ-ray detectors. For comparison: Graddon et al.[131] described 
a yield of 87 % for the crude and not re-crystallised product. The yield found in this work can 
be optimised by reduction of physical product loss in the washing procedure. Even though 
the separation from the washing solution was done with utmost care, a portion of yellow 
precipitate was lost. Reprocessing of the washing solution may reduce this loss of yield. 
However, it was still high enough for the subsequent synthesis and therefore no further 
optimisation was undertaken. 
The ESI-MS spectra of the synthesised compound and of the purchased reference material 
are depicted in Figures 49 and 50. 
 
Figure 49: ESI-MS spectrum of synthesised Mn(acac)2 (M = 253.15 g/mol) without 
further purif ication. 
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Figure 50: ESI-MS spectrum of Mn(acac)2 (M = 253.15g/mol) reference standard. 
The prominent mass peak at 253.83 m/z in Figure 49 is identified as Mn(acac)2 
(M = 253.15 g/mol). This peak is also found in the reference spectrum, thus confirming the 
success of the synthesis. Other depicted peaks are fragments in the unlikely case and in the 
most likely case adducts of Mn(acac)2 with ions or neutral additives of the analysis solution, 
like Na+, CO32+, H2O, MeOH or AcOH. Furthermore, the formation of clusters is possible due 
to the very low ionisation voltage used. The relative abundances of peaks in these 
measurements are also not specific for Mn(acac)2, due to the soft ionisation method used. 
 
Inactive microwave assisted MnO-nanoparticle synthesis 
For the authentic labelling of nanoparticles a short reaction time is very important if 
radionuclides with shorter half-lives should be applied. In many organic syntheses the 
application of microwave heating leads to increased yields in a shorter reaction time and 
often a higher purity of the desired product. Recent reviews showed the potential of 
microwave heating in nanoparticle synthesis.[154, 155] Therefore, the translation of several 
different literature synthesis routes for water-dispersible, nanosized MnO particles to 
microwave supported synthesis was tested. The tests were performed with inactive precursor 
material only because the subsequently necessary analytical characterisation methods of the 
products were not available in a controlled area. None of the tested syntheses yielded water-
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dispersible MnO-nanoparticle in a reproducible manner. As the formation of nanoparticles is 
a very complex process, this lack of repeatability in the results could be caused by, but not 
exclusively, precursor structure, heating time, nucleation temperature, growth temperature, 
coating agent, washing solution, centrifugation speed and more. 
All assessed synthesis routes were based on the controlled decomposition of a manganese 
precursor (Mn(II)acetate; Mn(II)acetylacetonate) in a non-aqueous medium (triethylene 
glycol, trioctylamine, benzyl alcohol) and a combined or subsequent coating step with an 
amphiphilic coating agent, for example polyvinylpyrrolidone (PVP, avg. mol. weight: 40,000) 
or polyethylene glycol (PEG, avg. mol. weight: 200 – 6,000). As described by Bilecka et 
al.[132], the decomposition of the manganese precursor occurred under inert conditions 
excluding oxygen with utmost care, as its presence led to the direct aggregation of the 
nanoparticles with or without coating agent. 
The following coating step was necessary to achieve water solubility and dispersion stability. 
Every nanoparticle solution without an extra coating agent aggregated or oxidised in a period 
of minutes to hours after the synthesis. Even with a suitable polymer coating, the 
nanoparticles synthesised in this work did not form aqueous dispersion that were stable over 
a longer time period. 
The reaction parameter of the most successful nanoparticle preparation with synthesised 
Mn(acac)2 as precursor and PVP 40,000 as coating agent is described in chapter 3.6.1. The 
DLS measurement of the unprocessed nanoparticle dispersion directly after the synthesis 
showed a mean radius of approx. 31 nm in triethylene glycol. After the separation of residual 
precursor and coating agent and re-dispergation in 2-propanol the DLS measurement 
showed an increased mean radius of 65 nm. The comparison of the size distribution curves 
is presented in Figure 51. 
 
Figure 51: DLS measurement of self-synthesised MnO nanoparticles in the init ial 
solvent triethylene glycol and isolated in 2-propanol. 
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In addition to the higher radius, a broadening of the size distribution can be observed which 
could be the beginning aggregation of the particles. TEM measurements were conducted 
with the re-dispersed nanoparticles in search of an explanation for the broadened size 
distribution. The images of the TEM and the SAED measurements are depicted in Figure 52. 
 
Figure 52: TEM images of a) synthesised MnO nanoparticles in 2-propanol and b) an 
electron diffraction pattern thereof. 
The TEM images clearly show nanocrystals aggregated into larger clusters. The 
nanocrystals and aggregates possess an average geometric diameter of approx. 22.2 ± 
5.5 nm and 70.1 ± 25.4 nm, respectively. This agrees well with the increasing radius of 
nanoparticles seen in the DLS measurements in triethylene glycol and 2-propanol. Some of 
the smaller particles are still left in the dispersion while the majority has aggregated to larger 
clusters. This means that the polymer coating with PVP is at least imperfect and cannot 
prevent the formation of larger aggregates. Still, the presented method shows another 
possibility to synthesise a crystalline product with particle sizes below 100 nm by microwave 
heating in a short time. Similar cubic and triangular shaped nanocrystals with a slightly larger 
edge length of 30 – 50 nm were found in another microwave assisted synthesis reported by 
Bilecka et al.[132]. The observed reduction of size in this work can be caused by the 
separation of the nucleation and growth period by explicit temperature control adapted from 
literature[156]. The uniform heating and cooling of the sample in the microwave oven is a clear 
advantage for such a controlled synthesis. 
An authentic core labelling is only reasonable with water-dispersible particles which are 
stable for several days. Otherwise, in vivo stability tests cannot be conducted, and the 
particles are just not suitable for PET/MR measurements. Therefore, further optimization 
work has to be invested regarding the polymer coating leading to the production of a water-
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dispersible manganese nanosized compound. In context with the recent concern regarding 
the usefulness of nanosized diagnostics and therapeutics[157] the question has to be asked if 
further efforts are indeed worthwhile. 
 
4.5.2 Irradiation of water-dispersible Mn3O4-nanoparticles 
An alternative to the challenging complete synthesis of an authentically core labelled 
nanoparticle is the direct irradiation of commercially available nanosized compounds with 
charged particles or neutrons. Therefore, water-dispersible Mn3O4 nanoparticles were 
activated here with isotopic and non-isotopic radionuclides to investigate their integrity and 
dispersion stability after an irradiation as described in chapter 3.6.2. Additionally, the release 
of manganese ions from neutron irradiated nanoparticles was examined. The size distribution 
results of all conducted activation studies are summarised in Table 21. 
Table 21: TEM- and DLS-determined sizes of Mn3O4 nanoparticles after the 
activation studies. 
 
Material 
 
Diameter TEM [nm] 
 
Diameter DLS [nm] 
 
Mn3O4 (purchased) 
 
15.6 ± 5.1 
 
68.6 ± 1 
Mn3O4 (proton activated) - 100 ± 8 
Mn3O4 (neutron activated) 11.7 ± 4.2 74 ± 2 
Mn3O4 (neutron activated, 
leeched in H2O) 
13.8 ± 3.7 87 ± 1 
Mn3O4 (neutron activated, 
leeched in PBS solution) 
- 227 ± 4 
 
Irradiation of Mn3O4-nanoparticles with charged particles 
The nuclear reaction 16O(p,α)13N is of interest regarding the activation of nanoparticles 
because of the high abundance of oxygen in many nanosized materials and the favourable 
decay characteristics of 13N for PET (half-life: 10 min, avg. β+-energy: 491.82 keV, β+-
emission: 99.8%). In an initial test, Mn3O4 nanoparticles were irradiated with 8.5 MeV protons 
to allow a subsequent characterisation and to assess the change induced by the charged 
particle irradiation. The proton energy was kept below the threshold of other nuclear 
reactions (<10.4 MeV) which would lead to longer-living radionuclides, e. g. the 
55Mn(p,pn)54Mn process. TEM images prepared from the irradiated and partial dispersed 
nanoparticles are depicted in Figure 53. 
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Figure 53: TEM images of a) purchased Mn3O4 nanoparticles, b) proton irradiated 
Mn3O4 nanoparticles, c) electron diffraction pattern of inactive Mn3O4 
nanoparticles, and of d) proton activated Mn3O4 nanoparticles. 
Directly after the irradiation and the disassembly of the sediment target a different physical 
behaviour was observed. Unlike before, only a fraction of the nanoparticles were dispersible 
in pure H2O by treatment with an ultrasonic bath. An influence of the target preparation on 
the dispersion behaviour was excluded by testing non-irradiated sediments beforehand 
which exhibited normal water-dispersibility. 
The radioactive decay of the resulting supernatant was analysed after the partial dispersion 
of the targets. The graphical extrapolation of the decay curve showed a half-life of 
10.03 ± 0.32 min which agrees well with the half-life of 13N. No radioactive impurities with 
longer half-lives were detected in long time γ-spectrometric measurements. The activation of 
Mn3O4 nanoparticles with 13N was thus successful. The DLS measurements, however, 
showed a diameter of 100 ± 8 nm which is 31 % larger than the original particles’ size 
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distribution. A considerable alteration of the nano-material can be observed in the TEM 
images showing larger crystals beside the original Mn3O4 nanoparticles due to the proton 
bombardment (see Figure 53 b). 
These larger crystals must have formed during the irradiation. The heat of a focused particle 
beam cannot be distributed fast enough throughout the complete sample leading to a partial 
melting and re-crystallisation within the sediment. Another side effect may also be the partial 
destruction of the polymer coating and, hence, a loss of water-dispersibility of the particles. 
The use of higher particle energies might principally be interesting considering the 
55Mn(p,p3n)52gMn reaction with a threshold of 31.7 MeV. But, no further activation studies 
were conducted due to the disintegration of the nanoparticles in the lower energy range. A 
possible solution to minimise the induced damage is the direct irradiation already in solution 
or the “softer” activation with neutrons.  
Irradiation of Mn3O4-nanoparticles with neutrons 
For the activation of Mn3O4-nanoparticles the neutron induced 55Mn(n,γ)56Mn reaction was 
used, due to its relatively high cross section of approx. 13.2 b for thermal neutrons[142, 158] and 
a high intensity γ-ray favourable for γ-spectrometry (see Table 1). The irradiation was 
explicitly done with thermal neutrons which do not deposit a significant energy within the 
target material. Thus, no change of the nano-structures is to be expected on the large scale 
except for the damage of the crystal structure due to the direct impact of neutrons and the 
subsequent emission of β-particles caused by the radioactive decay of the activated target. 
As expected, no macroscopic difference between untreated and activated Mn3O4 particles 
was observed before and after irradiation with neutrons. No aggregation was visible in a time 
interval of several weeks after irradiation in the clear darkish brown solution. This was 
confirmed by TEM measurements of the particles after the complete decay of 56Mn. No 
relevant changes were observed in the relatively broad spread size distribution of the primal 
particles depicted Figure 54 a) and their neutron irradiated counterparts in Figure 54 b). 
The analysis of 194 not activated nanoparticles yielded a poly-disperse size distribution of 
crystalline nanoparticles ranging from 4.8 nm up to 46.3 nm. The diameters of the 57 
analysed activated nanoparticles ranged from 3.6 nm to 25.8 nm. These minor size 
differences between both probes can be accounted to the poly-disperse nature of the 
samples, the limited amount of analysed particles, and their non-spherical shape, which 
broadened the size distribution even further. Therefore, the TEM analyses provided the first 
evidence for a successful authentic radiolabelling of manganese oxide nanoparticles without 
significant change in size or shape. 
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Figure 54: TEM images of a) purchased Mn3O4 nanoparticles, b) neutron irradiated 
Mn3O4 nanoparticles, c) electron diffraction pattern of inactive Mn3O4 
nanoparticles, and d) of neutron activated Mn3O4 nanoparticles. 
 
Further evidence of a successful radiolabelling without destruction of the target matrix can be 
obtained from the electron diffraction pattern comparison of the primary and the irradiated 
nanoparticles. While the direct determination of the crystal lattice is very elaborate with 
SAED, diameters of the occurring diffraction circles are conclusive in case of a direct probe 
comparison. The first and second diffraction circles of the primal and activated nanoparticles 
were 4.05 ± 0.05 nm-1 and 6.41 ± 0.07 nm-1 in diameter and 4.05 ± 0.01 nm-1 and 
6.38 ± 0.02 nm-1, respectivly. They are congruent within their uncertainty limits with a 
deviation below 1 %. Therefore, it can be concluded that no macroscopic crystallographic 
change occurred during the irradiation and decay. For further stability assessment of the 
introduced label 56Mn, leaching experiments were conducted subsequently. 
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Stability and leaching experiments with activated Mn3O4-nanoparticles 
Complementary to the nanoparticle size and crystal structure characterisation the performed 
irradiation allowed the investigation of their dispersion stability and the examination of a 
possible Mn ion release. While decomposition over time is highly desirable for in vivo 
contrast agents based on iron oxide for their excretion, manganese ions are toxic and thus 
the release has to be kept at trace levels. 
In the characterisation of neutron irradiated nanoparticles (see chapter 3.6.3) leached with 
pure water, no aggregation was visible in the clear darkish brown solution over a time interval 
of several weeks after irradiation. Incubation in phosphate buffered saline (PBS) led to an 
aggregation of the particles in course of the experiments and no TEM analysis was anymore 
possible afterwards. 
However, the leaching experiments allowed the investigation of the Mn ion release in H2O 
and PBS for a time interval of approx. 15 h after the initial irradiation. After these 6 half-lives 
of 56Mn the radioactivity was too low for further γ-ray measurements. The results of the 
potential leaching in PBS and HPLC-grade water are depicted in Figure 55 while the 
respective TEM images are depicted in Figure 56. 
A steady increase of manganese concentration was observed with up to (2.1 ± 0.3) µg Mn in 
solution after 15 h of leaching, which corresponds to a very low fraction of (0.033 ± 0.005) % 
of the complete manganese inventory of 8.8 ± 0.7 mg Mn3O4. 
 
Figure 55: Percentage of released Mn ions from a sample of 8.8 mg Mn3O4-
nanoparticles within 15 h after irradiation with neutrons. 
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Figure 56: TEM images of a) neutron irradiated Mn3O4 nanoparticles before leaching, 
and b) after leaching, c) electron diffraction pattern of irradiated Mn3O4 
nanoparticles before leaching, and d) after leaching. 
 
For comparison, the known acute oral toxicity of MnCl2 ∙ 4 H2O in Sprague-Dawley rats is 
relatively low with a LD50 value of 1484 mg/kg.[159] The toxicity by intraperitoneal injections in 
rats on the other hand is LD50 = 138 mg/kg and therefore one order of magnitude higher.[160] 
While the released amount of free manganese is low in comparison, a meaningful and 
precise discussion, if this amount is high enough to induce a toxic effect, can only be done 
with a known biological half-life of the nanoparticles. The authentic activation of Mn3O4-
nanoparticles by neutrons, as shown here, could deliver the precise answer for the first 15 h 
after exposure, without the introduction of any additional analysing agents. 
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5. Summary 
In this work, some of the nuclear chemical aspects of the production of suitable radionuclides 
for authentic labelling of current or experimental MR contrast enhancing agents based on 
gadolinium (III) and manganese (II) were studied. This includes the identification of suitable 
radioisotopes of gadolinium and manganese for application in nuclear imaging methods 
(SPECT/PET), the measurement of nuclear data important for their production, their actual 
production, radiochemical separation from the target material, and a proof of principle 
application. In addition, the concept of activation with charged particles and neutrons was 
assessed with commercial manganese oxide nanoparticles in order to examine their 
applicability for in vivo application in MRI. 
The radioisotopes 147,149Gd were chosen for application with SPECT and autoradiographic 
studies because of their favourable γ-ray energies. The shorter half-life of 147Gd (38.06 h) 
benefits an application in vivo while the longer half-life of 149Gd (9.28 d) is ideal for laboratory 
studies. The cross sections of the nuclear reactions induced by deuterons and protons on 
natEu2O3 leading to both radionuclides as well as the relevant by-products were measured up 
to 70.9 MeV and 44.8 MeV, respectively. A maximum of the 147Gd excitation functions for 
deuteron induced reactions was found at 56.3 ± 0.5 MeV with 190 ± 19 mb while no clear 
maximum can be observed in the examined energy region of proton induced reactions. The 
149Gd excitation function for deuteron induced reactions showed two maxima at 
56.3 ± 0.5 MeV (327 ± 32 mb) and 32.6 ± 0.8 MeV (327 ± 34 mb). The proton excitation 
function exhibited one clear maximum at 25.3 ± 0.7 MeV (432 ± 26 mb) while the second was 
only indicated at 44.8 ± 0.4 MeV (332 ± 36 mb), respectively. The excitation functions of the 
151Gd impurity showed nearly the same trend in comparison to 149Gd making a 
radionuclidically pure production with natural europium impossible. 
Integral yields were calculated with the measured excitation functions of 147Gd and 149Gd 
over the complete examined energy range to 177.3 ± 19.7 and 81.6 ± 8.5 MBq/µAh for 
deuteron induced reactions and to 43.3 ± 4.4 and 61.8 ± 4.9 MBq/µAh for proton induced 
reactions, respectively. Experimental thick target yields were determined for proton induced 
reactions on natEu2O3 in the energy region from 45 to 31 MeV and from 36 to 18 MeV. The 
results in the upper energy region for 147Gd and 149Gd were 27.9 ± 1.5 MBq/µAh and 
19.6 ± 1.0 MBq/µAh in the lower energy region. This corresponds to 81.7 % and 82.7 % of 
the theoretically calculated yields integrated over the same energy region. In the lower 
energy region 149Gd was produced with a thick target yield of 27.1 ± 1.4 MBq/µAh which 
corresponds to 81.1 % of its theoretically calculated integral yield. 
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A small amount of longer lived isotopic impurities of 151Gd and 153Gd was measured as 
0.79 ± 0.04  and 0.025 ± 0.003 MBq/µAh in the higher energy region and to be 1.8 ± 0.1 and 
0.037 ± 0.003 MBq/µAh in the lower energy region, respectively. This amounted to a 
maximum of produced isotopic impurities of 7 % in the examined energy regions. Therefore, 
the cross section determinations as well as the thick target yield measurements indicated the 
need of enriched Eu target material for the isotopically pure production of either 147Gd or 
149Gd due to overlapping excitation functions. However, the use of enriched Eu target 
material could be still more cost efficient than the previously proposed irradiation of highly 
enriched 144,147Sm with α- or 3He-particles due to the low availability of accelerators with 
exotic particles like 3He, the significantly lower natural abundance of Sm (144Sm nat. 
ab.: 3.07 %; 147Sm nat. ab.: 14.99 %) and the 3 to 6 times higher production of 147Gd in an 
actual proton irradiation of natural europium. 
A coarse separation of Gd from the macroscopic Eu target material was adapted from a 
previously developed Na-Hg amalgam extraction for the separation of Sm and Gd. The 
extraction time period, the europium mass and the amalgam mass of the available 
separation were optimised. The use of inert atmosphere was tested and proved to be 
beneficial for an optimised Eu extraction. The best extraction parameters for a 500 mg Eu2O3 
target pellet were found to be 10 mL of 0.4 wt% Na-Hg amalgam and an extraction time of 
20 min. The other parameters, namely the starting pH value of 2 and the buffer solution 
concentration of 0.4 M NaOAc and 1 M NaCl, were kept constant. A 99.92 % reduction of the 
Eu contamination down to 0.4 mg was achieved without loss of 147/149Gd. The necessary 
removal of excess sodium, chloride and acetate was easily achieved by extraction 
chromatography on DGA normal resin. The final product was a 0.5 mL aqueous solution of 
Gd ready for further processing. 
As proof of principle, the commercially available contrast agent DOTArem™ was 
radiolabelled with the prepared 147,149Gd, and its stability in water, phosphate buffered saline 
and human blood serum was assessed. A 5 min synthesis at 90°C was sufficient for 
complete labelling. In the stability tests, no ion leaching was observed with the n.c.a. or c.a. 
Gd-DOTA complexes over a time period of 6 d. Furthermore, the physiological distribution 
after injection of the complex into rats was compared with that of the commercial complex by 
respective in and ex vivo measurements of the tumour implanted brain with MRI and 
autoradiography. A similar distribution of both compounds in the brain of the rat was 
observed in the experiments. Different accumulations, however, were noticed in the necrotic 
regions of the tumour with the autoradiograms and the histologic images. Additionally, 
carrier-added administration of Gd-DOTA led to a nearly uniform distribution of radioactivity 
within the striatum in the tumour bearing hemisphere of the brain. The uniform distribution 
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may be explained by diffusion of the compound after sacrificing the animal and a lower 
detection limit of radioactivity in autoradiography. An extended animal study would be 
necessary to ascertain these artefacts. 
For manganese, the focus was on the β+-emitting radioisotope 52gMn. Integral and 
experimental thick target yields of this PET-suitable radioisotope were determined to be 
13.7 ± 1.6 and 13.1 ± 1.6 MBq/µAh, respectively, for the proton irradiation of natural 
chromium. A new chromatographic separation based on the elution of chromium with an 1:1 
acetic acid:methanol mixture from the anion exchange resin Amberlite CG400 was 
developed. The separation led to the elution of 52gMn in 2.1 mL of 3M hydrochloric acid. A 
feasible production route with an inexpensive, sturdy target material and a facile separation 
is thereby available, providing 52gMn more easily for experimental and PET studies. 
The resulting 52gMn was also successfully applied for a radioactive synthesis of the MnO 
nanoparticle precursor Mn(acac)2 with a radiochemical yield of 74 ± 5 % and a chemical yield 
of 79 ± 5 %. To develop a direct authentic labelling of water-dispersible MnO nanoparticles, 
literature synthesis routes of MnO nanoparticles were investigated. However, the available 
synthesis routes were far too time consuming, ranging from several hours to days, 
considering radiolabelling of MnO nanoparticles with the more PET-suitable, but shorter 
lived, 51Mn isotope. Thus, the use of a microwave supported system seemed promising. 
However, no successful synthesis for water-dispersible MnO nanoparticles with a microwave 
supported system was found. Results obtained were not reproducible, and the resulting 
dispersions were unstable. 
An activation of commercial, water-dispersible Mn3O4 nanoparticles with protons led to the 
production of 13N, the formation of larger structures (some of them crystalline), and the partial 
loss of water-dispersibility. On the other hand, neutron activation left the particles unaffected, 
and the successful determination of trace amounts of free Mn, using 56Mn, was shown in 
leaching studies. A maximal release of 2.1 ± 0.3 µg (0.033 ± 0.005 %) Mn after an incubation 
time period of 15 h in PBS was observed in a sample with 8.8 ± 0.7 mg of dispersed Mn3O4. 
In comparison to the toxicity of MnCl2 ∙ H2O by intraperitoneal injections in rats of 
LD50 = 138 mg/kg, the release of Mn from this nanoparticle dispersion is rather low which 
proves its leaching stability in solution. This shows the suitability of the neutron activation of 
water-dispersible nanoparticles for first stability tests over a time period of at least 15 h. This 
is a first indication that the leaching stability of Mn from Mn3O4-nanoparticles could by high 
enough to avoid the toxic effects of Mn when used as contrast agent. 
In conclusion, the presented investigations led to a facile and more efficient production of 
147,149Gd and also of 52gMn due to the enhancement of existing nuclear data and the 
development of optimised separation procedures. The radioisotopes are now available in a 
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5. Summary 
suitable chemical form for their subsequent use in isotopic labelling of MR contrast agents. 
The proof of principle application of a bimodal probe for in vivo distribution studies in rats 
showed the high potential of this isotopic labelling. Additionally, the radiochemical studies of 
manganese oxide nanoparticles provided a method to assess the ion leaching of 
nanoparticles with a low detection limit which is of high importance for future applications in 
vivo. 
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